Design Rules for the Nucleation, Growth, and Encapsulation of Gold Nanoparticles with Applications to Cancer Imaging by Wall, Matthew A
City University of New York (CUNY) 
CUNY Academic Works 
All Dissertations, Theses, and Capstone 
Projects Dissertations, Theses, and Capstone Projects 
2-2016 
Design Rules for the Nucleation, Growth, and Encapsulation of 
Gold Nanoparticles with Applications to Cancer Imaging 
Matthew A. Wall 
Graduate Center, City University of New York 
How does access to this work benefit you? Let us know! 
More information about this work at: https://academicworks.cuny.edu/gc_etds/778 
Discover additional works at: https://academicworks.cuny.edu 











DESIGN RULES FOR THE NUCLEATION, GROWTH, AND ENCAPSULATION OF 









A dissertation submitted to the Graduate Faculty in Chemistry in partial fulfillment of the 
























MATTHEW AARON WALL 




This manuscript has been read and accepted for the 
Graduate Faculty in Chemistry to satisfy the dissertation 


























Charles Michael Drain 
 
































DESIGN RULES FOR THE NUCLEATION, GROWTH, AND ENCAPSULATION OF 
GOLD NANOPARTICLES WITH APPLICATIONS TO CANCER IMAGING 
by 
Matthew A. Wall 
 
Advisors: 
Professors Moritz F. Kircher & Charles Michael Drain 
  
Surface-enhanced Raman scattering (SERS) nanoparticles are exciting candidates for 
high-precision cancer imaging due to their highly specific spectral signature (Raman 
“fingerprint”) and propensity for passive targeting of cancerous tissues. However, the 
signal intensity of currently available SERS nanoparticles is insufficient for cancer 
imaging via passive targeting in most solid tumors. The overarching aim of this body of 
work is to develop a new generation of SERS nanoparticles with sufficiently low limits of 
detection to enable robust detection of various solid tumors in vivo.  
 The optimization of SERS nanoparticle constructs requires significant advances to 
the theoretical and experimental understanding of metal nanoparticle syntheses and the 
methods of their encapsulation. In particular, the requirement that the Raman-active 
molecules adsorb to the metal nanoparticle for maximum surface enhancement 
necessitates nucleation, growth and encapsulation methods that maximize the potential 
for metal-molecule binding. This poses a substantial roadblock to overcoming the current 
 v 
limitations of SERS nanoparticle intensity, because metal nanoparticle syntheses rely 
upon surface-passivating surfactants or polymers to enable morphological control. 
Moreover, metal nanoparticles typically require priming of their surface with silicate or 
polymer layers to ensure successful encapsulation under high ionic strength (e.g., from 
the presence of Raman-active molecules and counterions). These challenges make the 
optimization of SERS nanoparticles a case study in the theoretical and experimental 
frontiers of nanoparticle engineering. 
 The following advancements will be presented in this dissertation: i) a new, 
generalized thermodynamic theory of crystal nucleation (chapter 2); ii) a new, 
generalized theory of shape-controlled crystal growth (chapter 3); iii) a theoretical and 
experimental description of encapsulation including a novel method for chelator-free 
radiolabeling (chapter 4); and iv) the in vivo results of the new generation of SERS 
nanoparticles in state-of-the-art orthotopic and transgenic mouse models. The generality 
of these findings extend beyond the scope of cancer imaging. Accordingly, context will 
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CHAPTER 1   
Introduction  
1.1 Introduction  
  Cancer is the second leading cause of death in the United States and its burden 
continues to increase (1). The complexity and heterogeneity of cancer requires that it be 
battled on every front, including research into preventative measures, early detection, 
proper diagnosis, improved resection, drug development and therapeutic monitoring, and 
prevention of recurrence (1-4). Success in these endeavors is often limited by the extent 
to which we can image pre-cancerous and cancerous tissue (5).   
  Ideal imaging techniques would demonstrate sufficient sensitivity and specificity 
to detect cancer on the scales of both solid tumors and single cells in vivo (6). The 
development of such sensitive techniques is exceptionally difficult, and has only recently 
become feasible as a result of innumerable researchers making revolutionary 
advancements across many generations. Given that there are tens to hundreds of trillions 
of cells in the average adult human body, searching for individual rogue cells must be 
done strategically, rather than by brute force (7). To that end, contrast agents have proved 
invaluable in the detection of cancer (5, 8-10).  
  The basic requirements of a contrast agent are that they accumulate in the region 
of interest (e.g., cancer), and have a detectable signal for an imaging instrument, which is 
often developed in parallel. For example, if a tissue of interest is known to exhibit 
particularly high glucose metabolism, then contrast agents for that tissue can be created 
by modifying glucose molecules to become detectable by specific instruments.  
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Substituting the 2’ hydroxyl of glucose with a radioactive isotope of fluorine (18F), for 
example, yields fluorodeoxyglucose – a molecule that accumulates in tissues with high 
glucose metabolism and can be detected via positron emission tomography (PET) (9). 
Arguably, the greatest challenge in contrast agent development is the dearth of biological 
properties sufficiently unique to a tissue or cell type to enable selective targeting in vivo  
(11).   
  One biological property that can be exploited in many cancers is the enhanced 
permeability and retention (EPR) effect. The EPR effect is a phenomenon typically 
attributed to porous vasculature (i.e., enhanced permeability) and impaired lymphatic 
drainage (i.e., enhanced retention) that allows macromolecules and nanoparticles to 
passively accumulate in cancerous tissue (12). Recent studies suggest that other, more 
active processes (e.g., macropinocytosis) may contribute to the mechanism of the EPR 
effect, but a comprehensive explanation remains elusive (6). Because the EPR effect is 
most pronounced for materials with nanoscale dimensions, nanoparticles have become 
widely investigated as potential contrast agents for cancer imaging (13-16).  
  
  Nanoparticles offer many routes to instrumental detection (17-21). Radioisotopes 
can be directly incorporated into nanoparticle structures or attached to nanoscale 
platforms via molecular chelators (22-25). Materials with high electron density or 
superparamagnetic properties can be used to provide computed tomography (CT) or 
magnetic resonance (MR) contrast, respectively (26-30). Semiconductor nanoparticles 
(i.e., quantum dots) can provide fluorescence contrast at tunable wavelengths by control 
of their composition (31, 32). Thus, nanoparticles have the necessary properties to serve 
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as a new generation of contrast agents, so long as they accumulate with sufficient 
concentrations in regions of interest to provide detectable signals.  
  
  One class of nanoparticle contrast agents – surface-enhanced Raman scattering 
(SERS) nanoparticles – has become an especially interesting candidate for intraoperative 
imaging (4, 33-35). SERS nanoparticles exhibit highly specific “fingerprint” spectra that 
are unambiguously identifiable by Raman detectors (33, 36-38). Furthermore, the 
“background” Raman spectrum of biological tissue is extremely weak compared to SERS 
nanoparticle signals, such that very high signal-to-noise ratios (SNR) are achievable (4, 
34, 39). The intravenous injection of SERS nanoparticles has been shown to enable 
accurate delineation of glioblastoma for high-precision intraoperative guidance during 
cancer resection (4). The nanoparticles used in that study did not demonstrate the same 
success outside of the brain, however, raising questions as to whether or not SERS 
nanoparticles could be broadly applied as effective contrast agents (40).  
  
  The overarching motivation of this body of work is the following hypothesis: If 
the sensitivity of SERS nanoprobes is sufficiently high, then they can be detected in 
cancerous tissues throughout the body. The basis of this hypothesis is that SERS 
nanoparticles are expected to accumulate in all solid tumors known to exhibit the EPR 
effect, which are not restricted to the brain (12, 15). The likely explanation for the 
absence of SERS contrast in these tissues is that the accumulated concentration of 
nanoparticles remains below the limit of Raman detection (41). Indeed, it is well 
established that the overwhelming majority of injected nanoparticles are filtered out of 
circulation by the reticuloendothelial system, so it is plausible that the SERS 
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nanoparticles are present at very low concentrations in tumors where their signal has not 
been detected (42). Increasing the SERS intensity per particle sufficiently could 
hypothetically make that same small concentration of nanoparticles detectable by a  
Raman scanner.  
  In order to identify methods by which the intensity of SERS nanoparticles can be 
substantially increased, we must first review the fundamentals of Raman scattering.    
  
1.2 Fundamental principles of Raman scattering  
  
  Oscillating electric fields induce oscillations in the electron clouds of molecules, 
referred to as induced dipoles (43). These oscillating electron clouds in turn generate 
light. The light so generated is referred to as scattered light, and the intensity of the 
scattered light is dependent upon the amplitude of the dipole oscillation (i.e. the 
amplitude of the electron cloud oscillation) (44).  
  The electric field vector, Eσ, of a photon is expressed in terms of a maximum 
amplitude, Eσ0, an oscillating frequency, ν0, and time, t:  
  
When a photon approaches a molecule from a direction, σ, the amplitude, Pρ, of the 
resulting induced dipole in the direction ρ is proportional to Eσ(45):  
𝑃⃑  𝜌 = 𝛼𝜌𝜎𝐸⃑  𝜎  
The proportionality relationship is defined by the polarizability, αρσ, which depends upon 
the relative orientations of the incident electric field and induced dipole. Thus, αρσ is a 
tensor of proportionality constants. The polarizability tensor is a function of the normal 
coordinates (i.e., relative positions of the atoms in a molecule), Qk, of the molecule and 
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the magnitude of αρ will vary for certain normal modes as the molecule vibrates (44, 45). 
Since the polarizability is a function of the normal coordinates, it can be expressed as a  
Taylor series about the equilibrium value of αρσ. As a simplification, which holds well for 
relatively small nuclear displacements, the Taylor series can be approximated by the first 
two terms(45):  
  
  
The normal mode coordinate Qk has a corresponding vibrational frequency, νk, such that 
it varies over time according to:  
𝑄𝑘 = 𝑄𝑘0cos(2𝜋𝜈𝑘𝑡)  
Combining all of the equations above reveals that the time-dependent expression for the 
induced dipole is given by:  
  
Applying the trigonometric identity cos(a)cos(b) = (1/2)[cos(a + b) + cos(a – b)] yields 
the classic form of the induced dipole expression(43-45):  
  
  This equation demonstrates that incident photons will induce a dipole in a 
molecule’s electron cloud which can oscillate, and therefore produce scattered light, at 
three frequencies: ν0, ν0 – νk, and ν0 + νk. Oscillation at the first of these frequencies 
generates elastically, or Rayleigh, scattered light, while oscillation at either of the shifted 
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frequencies produces inelastically, or Raman, scattered light. The lower-frequency 
inelastic scattering is referred to as Stokes scattering and the higher-frequency inelastic 
scattering is called Anti-Stokes scattering (45).  
The intensity, IR, of Raman scattered light is expressed as a function of the 
incident laser intensity, IL, the speed of light, c, the angular frequency of the k
th normal 
vibrational mode, ωk = 2πνk, and the polarizability tensor (46):  
  
1.3 Strategies for increasing the intensity of Raman scattering  
  
The intensity of Raman scattering can be increased by either increasing the total number 
of scattering events or increasing the percentage of total scattering events that generate 
Raman photons. The total number of scattering events is proportional to the intensity of 
the incident electromagnetic field (e.g., the incident laser intensity), such that larger fields 
yield more scattering events. Control of Raman scattering efficiency, however, is a more 
subtle matter.   
  The Raman scattering efficiency will be greatest near an electronic resonance  
(45). Conceptually, this occurs because the lifetime of the “virtual” excited state that 
precedes emission of scattered light is significantly increased at excitation frequencies. 
Because of this longer excitation, the initial and final nuclear coordinates (i.e., relative 
atomic positions within the molecule) become further displaced than they would have for 
a non-resonant molecule (i.e. the nuclei have more time to move before the virtual state 
relaxes). This large change in nuclear coordinates results in a shift in the favored 
vibrational state to which the virtual excited state relaxes, as described by the 
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FranckCondon principle. Thus, molecules with an electronic resonance at an incident 
laser wavelength will yield more intense Raman scattering than molecules without 
electronic resonances at the incident wavelength.  
In order to achieve enhancements to Raman scattering exceeding a few orders of 
magnitude, the local electromagnetic field and polarizability tensor must be dramatically 
increased (47). In order for this to occur, molecules would have to electronically couple 
to a system that has very high polarizability. The prototypical example this phenomenon 
is surface-enhanced Raman scattering by noble metal nanoparticles (37, 48-50).   The 
high polarizability of noble metals originates in their electron structure. The electron 
density in noble metals is so large that their Hamiltonian is dominated by electron-
electron repulsion, driving the electrons to align in a lattice (51). When part of the 
electron lattice is exposed to an incident electric field, a force is exerted on the electrons 
that displaces them from their local equilibrium positions (52). This displacement 
propagates throughout the electron lattice in a fashion analogous to phonons moving 
through a crystal lattice (53). The collective oscillation of electrons is called a plasmon.   
  When the dimensions of a noble metal nanoparticle are smaller than the 
wavelength of an incident photon, the plasmons generated rapidly propagate from one 
end of the nanoparticle to the other. The net effect of this concerted motion is an 
oscillating surface charge, called a localized surface plasmon (LSP), which generates 
very large electromagnetic fields at the nanoparticle surface (52). The optical extinction 
of the nanoparticle exhibits a maximum at the plasmon resonance frequency, which is a 
sensitive function of the nanoparticles shape and size (52, 53). Accordingly, noble metal 
nanoparticles can be rationally synthesized such that they act as optical antennas for a 
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given frequency of light (e.g., near-infrared light), effectively concentrating incident 
electromagnetic fields from laser sources onto their surfaces (54, 55).   
When molecules adsorb to noble metal nanoparticles, their Raman scattering 
exhibits resonances at the molecular electronic transition, the metal-molecule 
chargetransfer transition, and the localized surface plasmon resonance (46, 47, 50). The 
conceptual explanation for the large Raman intensity at molecular electronic and charge 
transfer transitions is the increased Raman scattering efficiency that occurs for 
longerlived excited state lifetimes. The surface plasmon resonance yields increased 
intensity of Raman scattering by greatly increasing the number of scattering events (i.e., 
the surface electromagnetic field is increased). When all three of these resonances 
overlap, the largest possible enhancement to Raman scattering is achieved (50). Thus, 
Raman-active molecules with electronic transitions at the incident laser wavelength 
should be combined with nanoparticles that have been optimized for electric field 
enhancement in order to generate optimal metal-molecule interfaces.  
  The final step toward maximizing the intensity of Raman scattering is to optimize 
the number of dye molecules at the surface of the nanoparticle. Synthetic methods that 
passivate the nanoparticle surface will inhibit metal-molecule coupling, thus preventing 
the optimal surface concentration of resonant dye molecules from be achieved. In other 
words, if the synthetic methods used to control nanoparticle growth or encapsulation 
block surface binding sites for resonant dye molecules, the optimal Raman intensity 
cannot be achieved. Accordingly, metal nanoparticle syntheses that employ surfactants or 
polymers, and encapsulation procedures that require surface primers (i.e., surface 
coatings that render a substrate more amenable to encapsulation) are undesirable. 
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Because the existing shape-controlled metal nanoparticle syntheses require the use of 
surfactant or polymer “shape-directing agents,” a new approach to controlling the 
morphology of nanoparticles is required for the development of optimized SERS 
nanoparticles (56, 57).  
  
1.4 Concluding remarks  
  
  The subsequent chapters and appendices present literature summaries and novel 
theoretical and experimental findings on nanoparticle nucleation, growth, and 
encapsulation.  The intention of this work is to review the contemporary understanding 
and practices of these fields, highlight their strengths and weaknesses, and provide new 
solutions to overcome their critical limitations. The theoretical and experimental 
advances presented in this dissertation enabled the development of a new generation of 
SERS nanoparticles with unprecedented limits of detection (6, 58). The utility of these 
nanoparticles for in vivo cancer imaging has been evaluated in state-of-the-art orthotopic 
and transgenic cancer models (6). The published results of this study can be found in 
reference 6 of this chapter.  
    
1.5 References  
1. Siegel RL, Miller KD, Jemal A. Cancer Statistics, 2015. Ca-Cancer J Clin.  
2015;65(1):5-29. doi: 10.3322/caac.21254. PubMed PMID: 
WOS:000347966900003.  
2. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global Cancer 
Statistics. Ca-Cancer J Clin. 2011;61(2):69-90. doi: 10.3322/caac.20107. PubMed 
PMID: WOS:000288278400004.  
3. Gambhir SS. Molecular imaging of cancer with positron emission tomography.  
Nature Reviews Cancer. 2002;2(9):683-93. doi: 10.1038/nrc882. PubMed PMID: 
WOS:000180447400014.  
4. Kircher MF, de la Zerda A, Jokerst JV, Zavaleta CL, Kempen PJ, Mittra E, Pitter  
  10  
K, Huang RM, Campos C, Habte F, Sinclair R, Brennan CW, Mellinghoff IK, 
Holland EC, Gambhir SS. A brain tumor molecular imaging strategy using a new 
triple-modality MRI-photoacoustic-Raman nanoparticle. Nature Medicine.  
2012;18(5):829-U235. doi: 10.1038/nm.2721. PubMed PMID: 
WOS:000303763500053.  
5. Kircher MF, Hricak H, Larson SM. Molecular imaging for personalized cancer 
care. Molecular Oncology. 2012;6(2):182-95. doi: 10.1016/j.molonc.2012.02.005. 
PubMed PMID: WOS:000304632000008.  
6. Harmsen S, Huang RM, Wall MA, Karabeber H, Samii JM, Spaliviero M, White  
JR, Monette S, O'Connor R, Pitter KL, Sastra SA, Saborowski M, Holland EC, 
Singer S, Olive KP, Lowe SW, Blasberg RG, Kircher MF. Surface-enhanced 
resonance Raman scattering nanostars for high-precision cancer imaging. Sci 
Transl Med. 2015;7(271):11. doi: 10.1126/scitranslmed.3010633. PubMed PMID: 
WOS:000348353900004.  
7. Bianconi E, Piovesan A, Facchin F, Beraudi A, Casadei R, Frabetti F, Vitale L, 
Pelleri MC, Tassani S, Piva F, Perez-Amodio S, Strippoli P, Canaider S. An 
estimation of the number of cells in the human body. Annals of Human Biology.  
2013;40(6):463-71. doi: 10.3109/03014460.2013.807878. PubMed PMID: 
WOS:000327259600001.  
8. Caravan P, Ellison JJ, McMurry TJ, Lauffer RB. Gadolinium(III) chelates as MRI 
contrast agents: Structure, dynamics, and applications. Chem Rev.  
1999;99(9):2293-352. doi: 10.1021/cr980440x. PubMed PMID: 
WOS:000082569800006.  
9. Gambhir SS, Czernin J, Schwimmer J, Silverman DHS, Coleman RE, Phelps ME.  
A tabulated summary of the FDG PET literature. Journal of Nuclear Medicine. 
2001;42(5):1S-93S. PubMed PMID: WOS:000168669400001.  
10. Weissleder R. Molecular imaging in cancer. Science. 2006;312(5777):1168-71. 
doi: 10.1126/science.1125949. PubMed PMID: WOS:000237957400040.  
11. Rifai N, Gillette MA, Carr SA. Protein biomarker discovery and validation: the 
long and uncertain path to clinical utility. Nature Biotechnology. 
2006;24(8):97183. doi: 10.1038/nbt1235. PubMed PMID: 
WOS:000239702300038.  
12. Maeda H, Nakamura H, Fang J. The EPR effect for macromolecular drug delivery 
to solid tumors: Improvement of tumor uptake, lowering of systemic toxicity, and  
distinct tumor imaging in vivo. Adv Drug Deliver Rev. 2013;65(1):71-9. doi:  
10.1016/j.addr.2012.10.002. PubMed PMID: WOS:000315547400011.  
13. C. Kaittanis TMS, D. L. Thorek, & J. Grimm. Dawn of Advanced Molecular 
Medicine: Nanotechnological Advancements in Cancer Imaging and Therapy. 
Critical Reviews in Oncogenesis. 2014(19):143-76.  
14. Brigger I, Dubernet C, Couvreur P. Nanoparticles in cancer therapy and 
diagnosis. Adv Drug Deliver Rev. 2002;54(5):631-51. doi: Pii 
S0169409x(02)00044-3  
Doi 10.1016/S0169-409x(02)00044-3. PubMed PMID: ISI:000178148600003.  
  11  
15. Danhier F, Feron O, Preat V. To exploit the tumor microenvironment: Passive and 
active tumor targeting of nanocarriers for anti-cancer drug delivery. Journal of 
Controlled Release. 2010;148(2):135-46. doi: 10.1016/j.jconrel.2010.08.027. 
PubMed PMID: WOS:000285662000003.  
16. Albanese A, Tang PS, Chan WCW. The Effect of Nanoparticle Size, Shape, and 
Surface Chemistry on Biological Systems. In: Yarmush ML, editor. Annual 
Review of Biomedical Engineering, Vol 14. Palo Alto: Annual Reviews; 2012. p. 
1-16.  
17. Nie SM, Xing Y, Kim GJ, Simons JW. Nanotechnology applications in cancer.   
Annual Review of Biomedical Engineering. Palo Alto: Annual Reviews; 2007. p. 
257-88.  
18. Cheon J, Lee JH. Synergistically Integrated Nanoparticles as Multimodal Probes 
for Nanobiotechnology. Accounts Chem Res. 2008;41(12):1630-40. doi:  
10.1021/ar800045c. PubMed PMID: WOS:000261767600008.  
19. Huang XH, El-Sayed IH, Qian W, El-Sayed MA. Cancer cell imaging and 
photothermal therapy in the near-infrared region by using gold nanorods. J Am 
Chem Soc. 2006;128(6):2115-20. doi: 10.1021/ja057254a. PubMed PMID: 
WOS:000235452200054.  
20. Zhou J, Liu Z, Li FY. Upconversion nanophosphors for small-animal imaging.  
Chem Soc Rev. 2012;41(3):1323-49. doi: 10.1039/c1cs15187h. PubMed PMID: 
WOS:000299176700018.  
21. Kim J, Piao Y, Hyeon T. Multifunctional nanostructured materials for multimodal 
imaging, and simultaneous imaging and therapy. Chem Soc Rev. 
2009;38(2):37290. doi: 10.1039/b709883a. PubMed PMID: 
WOS:000264374600006.  
22. Zhou M, Zhang R, Huang MA, Lu W, Song SL, Melancon MP, Tian M, Liang D,  
Li C. A Chelator-Free Multifunctional Cu-64 CuS Nanoparticle Platform for  
Simultaneous Micro-PET/CT Imaging and Photothermal Ablation Therapy. J Am 
Chem Soc. 2010;132(43):15351-8. doi: 10.1021/ja106855m. PubMed PMID: 
WOS:000283621700049.  
23. Goel S, Chen F, Ehlerding EB, Cai W. Intrinsically Radiolabeled Nanoparticles:  
An Emerging Paradigm. Small. 2014. Epub 2014/07/01. doi:  
10.1002/smll.201401048. PubMed PMID: 24978934.  
24. de Barros AB, Tsourkas A, Saboury B, Cardoso VN, Alavi A. Emerging role of 
radiolabeled nanoparticles as an effective diagnostic technique. EJNMMI 
research. 2012;2(1):39. Epub 2012/07/20. doi: 10.1186/2191-219X-2-39. PubMed 
PMID: 22809406; PMCID: 3441881.  
25. Wadas TJ, Wong EH, Weisman GR, Anderson CJ. Coordinating Radiometals of 
Copper, Gallium, Indium, Yttrium, and Zirconium for PET and SPECT Imaging 
of Disease. Chem Rev. 2010;110(5):2858-902. doi: Doi 10.1021/Cr900325h. 
PubMed PMID: ISI:000277811600012.  
26. Lee JH, Huh YM, Jun Y, Seo J, Jang J, Song HT, Kim S, Cho EJ, Yoon HG, Suh 
JS, Cheon J. Artificially engineered magnetic nanoparticles for ultra-sensitive 
  12  
molecular imaging. Nature Medicine. 2007;13(1):95-9. doi: 10.1038/nm1467. 
PubMed PMID: WOS:000243301800042.  
27. Sun C, Lee JSH, Zhang MQ. Magnetic nanoparticles in MR imaging and drug 
delivery. Adv Drug Deliver Rev. 2008;60(11):1252-65. doi: 
10.1016/j.addr.2008.03.018. PubMed PMID: WOS:000258313900004.  
28. Popovtzer R, Agrawal A, Kotov NA, Popovtzer A, Balter J, Carey TE, Kopelman 
R. Targeted Gold Nanoparticles Enable Molecular CT Imaging of Cancer. Nano 
Lett. 2008;8(12):4593-6. doi: 10.1021/nl8029114. PubMed PMID: 
WOS:000261630700087.  
29. Kircher MF, Willmann JK. Molecular Body Imaging: MR Imaging, CT, and US.  
Part I. Principles. Radiology. 2012;263(3):633-43. doi: 10.1148/radiol.12102394. 
PubMed PMID: WOS:000304416900004.  
30. Kircher MF, Willmann JK. Molecular Body Imaging: MR Imaging, CT, and US. 
Part II. Applications. Radiology. 2012;264(2):349-68. doi:  
10.1148/radiol.12111703. PubMed PMID: WOS:000306660000007.  
31. Michalet X, Pinaud FF, Bentolila LA, Tsay JM, Doose S, Li JJ, Sundaresan G, 
Wu AM, Gambhir SS, Weiss S. Quantum dots for live cells, in vivo imaging, and 
diagnostics. Science. 2005;307(5709):538-44. doi: 10.1126/science.1104274. 
PubMed PMID: WOS:000226694000036.  
32. Medintz IL, Uyeda HT, Goldman ER, Mattoussi H. Quantum dot bioconjugates 
for imaging, labelling and sensing. Nature Materials. 2005;4(6):435-46. doi:  
10.1038/nmat1390. PubMed PMID: WOS:000229502700008.  
33. Wang YQ, Yan B, Chen LX. SERS Tags: Novel Optical Nanoprobes for 
Bioanalysis. Chem Rev. 2013;113(3):1391-428. doi: 10.1021/cr300120g. PubMed 
PMID: WOS:000316243600003.  
34. Andreou C, Kishore SA, Kircher MF. Surface-Enhanced Raman Spectroscopy: A 
New Modality for Cancer Imaging. Journal of Nuclear Medicine.  
2015;56(9):1295-9. doi: 10.2967/jnumed.115.158196. PubMed PMID: 
WOS:000361153000008.  
35. Vendrell M, Maiti KK, Dhaliwal K, Chang YT. Surface-enhanced Raman 
scattering in cancer detection and imaging. Trends in Biotechnology.  
2013;31(4):249-57. doi: 10.1016/j.tibtech.2013.01.013. PubMed PMID: 
WOS:000317457900008.  
36. Qian XM, Nie SM. Single-molecule and single-nanoparticle SERS: from 
fundamental mechanisms to biomedical applications. Chem Soc Rev.  
2008;37(5):912-20. doi: 10.1039/b708839f. PubMed PMID: 
WOS:000255444700004.  
37. Nie SM, Emery SR. Probing single molecules and single nanoparticles by 
surface-enhanced Raman scattering. Science. 1997;275(5303):1102-6. doi:  
10.1126/science.275.5303.1102. PubMed PMID: WOS:A1997WJ50300037.  
38. Zavaleta CL, Kircher MF, Gambhir SS. Raman's "Effect" on Molecular Imaging. 
Journal of Nuclear Medicine. 2011;52(12):1839-44. doi:  
10.2967/jnumed.111.087775. PubMed PMID: WOS:000298162500016.  
  13  
39. Qian XM, Peng XH, Ansari DO, Yin-Goen Q, Chen GZ, Shin DM, Yang L, 
Young AN, Wang MD, Nie SM. In vivo tumor targeting and spectroscopic 
detection with surface-enhanced Raman nanoparticle tags. Nature Biotechnology.  
2008;26(1):83-90. doi: 10.1038/nbt1377. PubMed PMID: 
WOS:000252222500027.  
40. Kircher MF. Personal communication with the manuscript's first author.  
41. Jain RK, Stylianopoulos T. Delivering nanomedicine to solid tumors. Nature 
Reviews Clinical Oncology. 2010;7(11):653-64. doi: 10.1038/nrclinonc.2010.139. 
PubMed PMID: WOS:000283573400010.  
42. Decuzzi P, Godin B, Tanaka T, Lee SY, Chiappini C, Liu X, Ferrari M. Size and 
shape effects in the biodistribution of intravascularly injected particles. Journal of 
Controlled Release. 2010;141(3):320-7. doi: 10.1016/j.jconrel.2009.10.014. 
PubMed PMID: WOS:000275569600007.  
43. Long DA. Raman Spectroscopy: McGraw-Hill International Book Company; 
1977.  
44. Colthup N, B.; Daly, L. H.; Wiberley, S. E. Introduction to Infrared and Raman 
Spectroscopy: Academic Press; 1990.  
45. Long DA. The Raman Effect: John Wiley & Sons Ltd.; 2002.  
46. Lombardi JR, Birke RL. A unified approach to surface-enhanced Raman 
spectroscopy. Journal of Physical Chemistry C. 2008;112(14):5605-17. doi:  
10.1021/jp800167v. PubMed PMID: WOS:000254710800052.  
47. Lombardi JR, Birke RL. A Unified View of Surface-Enhanced Raman Scattering. 
Accounts Chem Res. 2009;42(6):734-42. doi: 10.1021/ar800249y. PubMed 
PMID: WOS:000267049000006.  
48. Lee PC, Meisel D. ADSORPTION AND SURFACE-ENHANCED RAMAN OF 
DYES ON SILVER AND GOLD SOLS. Journal of Physical Chemistry.  
1982;86(17):3391-5. doi: 10.1021/j100214a025. PubMed PMID: 
WOS:A1982PC66700025.  
49. Campion A, Kambhampati P. Surface-enhanced Raman scattering. Chem Soc 
Rev. 1998;27(4):241-50. doi: 10.1039/a827241z. PubMed PMID: 
WOS:000075103200002.  
50. Lombardi JR, Birke RL. The theory of surface-enhanced Raman scattering. 
Journal of Chemical Physics. 2012;136(14):11. doi: 10.1063/1.3698292. PubMed 
PMID: WOS:000303146800048.  
51. Pines D, Bohm D. A COLLECTIVE DESCRIPTION OF ELECTRON  
INTERACTIONS .2. COLLECTIVE VS INDIVIDUAL PARTICLE ASPECTS 
OF THE INTERACTIONS. Physical Review. 1952;85(2):338-53. doi:  
10.1103/PhysRev.85.338. PubMed PMID: WOS:A1952UB40100025.  
52. Willets KA, Van Duyne RP. Localized surface plasmon resonance spectroscopy 
and sensing.  Annual Review of Physical Chemistry. Palo Alto: Annual Reviews; 
2007. p. 267-97.  
53. Pitarke JM, Silkin VM, Chulkov EV, Echenique PM. Theory of surface plasmons 
and surface-plasmon polaritons. Reports on Progress in Physics. 2007;70(1):1-87.  
doi: 10.1088/0034-4885/70/1/r01. PubMed PMID: WOS:000243752100001.  
  14  
54. Kelly KL, Coronado E, Zhao LL, Schatz GC. The optical properties of metal 
nanoparticles: The influence of size, shape, and dielectric environment. Journal of 
Physical Chemistry B. 2003;107(3):668-77. doi: 10.1021/jp026731y. PubMed 
PMID: WOS:000180545300005.  
55. Jain PK, Lee KS, El-Sayed IH, El-Sayed MA. Calculated absorption and 
scattering properties of gold nanoparticles of different size, shape, and 
composition: Applications in biological imaging and biomedicine. Journal of 
Physical Chemistry B. 2006;110(14):7238-48. doi: 10.1021/jp057170o. PubMed 
PMID: WOS:000236772900027.  
56. Murphy CJ, San TK, Gole AM, Orendorff CJ, Gao JX, Gou L, Hunyadi SE, Li T.  
Anisotropic metal nanoparticles: Synthesis, assembly, and optical applications.  
Journal of Physical Chemistry B. 2005;109(29):13857-70. doi:  
10.1021/jp0516846. PubMed PMID: WOS:000230698100005.  
57. Xia YN, Xiong YJ, Lim B, Skrabalak SE. Shape-Controlled Synthesis of Metal 
Nanocrystals: Simple Chemistry Meets Complex Physics? Angew Chem Int Edit.  
2009;48(1):60-103. doi: 10.1002/anie.200802248. PubMed PMID: 
WOS:000262420700006.  
58. Harmsen S, Bedics MA, Wall MA, Huang RM, Detty MR, Kircher MF. Rational 
design of a chalcogenopyrylium-based surface-enhanced resonance Raman 
scattering nanoprobe with attomolar sensitivity. Nat Commun. 2015;6:9. doi:  
10.1038/ncomms7570. PubMed PMID: WOS:000352720700005.  
  
 15 
CHAPTER 2  
 
Nucleation in Solution 
 
2.0 List of variables and constants 
 
G................................................................................................................Gibbs free energy 
Qr...............................................................................................................Reaction quotient 
Keq........................................................................................................Equilibrium constant 
dG........................................................................Infinitesimal change in Gibbs free energy 
R.........................................................................................................Universal gas constant 
T...........................................................................................................Absolute temperature 
Ccryst......................................................................Concentration of crystalline growth units 
Csolv..........................................................................Concentration of solvated growth units 
a(Ccryst)...........................................................................Activity of crystalline growth units 
a(Csolv)...............................................................................Activity of solvated growth units 
Ceq...................................................................................Solubility of solvated growth units 
NA...........................................................................................................Avogadro’s number 
κ...........................................................................................................Boltzmann’s constant 
σ.................................................................................................Specific surface free energy 
A.........................................................................................................................Surface area 
V................................................................................................................................Volume 
Gvol......................................................................Volume contribution to Gibbs free energy 
Gsurf......................................................................Surface contribution to Gibbs free energy 
μ...............................................................................................................Chemical potential 
P................................................................................................................................Pressure 





Ω.........................................................................Volume of a single crystalline growth unit 
n...................................................................Number of growth units in a crystal or nucleus 
r...............................................................................Radius of a spherical crystal or nucleus 
n*...........................................................................................................Critical nucleus size 
r*.....................................................................................................................Critical radius 
W(n)..............................................................Work of formation to create nucleus of size n 
W(n*)..............................................................................................Critical nucleation work 
C0...........................................................................................Concentration nucleation sites 




β.................................................................................................Monomer impingement rate 
D...............................................................................................................Diffusion constant 
x.................Stoichiometric coefficient of crystal precipitate in balanced chemical reaction 
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E..............................................................................................................Reduction potential 





 In this chapter, the essential concepts of classical nucleation theory (CNT) will be 
developed and applied to the study of gold nanoparticles (sections 2.2 – 2.11). It will be 
observed that the nucleation of gold nanoparticles is forbidden according to CNT (section 
2.11). A generalized nucleation theory (GNT) will be presented that corrects a critical 
oversight in CNT (sections 2.12 – 2.21). In particular, the GNT presented here models the 
nucleation of crystals from arbitrary reactants, in contrast to CNT, which cannot account 
for crystal formation as the result of a chemical reaction. A prototypical gold nanoparticle 
synthesis will be analyzed in the context of the GNT and the experimental observations 
will be explained by the new theory (sections 2.18 – 2.21). 
 
2.2 Background  
 
 The laws of thermodynamics describe the evolution of systems in terms of energy 
(1-3). In chemistry, the concept of free energy, particularly Gibbs free energy, G, is 
essential to the study of how systems will change over time. Free energy is a measure of 
the amount of energy that a system has available to transfer to another system. In the 
particular case that the system is held to constant temperature and pressure, the free 
energy is referred to as Gibbs free energy (3).  
 A system evolves as a result of thermodynamic driving forces (4, 5). The 
thermodynamic driving force of a chemical reaction or phase transformation is the 
minimization of free energy. That is, as a system changes states, it will tend toward the 
state of lowest energy. According to the principle of detailed balance, this state is 
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achieved when all reversible processes are in equilibrium (6, 7). The thermodynamic 
driving force can be quantitatively expressed in terms of a reaction quotient and 
equilibrium constant (1-3). For the general chemical equilibrium characterized by the 
equation: 
𝑎𝐴 + 𝑏𝐵 +⋯ ⇌ 𝑥𝑋 + 𝑦𝑌 +⋯ 





Where the lowercase letters a, b, x, and y are the stoichiometric coefficients 
corresponding to the chemical species A, B, X, and Y involved in the equilibrium reaction, 
and the angular brackets denote the chemical activity of the species. When all species 
exist in their equilibrium proportions, the reaction quotient is referred to as the 










 In order to predict the most energetically favorable evolution of a system it is 
necessary to have a measure of how far a reaction is from equilibrium. The measure used 
by chemists is the infinitesimal change in free energy, dG, with respect to an infinitesimal 
change in the chemical composition of the system: 




The subscript molar indicates that the change in free energy is given on the molar scale 
(i.e., the units of reactants and products are moles). When the value of dG is negative, 
there is a driving force to increase the concentration of products, and when it is positive, 
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there is a driving force to decrease the concentration of products. Thus, when dG is 
negative there is a thermodynamic driving force to produce more products. 
 
2.3 Driving Force for Crystallization  
 
 When a crystalline substance is placed into a solvent, a driving force is 
established for the crystalline substance to reach equilibrium with its solvated state (3, 8-
12). If we denote the concentration of the crystalline substance by Ccryst and the 
concentration of the solvated substance by Csolv, then the phase equilibration reaction is 
given by: 
𝐶𝑐𝑟𝑦𝑠𝑡 ⇌ 𝐶𝑠𝑜𝑙𝑣 





In this expression, a(Csolv) and a(Ccryst) are the activities of the solvated and crystalline 
substance. When determining the activity, we treat all crystalline growth units as fully 
coordinated (i.e., they have no broken bonds) such that they are in their most stable state. 
This is an approximation because the surface growth units are not fully coordinated. In 
CNT, this approximation is corrected by adding a surface energy term at the end of the 
derivation. The activity of the crystalline growth units thus equals 1 by definition (i.e., 
they are in the most stable state), and the activity of the solvated substance is assumed to 
equal its concentration (11, 13). This assumption tends to be a good approximation 
because the concentrations encountered in typical crystallization studies are small enough 
to exhibit ideal behavior (10, 13). The reaction quotient is therefore described by the 
equation: 
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𝑄𝑟 = 𝐶𝑠𝑜𝑙𝑣 
At equilibrium, the reaction quotient is equal to the equilibrium constant, Keq, and the 
solvated substance takes its equilibrium concentration, Ceq, called the solubility: 
𝐾𝑒𝑞 = 𝐶𝑒𝑞 
 The thermodynamic driving force for crystal dissolution is given by substituting 
the values for Qr and Keq into the equation for the infinitesimal change in free energy on 
the molar scale, dGmolar: 








We say that the right-hand and left-hand sides of these expressions are almost equal 
because we are still neglecting the surface energy contributions.  
 When considering the formation of crystals, the solvated growth units will be 
treated as reactants and the crystalline growth units will be products. Accordingly, the 
expression for the change in free energy will be the opposite of the expression for 
dissolution of crystals: 




 Note that the expressions for the change in free energy derived thus far are on the 
molar scale. This is counterintuitive considering that we are considering infinitesimal 
changes. In practice, we are actually describing the infinitesimal change in free energy 
with respect to a single reaction and then scaling that change by Avogadro’s number, NA. 
The change in free energy on the scale of a single reaction dissolution or formation 
 20 
reaction is given by replacing the universal gas constant, R, with Boltzmann’s constant, κ 
= R/NA: 








Before we can apply these expressions to crystallization processes, we have to correct for 
the approximation that all crystalline growth units are fully coordinated. We define the 
quantity σ to be the specific surface free energy (i.e., the excess free energy per unit 
surface area) such that addition of the term d(σA) makes the following equations exact: 
𝑑𝐺𝑑𝑖𝑠𝑠𝑜𝑙𝑢𝑡𝑖𝑜𝑛 = 𝜅𝑇𝑙𝑛 (
𝐶𝑠𝑜𝑙𝑣
𝐶𝑒𝑞
) + 𝑑(𝜎𝐴) 
𝑑𝐺𝑓𝑜𝑟𝑚𝑎𝑡𝑖𝑜𝑛 = −𝜅𝑇𝑙𝑛 (
𝐶𝑠𝑜𝑙𝑣
𝐶𝑒𝑞
) + 𝑑(𝜎𝐴) 
In order to develop an intuition for the nucleation of crystals, we must further evaluate 
these free energy terms. 
 
2.4 Free Energy of Crystallization System 
 
 The total free energy of the system, G, is the sum of the free energy of all 
components within the system. We express the total free energy as the sum of the free 
energy of the crystalline substance, Gcryst, the solvated substance, Gsolv, and all other 
contributions not involved in the crystallization process, ΣGi: 
 





The free energy of the crystal will vary depending upon its shape and size (8, 9). In fact, 
changes in geometry will change the value of Gcryst even if the number of atoms remains 
constant (14-17). This variability comes from the surface energy of the crystal. As shown 
in section 2.3, we describe the total free energy of the crystalline substance as the sum of 
a volume free energy (i.e., perfect coordination assumption) and a surface free energy: 
𝐺𝑐𝑟𝑦𝑠𝑡 = 𝐺𝑣𝑜𝑙 + 𝐺𝑠𝑢𝑟𝑓 
 
𝐺𝑠𝑢𝑟𝑓 = 𝜎𝐴 
 




 The free energy of substances undergoing phase transitions or chemical reactions 
is described in terms of chemical potential. The chemical potential, μi, of a substance, i, is 
equal to the change in free energy that results from exclusively changing the amount, Ni, 








The subscripts T, P, and Nj≠i, mean that the temperature, pressure, and concentration of 
all other substances are constant when defining μi. 
 The chemical potentials of crystalline and solvated growth units have an 
important relationship in nucleation theory. In order to illustrate this, we recall that the 
first law of thermodynamics relates the internal energy, U, the temperature, T, the 
entropy, S, the pressure, P, the volume, V, the chemical potentials of species i, μi, and the 
amount of species i, Ni, the specific surface free energy, σ, and the crystalline surface 
area, A, using exact differentials as: 
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𝑑𝑈 = 𝑇𝑑𝑆 − 𝑃𝑑𝑉 +∑𝜇𝑖𝑑𝑁𝑖
𝑖
+ 𝑑(𝜎𝐴) 
Rearrangement of this equation yields: 
𝑇𝑑𝑆 = 𝑑𝑈 + 𝑃𝑑𝑉 −∑𝜇𝑖𝑑𝑁𝑖
𝑖
− 𝑑(𝜎𝐴) 
Substitution of the identities d(TS) = TdS + SdT and d(PV) = PdV + VdP gives: 
𝑑(𝑇𝑆) − 𝑆𝑑𝑇 = 𝑑𝑈 + 𝑑(𝑃𝑉) − 𝑉𝑑𝑃 −∑𝜇𝑖𝑑𝑁𝑖
𝑖
− 𝑑(𝜎𝐴) 
𝑉𝑑𝑃 − 𝑆𝑑𝑇 +∑𝜇𝑖𝑑𝑁𝑖
𝑖
+ 𝑑(𝜎𝐴) = 𝑑𝑈 + 𝑑(𝑃𝑉) − 𝑑(𝑇𝑆) 
𝑑(𝑈 − 𝑇𝑆 + 𝑃𝑉) = 𝑉𝑑𝑃 − 𝑆𝑑𝑇 +∑𝜇𝑖𝑑𝑁𝑖
𝑖
+ 𝑑(𝜎𝐴) 
 The definition of Gibbs free energy, G, is G = U – TS + PV. Substitution of this 
identity gives: 
𝑑𝐺 = 𝑉𝑑𝑃 − 𝑆𝑑𝑇 +∑𝜇𝑖𝑑𝑁𝑖
𝑖
+ 𝑑(𝜎𝐴) 
 Now, consider a closed system at constant temperature and pressure containing 
growth units that either exist in solvated or crystalline form. If we consider the phase 
transition between solvated and crystalline states where the amount of all other chemical 
species remains constant, then we have: 
𝑑𝐺 = 𝜇𝑐𝑟𝑦𝑠𝑡𝑑𝑁𝑐𝑟𝑦𝑠𝑡 + 𝜇𝑠𝑜𝑙𝑣𝑑𝑁𝑠𝑜𝑙𝑣 + 𝑑(𝜎𝐴) 
Because the system is closed, the total amount of growth units remains constant. 
Accordingly, we have: 
𝑑𝑁𝑠𝑜𝑙𝑣 = −𝑑𝑁𝑐𝑟𝑦𝑠𝑡 
𝑑𝐺 = 𝜇𝑐𝑟𝑦𝑠𝑡𝑑𝑁𝑐𝑟𝑦𝑠𝑡 − 𝜇𝑠𝑜𝑙𝑣𝑑𝑁𝑐𝑟𝑦𝑠𝑡 + 𝑑(𝜎𝐴) 
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𝑑𝐺 = −(𝜇𝑠𝑜𝑙𝑣 − 𝜇𝑐𝑟𝑦𝑠𝑡)𝑑𝑁𝑐𝑟𝑦𝑠𝑡 + 𝑑(𝜎𝐴) 
The expression in parentheses is called the supersaturation, and is usually denoted by the 
shorthand Δμ: 
Δ𝜇 ≡ 𝜇𝑠𝑜𝑙𝑣 − 𝜇𝑐𝑟𝑦𝑠𝑡 
 
 Recall from section 2.3 that the infinitesimal change in free energy of solvated 
growth units going to crystalline growth units is given by: 
𝑑𝐺𝑓𝑜𝑟𝑚𝑎𝑡𝑖𝑜𝑛 = −𝜅𝑇𝑙𝑛 (
𝐶𝑠𝑜𝑙𝑣
𝐶𝑒𝑞
) + 𝑑(𝜎𝐴) 
 
Hence, the supersaturation on the scale of a growth unit is defined as: 
 





The change in free energy per growth unit to move from solvated to crystalline form is 
therefore given by: 
𝑑𝐺 = −Δ𝜇 + 𝑑(𝜎𝐴) 
 
 
2.5 The Reaction Coordinate 
 
 In order to use these free energy equations, we must evaluate them at specific 
“points” during the reaction. That is, we must plug in numbers for how much solvated 
substance exists, how much crystalline substance exits, etc. We do this by considering the 
reaction, or phase transition in this case, to begin with a certain composition (e.g., all 
reactants) and proceed in a specific direction (e.g., toward product formation). Notice, 
however, that there is no dependence on time in the equations. Instead, we follow the 
reaction coordinate. The reaction coordinate, ξ, gives the progress along the reaction 
pathway, and thus defines the amount and phase of all substances present. In a plot of the 
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reaction (e.g., from reactants to products) the reaction coordinates would be the points on 
the line. 
 When studying nucleation processes, we consider the beginning state to be the 
reaction coordinate wherein all of the substance exists in its solvated form. That is, 
nucleation moves from solvated toward crystalline. We express the change in free energy 












Note that the specific surface free energy is treated as a constant in CNT (8). 
 
2.6 The Gibbs-Thomson Equation 
 
 The change in free energy during nucleation has been shown to be the sum of a 
volume and a surface term. When the concentration of the solvated substance is greater 
than its solubility (i.e., its equilibrium concentration), the supersaturation becomes greater 
than zero, and the volume term is negative. As the size of the nucleus increases, the 
volume term increases proportionately to the radius cubed, whereas the surface term 
increase is proportional to the square of the radius. For small sizes, the positive surface 
term tends to be larger than the negative volume term, because most of the growth units 
are situated at the surface. As the size becomes large, however, the negative volume term 
dominates. Accordingly, the growth of a nucleus requires an increase in free energy until 
a critical radius, r*, is reached, after which increasing the nucleus size decreases free 
energy. The critical radius is found by expressing the change in free energy as a function 
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of radius, then finding the radius that makes the change in free energy equal zero (i.e., the 
critical radius occurs at a maximum in free energy): 
𝜕𝐺
𝜕𝑛





 Let V equal the nucleus volume and Ω be the volume of a single growth unit 







In CNT, the nucleus is assumed to be spherical. The corresponding expressions for 




































Δ𝜇 + 8𝜋𝑟𝜎 
 










Δ𝜇 = 8𝜋𝑟𝜎 
 







The power of this equation is that it clearly relates the critical nucleus size with the 
specific surface free energy and the supersaturation in a simple, intuitive form that is easy 
to remember. As with all of CNT, the Gibbs-Thomson equation remains a staple for 
researchers in crystal growth not because of its accuracy – it can fail from a quantitative 
standpoint – but because it informs experimental design and analysis with an ostensibly 
reasonable approximation (19). The Gibbs-Thomson equation shows that nucleation can 
be favored by either decreasing the specific surface free energy, σ, or increasing the 
supersaturation of solvated growth units, Δμ. 
 
2.7 Nucleation Work 
 
 While the Gibbs-Thomson equation is a hallmark of nucleation theory, it is 
simply a consequence of a more fundamental concept: the nucleation work. The 
nucleation work is the amount of free energy required to produce a nucleus with n 
crystalline growth units from n solvated growth units (10). We can calculate this amount 
of free energy by integrating our expression for the infinitesimal change in free energy 
















𝑊(𝑛) = [−𝑚∆𝜇 + 𝜎𝐴(𝑚)]|0
𝑛 
𝑊(𝑛) = −𝑛∆𝜇 + 𝜎𝐴(𝑛) 
 
 We can arrive at an explicit equation by assuming that the nucleus is spherical and 
using the corresponding expression for the surface area and radius: 
















Substituting this into the expression for W(n) gives: 
 






This is the classical expression for nucleation work in CNT. As in the Gibbs-Thomson 
equation, we can define a critical nucleus by setting the derivative of W(n) with respect to 


































The work of formation for a nucleus with n* growth units is determined by simply 









































 The relationship between W(n), n*, W(n*), and Δμ is illustrated for the well-
known test case of barium sulfate (BaSO4) in Fig. 2.1. The study of BaSO4 is frequently 
encountered in classic texts on CNT because its physical parameters (solubility, lattice 
parameter, etc.) are well known and the crystallization of BaSO4 in oil pipelines has been 




Fig. 2.1 | Nucleation work diagram of BaSO4. The work required to form a nucleus, 
W(n), is plotted versus the number of growth units, n, in the nucleus for various 
supersaturations, Δμ. The critical nucleation work, W(n*), and critical nucleus, n*, are the 
values of W(n) and n evaluated at the maximum of the W(n) curve. 
 
2.8 The Nucleation Theorem 
 
 Although the principles of CNT are straightforward from a theoretical 
perspective, complications arise when trying to apply them to experiment. The greatest 
difficulty, historically, was the inability to determine whether or not nucleation was 
occurring freely in solution, called homogeneous nucleation, or on an existing surface, 
called heterogeneous nucleation (10). The reason why this was so problematic is that 
different theoretical models are used to describe heterogeneous and homogeneous 
nucleation, so it was not possible to experimentally validate or optimize CNT without 
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knowing which model to apply(13). The nucleation theorem was developed to relate 
W(n*), n*, and Δμ without the need to know which type of nucleation was occurring(21-
23). 
 
 The nucleation theorem holds that because the only dependence on 
supersaturation in the nucleation work expression comes from the volume term, - nΔμ, 





Experiments relating nucleation rates to supersaturation can be performed to determine 
n* (10, 13, 24).  
 
2.9 Ensembles of Nuclei 
 
 The concepts of nucleation work and critical nucleus size have been developed on 
the scale of a single nucleus, however experiments typically require consideration of an 
ensemble of nuclei. Classically, the concentration of nuclei comprising n growth units, 
Cn, is approximated by the equilibrium concentration of nuclei under ideal conditions 
(10). Although nucleation occurs under non-equilibrium conditions, more formal 
mathematical treatments reveal that the assumption of an equilibrium distribution is a 
good approximation. In particular, the steady-state concentration of critical nuclei is 1/2 
the equilibrium concentration of critical nuclei (25). Because the parameters of CNT 
cannot be experimentally resolved with sufficient precision for a factor of 1/2 to be 
significant (14), most treatments do not include it.  










The Arrhenius form of this expression comes from the Boltzmann statistics used to model 
ideal mixtures of nuclei at equilibrium. The prefactor, C0, is easily mistaken to be the 
concentration of growth units in solution, but that is incorrect to many orders of 
magnitude (13). Instead, C0 is the concentration of nucleation sites, defined as the 
locations where it is possible for nucleation to occur. In solution, homogeneous 


















2.10 Nucleation Rate 
 
 The development of a widely accepted rate equation took several decades, but 
ultimately became the cornerstone of CNT (20, 26-29). The nucleation rate, J, is defined 
as the rate at which stable nuclei (i.e., nuclei that will not redissolve) appear. Because 
steady-state assumptions are used in CNT, the rate of nucleation equals the rate at which 
the critical nucleus grows (i.e., the rate that clusters of size n* grow to size n*+1) (10). 





 In practice, it is exceptionally difficult to accurately describe the backward 
reaction in a simple analytic form (14). Instead, a scaling factor, Z, is added to the 
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forward reaction rate that decreases it by an amount representative of the expected 




The scaling parameter, called the Zeldovich factor, accounts for dissolution of nuclei with 
sizes greater than n* that occurs due to random thermal fluctuations (i.e., kT energy is 
sufficient to overcome the activation energy barrier to dissolution) (14, 29). The equation 



























 The Zeldovich factor typically ranges in value from 0.01 to 1 (13). In order to 
arrive at an expression for the nucleation rate, we must derive an equation for the forward 
growth rate of critical nuclei (i.e., 𝐽𝑛∗
+ ). In CNT, the forward growth rate equals the rate of 
monomer impingement, β*, per critical nucleus times the concentration of critical nuclei, 
Cn: 












 The rate of monomer impingement has two different forms, depending on whether 
the growth reaction is diffusion-limited or reaction-limited (10). Both forms of β* are 
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functions of the critical nucleus, n*, the volume per growth unit, Ω, the diffusion 
coefficient of the solvated growth units, D, and the concentration of the solvated growth 





























































2.11 Testing the Classical Nucleation Theory 
 
 Now that we have an explicit expression for the nucleation rate, we can plug in 
tabulated experimental data in order to test the accuracy of CNT for a common 
application. As a test case, we will examine the rate of gold nanoparticle nucleation from 
the ascorbic acid-mediated reduction of tetrachloroauric acid, which occurs rapidly at 
room temperature (30, 31). Table 2.1 lists the values of various parameters calculated by 
inputting literature values into the equations of the preceding sections. Although there is 
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no available data for the diffusion coefficient of gold atoms in water, the value of 1 x 10-5 
cm2/s is a common approximation for an atomic or molecular diffusion constant in water. 
 
Parameter Symbol Value (units) Reference 
Specific surface free 
energy 
σ 1.51 (J/m2) Galanakis et al 
2002(32) 
Growth unit volume Ω 1.70 x 10-2 (nm3) Davey et al 1925(33) 
Solubility Ceq 3.59 x 10
-16 (M) Calculated from 
approximation in 
Kashchiev et al 
2003(13) 
Diffusion coefficient D 1.0 x 10-5 (cm2/s) Approximated here 
Zeldovich factor Z 0 ≤ Z ≤ 0.2488 (unitless) Calculated here 
Thermal energy κT 4.11 x 10-21 (J) IUPAC Gold 
Book(34) 
Solvated growth unit 
concentration 





Supersaturation Δμ 0 ≤ Δμ ≤ 27.3 (κT) Calculated here 
Critical nucleus n* ≥ 23 (atoms) Calculated here 
Critical radius r* ≥ 0.453 (nm) Calculated here 
Critical nucleation 
work 
W(n*) ≥ 318.8 (κT) Calculated here 
Nucleation rate (DL) JDL 0 ≤ J ≤ 7.68 x 10
-132 
(nuclei L-1 s-1) 
Calculated here 
Nucleation rate (RL) JRL 0 ≤ J ≤ 1.09 x 10
-131 
(nuclei L-1 s-1) 
Calculated here 
 
Table 2.1. Classical nucleation theory (CNT) parameter values for the nucleation of gold. 
The values that have been calculated here correspond to a standard tetrachloroauric acid 
(AuCl4
-) reduction by ascorbic acid.  
  
 The nucleation work diagram for gold is shown in Fig. 2.2. Calculation of the 
critical work reveals that it exceeds 300 κT! Such a large activation energy barrier forbids 
nucleation on an experimental time scale (13). Indeed, the calculated nucleation rates are 
on the order of 10-131 nuclei per liter per second. In reality, the ascorbic acid reduction of 
tetrachloroauric acid proceeds rapidly upon mixture of the reactants, so why does CNT 
predict that nucleation is forbidden? The remainder of this chapter explores the critical 
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oversight in CNT that must be corrected in order to explain how gold nanoparticle 
nucleation is allowable. 
 
 
Fig. 2.2 | Classical nucleation theory nucleation work plot for gold. The plot of W(n) 
predicted from CNT is shown as the black curve. The critical nucleation work, W(n*), 
greatly exceeds 80 κT, which means that gold nucleation is forbidden according to CNT. 
The large value of W(n*) results from the high surface energy of gold. 
 
2.12 The Oversight of Classical Nucleation Theory 
 
 In CNT, it is assumed that solvated growth units exist in solution and can form 
nuclei simply by ordering into a cluster. In other words, the nucleation event involves 
only a phase transition. Oftentimes, however, solvated growth units are not present at the 
beginning of a nucleation reaction (35-37). Instead, a growth unit precursor (e.g., 
tetrachloroauric acid) exists in solution that must be converted into an active growth unit 
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form (e.g., solvated gold atoms) that subsequently becomes incorporated into nuclei. 
Moreover, some growth unit precursors react directly with nuclei to deposit growth units, 
as when the disproportionation of gold halides occurs on the surface of a gold cluster. In 
this case, the crystalline growth unit does not have an equivalent solvated form (e.g., the 
solvated monomers are gold chloride, not gold atoms). 
 The chemical reaction responsible for generating growth units from precursors 
liberates free energy that can be used to overcome the energy barrier to nucleation. 
Accordingly, the nucleation work expression must be modified to include this 
contribution. As a general rule, the total free energy change of a nucleation reaction can 
be determined from the balanced chemical reaction, with the addition of a surface energy 
term. 
 
2.13 Generalized Expression for Nucleation Work 
 
 Consider a general nucleation reaction wherein a precipitate, X, nucleates from a 
given set of reactants: 
𝑎𝐴 + 𝑏𝐵 +⋯ ⇌ 𝑥𝑋 + 𝑦𝑌 +⋯ 
Recall from section 2.2 that the reaction quotient, Qr, equilibrium constant, Keq, and 
infinitesimal change in free energy, dG, of this chemical reaction (in Joules per mole) are 














𝑑𝐺𝑚𝑜𝑙𝑎𝑟 = −𝑅𝑇𝑙𝑛 (
𝐾𝑒𝑞
𝑄𝑟
) + 𝑑(𝜎𝐴) 
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The average change in free energy of a single reaction is given by: 
𝑑𝐺 = −𝜅𝑇𝑙𝑛 (
𝐾𝑒𝑞
𝑄𝑟
) + 𝑑(𝜎𝐴) 
 In order to obtain the average free energy change per growth unit generated, we 








) + 𝑑(𝜎𝐴) 
This formula gives the average free energy liberated during the generation of a single 
growth unit of the precipitated phase (e.g., in the crystalline phase). The generalized 
nucleation work, W(n)GNT, is obtained by integrating the infinitesimal free energy change. 
 Following section 2.7, let m be the dummy variable for the number of growth 


















































From this formula, we can generalize all of the essential equations of CNT presented in 
the previous sections. 
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 As in interesting test case, we can apply this expression for the change in free 
energy to the classical phase transition modeled in CNT: 
𝐶𝑠𝑜𝑙𝑣 ⇌ 𝐶𝑐𝑟𝑦𝑠𝑡 














 Thus, application of the general expression for free energy change per growth unit 
yields the classical result when applied to a phase transition: 
𝑑𝐺𝑝ℎ𝑎𝑠𝑒 = −𝜅𝑇𝑙𝑛 (
𝐶𝑠𝑜𝑙𝑣
𝐶𝑒𝑞
) + 𝑑(𝜎𝐴) 
𝑑𝐺𝑝ℎ𝑎𝑠𝑒 = −∆𝜇 + 𝑑(𝜎𝐴) 
The generalized framework presented here and in subsequent sections reduces to the 
equations of CNT when the nucleation reaction is a pure phase transition. 
 
2.14 The Generalized Critical Nucleus and Critical Work of Nucleation 
 
 Setting the derivative of our new nucleation work expression equal to zero and 





































































 In contrast to the critical nucleus expression from CNT, the generalized 
expression for n* depends strongly upon the driving force of the chemical reaction. 
Substituting the critical nucleus into the nucleation work expression yields the 























































































 The generalized expression W(n*)GNT reveals that a nucleation reaction forbidden 
by CNT can be achieved by careful choice of the reactants. Consider, for example, the 
nucleation of gold nanoparticles that we showed is forbidden by CNT in section 2.11. 
The reason why the nucleation reaction will not proceed, according to CNT, is that the 
critical nucleation work is very high – over 300 κT. This high energetic barrier is an 
artifact of the CNT assumption that nucleation can be modeled by a phase transition, 
wherein the “reactants” are solvated gold atoms, and the work of nucleation is the change 
in free energy between the initial state of solvated gold atoms and the final “product” 
state of gold nuclei. According to our generalized expression, however, if we choose 
reactants that produce gold via a very exothermic reaction, the nucleation work becomes 
negligible. This concept is not restricted to a particular material or reaction, as can be 
seen in the following theorem: 
Theorem 2.1. The nucleation of any material can be made to proceed without a 
nucleation work barrier (i.e., the critical nucleation work is less than or equal to zero) by 
incorporation of sufficiently exothermic reaction steps. 
Proof: The work of nucleation is a state function, such that the nucleation work done 
between an initial state I and a final state F is independent of the path between I and F: 
𝑊(𝐼 → 𝐹) = 𝑊(𝐹) −𝑊(𝐼) 
 Consider a system with initial state M wherein the maximum value of n equals 1 
(i.e., there exist no nuclei in solution). Let N* be the state of the system corresponding to 
the maximum free energy, such that the free energy of the critical nucleation state is less 
than or equal to N*.  The work to move from state M to state N* is finite and given by: 
𝑊(𝑀 → 𝑁∗) = 𝑊(𝑁∗) −𝑊(𝑀) 
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Because the change in free energy is finite, there always exists some value P that 
satisfies: 
𝑊(𝑁∗) −𝑊(𝑀) < 𝑃 
 Now, suppose there exists a system at state I that can evolve to the state M via 
sufficiently exothermic steps such that W(M) – W(I) < -P. Then the work to form the 
maximum free energy state of the system from the initial state I is given by: 
𝑊(𝐼 → 𝑁∗) = 𝑊(𝑁∗) −𝑊(𝐼) 
Accordingly, we know that: 
𝑊(𝑁∗) < 𝑊(𝑀) + 𝑃 
𝑊(𝐼) > 𝑃 +𝑊(𝑀) 
Thus, it follows that: 
𝑊(𝐼 → 𝑁∗) < [𝑊(𝑀) + 𝑃] − [𝑃 +𝑊(𝑀)] 
𝑊(𝐼 → 𝑁∗) < 0 
Because the free energy of the critical nucleation state is less than or equal to the 
maximum free energy state, the critical nucleation work is less than zero. 
 
2.15 The Generalized Nucleation Theorem 
 
 A generalization of the nucleation theorem is straightforward given that the 

























 The generalized nucleation theorem assumes its familiar form from CNT when 
the nucleation reaction is a simple phase transition because (κT/x)ln(Keq/Qr) = Δμ for 
phase transitions. 
 
2.16 Nucleation Rate 
 
 The nucleation rate in CNT is given by the product of the Zeldovich factor, Z, the 
impingement rate, β, and the concentration of nuclei, Cn, all evaluated at the critical 
nucleus size, n*: 
𝐽 = 𝑍𝛽∗𝐶𝑛∗ 
 
In order to correct this formula for the influence of a chemical reaction driving 
nucleation, we can analyze the three terms of the right hand side individually. We begin 
















































































































 Correction of the impingement rate is straightforward. Because the mechanism of 
nucleus growth is still considered to be monomer growth unit addition to a critical 
cluster, the diffusion-limited and reaction-limited impingement rates are given by the 
same equations as in CNT, but with the proper expression for the critical nucleus of a 
























































 Because Boltzmann statistics are still used to determine the ensemble distribution 
of nucleus sizes, we arrive at the same equilibrium expression for Cn as in CNT. The 



























 The nucleation rate expressions for diffusion-limited and reaction-limited growth 



































































 We emphasize that a fundamental assumption of the rate equation in CNT, and 
consequently our generalization of this equation, is that a critical nucleation work barrier 
greater than zero exists. This assumption will fail when the free energy of nuclei (i.e., the 
products) is less than the free energy of the reactants for all nuclei sizes. In this case, the 
critical nucleus size is theoretically equal to 1, and the Zeldovich factor becomes 
irrelevant (i.e., Z is only defined when W(n) is concave down at n*) (14) and the 
following forms of JDL,GNT  and JRL,GNT should be used: 
𝐽𝐷𝐿,𝐺𝑁𝑇










𝑐𝑜𝑛𝑐𝑎𝑣𝑒 𝑢𝑝 = (48𝜋2Ω)
1
3𝐷𝐶𝑠𝑜𝑙𝑣
2   
 
𝐽𝑅𝐿,𝐺𝑁𝑇





   
 
2.17 Testing the General Nucleation Theory 
 
 The predictions of our generalized nucleation theory can be compared to those of 
CNT by evaluating the same test case of tetrachloroauric acid reduction by ascorbic acid. 
In order to determine the nucleation rate, we must first obtain explicit expressions for the 
reaction quotient and equilibrium constant. Then we can calculate the thermodynamic 
driving force as a function of the reaction coordinate and identify the critical nucleus and 
nucleation work. The nucleation rate can be predicted once these expressions are known. 
 
2.18 Reaction Quotient of Ascorbic Acid Reduction of Tetrachloroauric Acid 
 
 We begin the test case evaluation by determining the reaction quotient, Qr, 
expression. The balanced chemical reaction is: 
 
3𝐶6𝐻8𝑂6 + 2𝐴𝑢𝐶𝑙4
− ⇌ 3𝐶6𝐻6𝑂6 + 6𝐻
+ + 2𝐴𝑢0 + 8𝐶𝑙− 
 


























 Ultimately, we want to evaluate the reaction quotient as a function of the fewest 
number of variables possible. This is important because it is often not possible or 
practical to measure all of the species involved in a reaction. Accordingly, we define the 
following identities: 
 













 If we assume that the intermediate disproportionation step is rapid with respect to 
reduction of AuCl4













{[𝐶6𝐻8𝑂6]0 − ∆𝜉[𝐶6𝐻8𝑂6]} 
 
[𝐶6𝐻6𝑂6]𝜉 = ∆𝜉[𝐶6𝐻8𝑂6] 
 





 We can therefore write the reaction quotient as a function of the initial 


















2.19 Calculation of the Equilibrium Constant 
 
 In order to calculate the equilibrium constant from electrochemical data we must 
turn to the Nernst equation (38): 





The Nernst equation relates reduction potential, E, to the standard reduction potential, E0, 
the number of electrons transferred, n, Faraday’s constant, F, and the reaction quotient, 
Qr. At equilibrium, the Nernst equation can be rearranged to give: 
𝑛𝐹𝐸0 = 𝑅𝑇𝑙𝑛(𝐾𝑒𝑞) 
 






Thus, we can determine the equilibrium constant from knowledge of electrochemical 
reactions.  
 The standard reduction potentials of the half-cell reactions relevant to our test 
case are: 
3{𝐶6𝐻8𝑂6 → 𝐶6𝐻6𝑂6 + 2𝐻
+ + 2𝑒−}     E0 = -0.166 
3{𝐴𝑢𝐶𝑙4
− + 2𝑒− → 𝐴𝑢𝐶𝑙2
− + 2𝐶𝑙−}      E0 = +0.926 
2{𝐴𝑢𝐶𝑙2
− + 𝑒− → 𝐴𝑢0 + 2𝐶𝑙−}      E0 = +1.154 
1{𝐴𝑢𝐶𝑙2
− + 2𝐶𝑙− → 𝐴𝑢𝐶𝑙4
− + 2𝑒−}      E0 = -0.926 























 The principle of detailed balance states that at equilibrium, all intermediate 
chemical reactions must also be in equilibrium. We can therefore study the overall 
equilibrium constant in terms of the equilibrium constants of AuCl4
- reduction and AuCl2
- 
disproportionation. For the initial reduction reaction, we have: 
3{𝐶6𝐻8𝑂6 → 𝐶6𝐻6𝑂6 + 2𝐻
+ + 2𝑒−}     E0 = - 0.252 
3{𝐴𝑢𝐶𝑙4
− + 2𝑒− → 𝐴𝑢𝐶𝑙2
− + 2𝐶𝑙−}      E0 = +0.926 
3𝐶6𝐻8𝑂6 + 3𝐴𝑢𝐶𝑙4
− → 3𝐶6𝐻6𝑂6 + 6𝐻3𝑂
+ + 3𝐴𝑢𝐶𝑙2






















The half-cell reactions relevant to the disproportionation reaction are: 
 
2{𝐴𝑢𝐶𝑙2
− + 𝑒− → 𝐴𝑢0 + 2𝐶𝑙−}      E0 = +1.154 
1{𝐴𝑢𝐶𝑙2
− + 2𝐶𝑙− → 𝐴𝑢𝐶𝑙4
− + 2𝑒−}      E0 = - 0.926 
3𝐴𝑢𝐶𝑙2
− → 𝐴𝑢𝐶𝑙4



















Combining the two equilibrium constants yields the overall expression for the 
equilibrium constant of the reaction: 
 
































𝐾𝑒𝑞 = (2.467 × 10
68) × (5.151 × 107) 
 
𝐾𝑒𝑞 = 1.271 × 10
76 
 
2.20 Calculation of the Change in Free Energy 
 
 In order to arrive at the free energy change per growth unit generated, we begin 
with the general expression for the molar change in free energy, dGmolar. The contribution 
of surface energy will be separately added at the end of the derivation.  
 















Assuming that disproportionation is rapid, we can express the change in free energy as a 
function of the ascorbic acid concentration (section 2.18): 
 
𝑑𝐺𝑚𝑜𝑙𝑎𝑟 = −𝑅𝑇𝑙𝑛 {













𝑑𝐺𝑚𝑜𝑙𝑎𝑟 = −𝑅𝑇𝑙𝑛 {





𝑑𝐺𝑚𝑜𝑙𝑎𝑟 = −𝑅𝑇𝑙𝑛[(4.680 × 10












2.21 Scaling the Reaction Coordinate 
 
 The expression for the change in free energy derived in the preceding section is a 
function of the reaction coordinate. In order to determine the amount of free energy 
liberated per growth unit, we must first know which reaction coordinates to evaluate. 
We begin by considering a volume of the solution that is sufficiently small such that, on 
average, only one nucleus forms within it throughout the entire course of the reaction. We 
call this volume the nucleation cell and can calculate it from knowledge of the 
concentration of nuclei at the end of the reaction. Typical nucleation reactions for gold 
nanoparticles yield approximately 60 nanomoles of nuclei per liter of solution (i.e., 60 
nM), as determined from ultraviolet-visible (UV-Vis) spectroscopy (37, 39). Therefore 










6.022 × 1023 𝑛𝑢𝑐𝑙𝑒𝑖
 
 
𝑉𝑐𝑒𝑙𝑙 = 2.768 × 10
−17𝐿 
 
 We can approximate the number of ascorbic acid molecules within the nucleation 
cell by multiplying its volume by the concentration of ascorbic acid. Typical 
concentrations of ascorbic acid and tetrachloroauric acid in a nucleation reaction are 
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approximately 2.25 x 10-4 M and 1.50 x 10-4 M, respectively (30). The initial number of 
ascorbic acid molecules in the nucleation cell is therefore: 
 
𝑁𝐶6𝐻8𝑂6 = (
2.25 × 10−4 𝑚𝑜𝑙𝑒𝑠
𝐿
) × (
6.022 × 1023 𝑚𝑜𝑙𝑒𝑐𝑢𝑙𝑒𝑠
𝑚𝑜𝑙𝑒
) × (










1.50 × 10−4 𝑚𝑜𝑙𝑒𝑠
𝐿
) × (
6.022 × 1023 𝑚𝑜𝑙𝑒𝑐𝑢𝑙𝑒𝑠
𝑚𝑜𝑙𝑒
) × (









 Because one gold atom is produced for each molecule of tetrachloroauric acid 
reduced, we know that the average nucleation event will generate a particle comprising 
2,500 gold atoms. The reaction coordinate can therefore be expressed as proceeding from 
0% to 100% complete in increments of 100/2,500 = 0.04%.  
 Scaling the free energy change per mole to the average free energy change per 

















𝑚𝑜𝑙𝑒 𝑔𝑟𝑜𝑤𝑡ℎ 𝑢𝑛𝑖𝑡 𝑔𝑒𝑛𝑒𝑟𝑎𝑡𝑒𝑑












) × ∆𝐺 (
𝐽𝑜𝑢𝑙𝑒𝑠























 We calculate the nucleation work corresponding to this reaction by substituting 
our formula for –(nκT/x)ln(Keq/Qr) into the expression for W(n)GNT. A plot of the 
nucleation work as a function of the nucleus size, n, is given in Fig. 2.3, and the critical 
values and predicted nucleation rates are listed in Table 2.2. The reduction reaction 
responsible for generating the gold atoms is shown to be sufficiently exothermic to 
compensate for the gold nuclei’s large free energy of formation. In contrast to the 
equations of CNT, our generalized nucleation theory correctly predicts that gold 
nucleation should occur rapidly at room temperature. 
 
Parameter Symbol Value (units) Reference 
Specific surface free 
energy 
σ 1.51 (J/m2) Galanakis et al 2002 
(32) 
Growth unit volume Ω 1.70 x 10-2 (nm3) Davey et al 1925 (33) 
Solubility Ceq 3.59 x 10
-16 (M) Calculated from 
approximation in 
Kashchiev et al 2003 
(13) 
Diffusion coefficient D 1.0 x 10-5 (cm2/s) Approximated here 
Zeldovich factor Z 0 ≤ Z ≤ 1 (unitless) Calculated here 
Thermal energy κT 4.11 x 10-21 (J) IUPAC Gold Book 
(34) 
Solvated growth unit 
concentration 





Supersaturation Δμ 0 ≤ Δμ ≤ 27.3 (κT) Calculated here 
Critical nucleus n* 2 (atoms) Calculated here 
Critical radius r* ≥ 0.201 (nm) Calculated here 
Critical nucleation 
work 
W(n*) -258.8 (κT) Calculated here 
Nucleation rate (DL) JDL 0 ≤ J ≤ 3.72 x 10
7 
(nuclei L-1 s-1) 
Calculated here† 
Nucleation rate (RL) JRL 0 ≤ J ≤ 2.34 x 10
7 
(nuclei L-1 s-1) 
Calculated here† 
Table 2.2. Generalized nucleation theory (GNT) parameter values for the nucleation of 
gold. The values that have been calculated here correspond to a standard tetrachloroauric 
acid (AuCl4
-) reduction by ascorbic acid.  
†These rates are reported for the concave up nucleation rate equations because the critical 




Fig. 2.3 | Generalized nucleation theory nucleation work plot for gold. The plot of 
W(n) predicted from GNT is shown as the black curve. The critical nucleation work, 
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 Precise control of nanoparticle shape is critical to their performance in catalytic 
(1, 2), sensing (3, 4), and biomedical applications (5, 6). Although synthetic protocols 
have been developed for a wide variety of morphologies, the mechanisms and design 
rules of shape-controlled growth remain poorly understood (7). The prevailing 
assumption is that surfactants, polymers, or other small adsorbates are responsible for the 
ultimate nanoparticle shape by preferentially blocking certain facets such that their 
growth is inhibited (Appendix 1) (7-9). In this chapter, we report the development of a 
shape controlled synthesis of gold nanoparticles free of shape-directing agents, and thus 
not explained by the most widely accepted growth mechanism. Of particular interest is 
the formation of gold nanorods, which is the prototypical shape thought to require the 
presence of surfactants (9-11). In order to better understand our observations, we 
developed a mathematical framework that unifies the fundamental principles of classical 
and modern crystal growth theories (12-16). We demonstrate the practical application of 
this quantitative framework by investigating the growth mechanism of surfactant-free 
nanoparticles. The origin of anisotropic growth is predicted to be re-entrant grooves 
catalyzing nucleation of monolayers on the fast-growing facets. Although grooved 
structures are known to exist on gold nanoplates, we report for the first time that re-
entrant grooves are consistently observed at the ends of gold nanorods, thus corroborating 
our proposed mechanism. The unified crystal growth theory is neither restricted to a 
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particular growth unit or size range, and will open new avenues in the study and design of 
crystal growth. 
3.2 Overview of Theoretical Framework 
 Here we present a theoretical framework describing crystal growth originating 
from seed crystals exhibiting well-defined facets. Growth is assumed to begin with 
nucleation of a two-dimensional (2D) island and proceed by step flow (i.e. lateral growth) 
of the nucleus into a partial monolayer. The step flow is fueled by the incorporation of 
monomer growth units that adsorb onto the step and diffuse to binding sites. The 
completion of a net monolayer occurs when the 2D nucleus spreads a distance λ = hf  – hi. 
If the surface is terraced, then multiple partial monolayers spread simultaneously and λ 
will be less than the length of the facet. The distance λ will also decrease as the number 
of 2D nuclei on a terrace increases. The goal of this theoretical framework is to develop 
an expression for facet growth rates (i.e. asymptotic growth rates) as a function of the 
expected time for 2D monolayer nucleation, the flux of growth units to the step front, and 
the jumping rates of adsorbed growth units. This rate expression can be used to determine 
the regimes of nucleation-limited, diffusion-limited, and reaction-limited growth. 
 
3.3 Mathematical Approach 
 We determine the expected time for net monolayer completion – the time required 
for a facet to increase its average height by one monolayer – by summing the expected 
time for nucleation and the expected time for partial monolayer spread of a distance λ. 
The expected time for nucleation is treated as a known input, thus the primary calculation 
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in this framework is the expected time for a step to become completely filled (henceforth 
called step completion). 
 The expected time for step completion is a function of the number of growth units 
in the step, the flux of growth units to the step front, and the activation energies for 
jumping into and along the step. In the following sections, we outline our theoretical 
framework by developing expressions for the expected times of growth unit arrival, one-
dimensional (1D) step nucleation, and growth unit incorporation into binding sites. The 
latter process is divided into three separate mechanisms. The mechanism with the lowest 
expected time for step completion is defined to be the operating mechanism for the 
corresponding input parameters. 
 
3.4 Expected Time of Growth Unit Arrival 
 Let the arrival of growth units at each site be modeled as a renewal process. Once 
growth units arrive at the step front, they diffuse into the step by a single jump. If the 
growth units are adsorbed on the surface, the rate at which they jump into the step is 
characterized by the vibrational frequency of the growth unit and activation energy of the 
jump. Growth units diffusing directly from solution into the step will have a different 
prefactor and activation energy than those corresponding to jumping into the step from a 
surface site. If the expected time for growth unit arrivals via diffusion, E(Tdiff), is small 
compared to the expected time for jumps into the step, then the frequency of arrivals at 







 Assuming that the expected time for growth unit arrival is constant along the step 
front, the arrival rate of growth units summed over x sites is xRdiff, and the expected 






 When the arrival time is slow on the scale of incorporation into the step, it can be 
modeled as a rare event, which is well approximated by an exponential distribution. Such 











 Let F denote the flux of growth units per nm per second to the step front, and let 
the length of a step unit, a||, be defined by the length, L, of the step and number, N, of 
growth units in the step: 








The flux of growth units per step site per second is 




Thus we have the following relation that holds for arrival times that are either small or 












 In this theoretical framework, we assume for simplicity that the expected time for 
growth unit arrival is well approximated by the reciprocal of the rate of growth unit 
arrival throughout the entire range of input flux values considered.  
 We are particularly interested in seeded (nano)crystal syntheses that proceed via 
reduction of a metal precursor by a weak reducing agent. Such syntheses are autocatalytic 
wherein the seed surface plays an essential role in catalyzing the reduction of metal atom 
precursors. In the present treatment, therefore, we will consider the rate of direct growth 
unit diffusion from solution into binding sites as negligible, since they must first interact 
with the surface before converting to the atomic form that is ultimately incorporated into 
the crystal. Application of this theory to systems wherein the direct diffusion from 
solution into binding sites is not negligible require modification of the equation for 
E(Tdiff)x to incorporate solution-to-binding site flux. 
 
3.5 Expected Time of 1D Nucleation 
 The binding of a growth unit into an empty step is herein considered to constitute 
the process of one-dimensional (1D) nucleation. The term nucleation in this context 
refers to the beginning of 1D growth (i.e. along the step), rather than the attainment of a 
thermodynamic critical nucleus. Because a growth unit adsorbed to a step can detach 
before bonding to additional growth units in the step, it is important to consider whether 
or not the detachment rate should be used to modify the expected time for 1D nucleation. 
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When the incorporation rate of a second growth unit is fast (e.g. more than an order of 
magnitude larger) with respect to the detachment of the first growth unit, the detachment 
rate can be neglected to a good approximation. 
 Let E(Tdiff)x denote the expected time for a growth unit to arrive at any one of x 
sites one jump away from a step site. The expected time for 1D nucleation will be a 
function of both E(Tdiff)x and the expected time for a growth unit to jump into a step site. 
Because a single surface jump is characterized by a large number of attempts (vibrational 
motion) and a low probability of success during each attempt, we can treat jumps into 
step sites as Poisson processes. As such, they are exponentially distributed, and the 
expected time of the process equals the reciprocal of the jump rate. 





Where 𝜈𝑖𝑗 is the component of vibrational frequency of the growth unit along the ij-
direction, Eij is the activation energy for jumping from i to j, κ is Boltzmann’s constant, 
and T is the absolute temperature. If the jump is defined to occur in a particular direction, 
then an additional factor, pij, must be included to account for the probability of jumping 





 For surface jumps, pij is well approximated as the reciprocal of the number of 
lattice sites that an adatom can reach in a single jump (e.g. pij = 1/3 for {111} and 1/4 for 













 Let the subscripts L, U, K, and S denote the lower terrace, upper terrace, kink, and 
non-kink step sites, respectively. The expected time, E(T1),  for jumps from the lower and 

















 Let Pj denote the probability that a growth unit arriving at the step front lands in 
site j, and let 𝐸(𝑇𝑠𝑡𝑒𝑝|𝑗) denote the expected time for a growth unit to jump from site j 
into the adjacent step site, provided the growth unit arrives at site j. The expected time for 






When the probability of arriving at each site j is equal and growth units arrive from both 















Figure 3.1 | Growth Unit Incorporation at the Step Front. a, 1D nucleation at the edge 
of a triangular partial monolayer. The filled and unfilled circles represent occupied and 
unoccupied sites, respectively. b, Expanded view of the incomplete step in a. The sites 
labeled “k” are kink binding sites and those labeled “s” are non-kink step sites. The 
variables “m” and “n” are highlighted, which respectively denote the total number of sites 
in a step and the number of sites in the largest unfilled fragment. c, Mechanism 1 – Step 
adsorption and diffusion to kink. Growth units jump into the step (blue arrows) at random 
locations and diffuse along the step (red arrows) until they bind at the kink site. The non-
kink step sites are modeled as a continuous time Markov chain to determine the expected 
time of step diffusion to the kink binding site. d, Mechanism 2 – Direct step 
incorporation. In contrast to Mechanism 1, this Mechanism 2 does not involve step 
diffusion. Mechanism 2 operates when the rate of step diffusion is slower than the rate of 
additional growth unit arrivals into the step sites. e, Mechanism 3 – Direct kink 
incorporation. Similar to Mechanism 2, Mechanism 3 does not involve step diffusion. In 
contrast to mechanisms 1 and 2, growth by Mechanism 3 occurs exclusively by jumps 
from the terrace to kink binding sites. This mechanism operates when the rate of step 
diffusion is slower than the rate of additional growth unit arrivals and the activation 







3.6 Expected Time of Incorporation – Step Adsorption and Diffusion 
 Let m denote the total number of step sites at the edge of a partial monolayer, as 
illustrated in Figure 3.1a,b: 
𝑚 ≡ 𝑛𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑠𝑡𝑒𝑝 𝑠𝑖𝑡𝑒𝑠 
The number of sites one jump from the step is a function of the facet index and step 
structure. Herein, we assume without loss of generality that there are 2m sites one jump 
away from step sites, corresponding to m sites on both the lower and upper terraces: 
2𝑚 = 𝑛𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑠𝑖𝑡𝑒𝑠 𝑜𝑛𝑒 𝑗𝑢𝑚𝑝 𝑎𝑤𝑎𝑦 
 Upon 1D nucleation, the step is fragmented into segments of length less than m on 
either side of the incorporated growth unit (i.e. the 1D nucleus). Because step completion 
proceeds independently on either side of the 1D nucleus, the expected time for step 
completion equals the expected time for completion of the largest fragment. We denote 
the number of sites in the largest fragment by n (Fig 3.1b). Given a step comprising m 
available sites for 1D nucleation, if a growth unit adsorbs at site 𝑗 ∈ (1, 2, … ,𝑚), n is 
defined as: 
𝑛 = 𝑚𝑎𝑥𝑖𝑚𝑢𝑚(𝑚 − 𝑗, 𝑗 − 1) 
 The step fragment comprises one kink binding site – the site adjacent to the 1D 
nucleus – and n-1 non-kink step sites. When the expected time for step diffusion to the 
kink binding site is less than the expected time for an additional growth unit to jump into 
the step we can model the step diffusion process by a continuous time Markov chain 
(CTMC). In particular, we construct an n-1 × n-1 infinitesimal generator matrix, 
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R1 - R1,2 0 0 0 0 0 0 
- R2,1 R2 - R2,3 0 0 0 0 0 
0 - R3,2 R3 - R3,4 0 0 0 0 
0 0 - R4,3 R4 - R4,5 0 0 0 
0 0 0 - R5,4 R5 - R5,6 0 0 
0 0 0 0 - R6,5 R6 - R6,7 0 
0 0 0 0 0 - R7,6 R7 - R7,8 
0 0 0 0 0 0 - R8,7 R8 
 
Where Rij is the rate of jumping from i to j, and Ri is the total rate of jumping out of site i. 
Here we have arbitrarily chosen n-1 = 8 for illustrative purposes. 
 The expected time, E(Tbind), for a growth unit in a step to reach the binding site 
from each initial step site is obtained by inverting the Q-matrix, and summing the entries 
in each row: 





𝑴 = 𝑸−1𝒐𝒏𝒆𝒔(𝑛 − 1,1) 
Entry M(j) gives the expected time of step diffusion to the binding site for a growth unit 
beginning in the step site j jumps from the kink binding site. The complete list of 
expected times to arrive at the binding site from any step site are given by the column 
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vector 𝑬(𝑇𝑏𝑖𝑛𝑑), where the first entry corresponds to a growth unit that is already in the 














































Where the coefficient 1/2n is the probability that an atom impinging upon the step front 
arrives at the specific site Lj or Uj  (e.g. if there are 2n = 18 sites one jump away from the 
step, each has probability = 1/18 that an impinging adatom arrives at that specific site). 
Here we have assumed that each site has equal likelihood of adatom arrival. For 
convenience, we construct a column vector with n entries, rather than 2n, where each 
entry equals the sum of the contribution from the corresponding upper terrace and lower 
terrace sites. If the probability of growth unit arrival is different for lower terrace versus 
upper terrace sites then each site must be given its own entry and corresponding 
probability of arrival in the E(Tstep) column vector. 
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 We determine the expected time of the growth unit incorporation reaction, 
𝐸(𝑇𝑟𝑥𝑛), by summing all entries in the two column vectors, 𝑬(𝑇𝑠𝑡𝑒𝑝) and 𝑬(𝑇𝑏𝑖𝑛𝑑).  










































𝒐𝒏𝒆𝒔(1, 𝑛) = [1,1, … ,1] 
 
𝐸(𝑇𝑟𝑥𝑛) = 𝒐𝒏𝒆𝒔(1, 𝑛)𝑬(𝑇𝑠𝑡𝑒𝑝 + 𝑇𝑏𝑖𝑛𝑑) 
 
















































 Given a flux of F atoms per nm per second to the step front, the expected time for 






The expected time for growth unit incorporation, E(Tinc), which corrects for the 







(𝑅𝐾𝐿)−1 − [𝐸(𝑇𝑑𝑖𝑓𝑓)2𝑛 + 𝐸
(𝑇𝑟𝑥𝑛)]
} 
The derivation of the correction factor is provided at the end of the theoretical 
framework. The expected time for step fragment completion, E(Tfragment), is obtained 
repeating the calculation of E(Tinc) after each new atom is added into the step until all 
sites have been filled : 







𝑬(𝑇𝑠𝑡𝑒𝑝 + 𝑇𝑏𝑖𝑛𝑑)𝑘] 
 Because the 1D nucleation event can occur at any one of the m available sites, we 
must randomize the initial growth unit adsorption in order to arrive at the expected time 
for step completion. The resulting equation gives the expected time for completion of an 
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Recall that n = maximum(m-j, j-1) 
 
3.7 Expected Time of Incorporation – Direct Step Binding 
 When the arrival of growth units into the step becomes sufficiently fast, the 
mechanism of incorporation no longer includes diffusion along the step (Fig 3.1d). The 
threshold where the incorporation mechanism changes from step adsorption and diffusion 
to direct step binding (i.e. incorporation without diffusion within the step) can be 
approximated by comparing the expected time for growth units to jump into the step and 
the expected time for growth units to diffuse to the kink. In particular, the mechanism 
changes when the expected time for a growth unit to diffuse to a kink is greater than the 
expected time for a second growth unit to jump into the step. 
 The expected time to complete a row of step atoms, E(Trow), via direct step 
binding is determined by summing the expected times for consecutive arrival and step 
adsorption events. For a step with m available binding sites prior to 1D nucleation we 
have: 

















Where the subscript k on the last term indicates that the expected time for jumping into 
the step can change as the number of adsorbed growth units in the step changes. When 
the activation energy for incorporation into the step does not depend strongly on the 
number of adsorbed growth units then the following approximation can be used: 














Note that because the step does not complete symmetrically outward from the 1D 
nucleation site it is not sufficient to consider only the completion of the largest step 
fragment of n sites. Notice also that the detachment rate has been neglected because step 
completion occurs very rapidly with respect to growth unit detachment.  
 
3.8 Expected Time of Incorporation – Direct Kink Binding 
 As the expected time for growth unit arrival at the step front approaches zero, 
incorporation into the step becomes reaction limited. When the activation energy for 
direct incorporation into a kink site is significantly lower than that for direct 
incorporation into a non-kink step site, the minimum expected time for step completion 
will occur via direct kink binding. That is, after 1D nucleation, growth units will 
exclusively incorporate into the step by jumping from the terraces into the kink binding 
sites. Because this mechanism creates symmetric kink propagation from the initial 1D 
nucleation site, the expected time for step completion equals the expected time for the 
largest step fragment of n sites. Thus, the expected time equals the expected time for 1D 
nucleation randomized over the m possible nucleation sites plus the expected time for n 





























𝑛 = 𝑚𝑎𝑥𝑖𝑚𝑢𝑚(𝑚 − 𝑗, 𝑗 − 1) 
 
3.9 Expected Time of Step Completion 
 The expected time to complete a row of step atoms is a function of the 
incorporation mechanism and flux of growth units to the step front, as described above. 
Here we present the six step completion equations: the three growth mechanism from 
above, each with an expression for a system wherein growth units arrive from the lower 
and upper terraces and a system wherein growth units arrive exclusively from the lower 
terrace. If the expected time for step diffusion to kink binding sites is less than the 
expected time for a second growth unit to jump into the step, then mechanism 1 (i.e. step 
adsorption and diffusion) is used. Otherwise, the expected time for step completion via 
mechanisms 2 and 3 are both computed and the minimum expected time is selected. This 
processes is repeated from the initial step – corresponding to the edge of the 2D critical 
nucleus – to the final step, defined as the step that completes a net monolayer.  
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Mechanism 2, Upper and Lower Terrace 
 















Mechanism 2, Lower Terrace Only 
 



































𝑛 = 𝑚𝑎𝑥𝑖𝑚𝑢𝑚(𝑚 − 𝑗, 𝑗 − 1) 
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𝑛 = 𝑚𝑎𝑥𝑖𝑚𝑢𝑚(𝑚 − 𝑗, 𝑗 − 1) 
 
3.10 Formula for Step Size as a Function of Partial Monolayer Radius 
 
 In order to employ the expected time for step completion to determine the 
expected time for layer completion, we must derive an expression for the number of step 
sites as a function of the partial monolayer size. If we consider step flow via the 
completion of consecutive single steps, then the geometry of the partial monolayer and 
the symmetry of its growth (e.g. a triangle growing from three edges, a triangle growing 
from one edge, etc.) will be the primary factors in developing an expression for the 
number of step sites, m(h), as a function of the length, h, of the partial monolayer. 
Because we are especially interested in growth originating from the corners of triangular 
{111} facets (i.e. symmetry of growth on {111} nanorod facets), we will use the 
expression for a triangular partial monolayer growing from one edge: 
 
𝑚(ℎ + 1) = 𝑚(ℎ) + 1 
 76 
 When alternative geometries and growth symmetries are used, the appropriate 
expression is likely to change. The form of the recursion formula will only change by the 
value of the constant for many relevant cases. 
 
3.11 Expected Time of Net Monolayer Completion 
 Once the expected time for step completion and the formula for the number of 
step sites as a function of partial monolayer size are known, the expected time of net 
monolayer completion is straightforward to compute. Using the example of a triangular 
partial monolayer spreading from one edge, we can see that the mth step requires m 
growth units for completion. We can therefore determine the expected time for 
monolayer completion by summing the expected time for step completion over the total 
number of steps required to complete a net monolayer: 
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Mechanism 2, Upper and Lower Terrace 
 


















Mechanism 2, Lower Terrace Only 
 















































Mechanism 3, Lower Terrace Only 
 



















𝑛 = 𝑚𝑎𝑥𝑖𝑚𝑢𝑚(𝑚 − 𝑗, 𝑗 − 1) 
 
3.12 Asymptotic Growth Rate Normal to Surface 
 Although the expected time for net monolayer completion has a clear meaning 
and strong mathematical foundation, it is much more common to experimentally measure 
and report crystal growth “rates”. Although the rate of a process has an intuitive 
colloquial meaning, it is important to articulate exactly which rate is referenced when 
attempting to provide a meaningful mathematical expression. Because there is no reason 
to assume that the time for monolayer completion should be an exponentially distributed 
random variable, it cannot be assumed that the “rate” of monolayer completion is defined 
as the reciprocal of the expected time for monolayer completion. It is, however, 
reasonable to consider the asymptotic rate of monolayer formation over growth of several 
tens of nanometers. In this case, we can treat monolayer formation as a renewal process, 
and thus the expected time for layer formation as constant. This requires that we assume 
that the expected time for nucleation and the flux of growth units per step site per second 
are constant throughout the timeframe of crystal growth. Note, however, that a seed 
crystal growing from time t1 to t2 and another seed crystal growing from time t3 to t4 can 
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be subject to different nucleation rates and flux. The (asymptotic) rate of crystal growth, 






 The units of Rhkl are nm per second, and the logarithm of this rate as a function of 
nucleation rate and growth unit flux is used to generate the crystal growth contour plots 
reported in the main text. The advantage of using this expression is that it can be 
compared to experimental measurements and alternative rate expressions commonly 
found in the literature. It should be noted, however, that working instead with the 
expected time for monolayer formation provides the advantages of a slightly less 
restricted mathematical foundation and distinct contributions from the expected times of 
2D nucleation and partial monolayer spread.  
 
3.13 Derivation of the Correction Factor for the Detachment of Growth Units 
 Suppose we want to know the expected time for a step fragment of n unfilled sites 
to be completely filled, one site at a time. If the expected time for one atom to fill a 
binding site is E(tatt), then the expected time, E(tn,att), for n binding events is: 
 
𝐸(𝑡𝑛,𝑎𝑡𝑡) =  𝑛𝐸(𝑡𝑎𝑡𝑡) 
 If detachment of atoms from binding sites did not occur, then E(tn) would be the 
expected time for the step fragment comprising n atoms to be completed. In reality, 
however, atoms detach from binding sites at a rate of Rdet. Because the detachment is a 







 From the expected times for incorporation and detachment of atoms at binding 
sites, we can write the expected number of attachments, Natt, and detachments, Ndet, from 









 The number of attachments minus the number of detachments gives the net 
number of atoms incorporated, Ninc. The net number of atoms incorporated in time τ, is: 




















 In order to determine the expected time, in seconds, for an atom to be 














 The expected time, E(tn,inc), for n sites to be filled (i.e. Natt – Ndet = n), is therefore 
given by: 
𝐸(𝑡𝑛,𝑖𝑛𝑐) =  𝑛𝐸(𝑡𝑖𝑛𝑐) 




 We see in the last expression, that the net time for n sites to be filled is equal to 












 Alternatively, we can derive this factor from the rates of attachment, detachment, 
and the net rate of incorporation: 
𝑅𝑖𝑛𝑐 = 𝑅𝑎𝑡𝑡 − 𝑅𝑑𝑒𝑡 
 If we assume that the incorporation of growth units is well modeled by a renewal 
process wherein the asymptotic rate of attachment gives a good approximation to the 






















Then the expected time for n sites to be filled is given by: 





































Which again defines the expected time for incorporation as the expected time of 













3.14 Application of the Theoretical Framework to Shape-Controlled Syntheses 
 Shape-controlled syntheses of metal nanoparticles typically rely upon surfactants 
or polymers as shape-directing agents, wherein shape control is thought to be a direct 
consequence of these species adsorbed to specific facets (9, 17, 18). The degree and 
symmetry of surface “blocking” is hypothesized to modulate the growth rates in each 
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crystallographic direction, thereby directing morphology. The motivation for the present 
work was our contrasting observation that a high degree of shape control can be achieved 
without auxiliary additives. Figure 3.2 shows several gold nanoparticle morphologies 
generated from the same starting seed population by finely controlling the kinetics of 
tetrachloroauric acid (HAuCl4) reduction by hydrogen peroxide (H2O2). Energy 
dispersive x-ray scattering (EDS) of the nanoparticles demonstrated clean gold spectra, 
indicating that morphology was not influenced by shape-directing contaminants (Fig. 
3.3). Protocols for each synthesis are provided in the Supplementary Methods. 
 The established (nano)crystal growth theories do not quantitatively explain all of 
our results (see Appendix 1). The existing theories can be broadly classified as 
nucleation-limited, diffusion-limited, or reaction-limited, as defined by the rate-limiting 
step – the nucleation of monolayers, the diffusion of growth units to binding sites, or the 
incorporation reaction of growth units, respectively (7, 9, 12-14, 19). The failure of these 
theories is that they do not correctly account for the rate-limiting step (RLS) of facet 
growth as a function of reaction conditions. For example, if the flux of growth units to 
binding sites is fast with respect to the nucleation rate, then a diffusion-limited theory 
will be invalid and overestimate the facet growth rate. A general expression for the 
design rules of shape-controlled growth will not be possible until the RLS of facet growth 




Figure 3.2 | Shape-controlled  synthesis of gold nanoparticles without surfactants. a, 
Selective formation of various morphologies from the same batch of 3.5 nm gold 
nanoparticle seeds. Nanostars form under the fastest rates of HAuCl4 reduction, followed 
by nanospheres, nanorods, and nanoplates as the reduction rate decreases. The size of all 
shapes can be tuned by adjusting the HAuCl4:seeds ratio. b, Nanostars, nanospheres, 
nanorods, and nanoplates synthesized under optimized conditions. While nanostars and 
nanospheres form virtually quantitatively, the nanorods and nanoplates require post-







Figure 3.3 | Energy Dispersive x-ray Spectra (EDS) of gold nanoparticles. EDS of 
nanostars, nanospheres, nanorods, and nanoplates indicate that the various morphologies 
have the same internal composition of pure gold (i.e. no inclusions or alloys), without 
significant differences in surface chemistry. 
 
 Herein, we solve the problem of identifying the rate-limiting step of facet growth 
from knowledge of the experimental rates. Our new theoretical framework uses literature 
values of diffusion activation energies and atomic vibrational frequencies at different 
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lattice sites to identify the ranges of nucleation rates and diffusional flux that correspond 
to nucleation-limited, diffusion-limited, and reaction-limited growth (16, 20, 21). Crystal 
growth is thus modeled as proceeding by three distinct steps: nucleation of a monolayer, 
diffusion of growth units to a step front, and incorporation of growth units into binding 
sites at the step front (Fig. 3.4).  
Figure 3.4 | Illustration of theoretical considerations. a, Schematic of a crystal facet 
during lateral growth. The surface is populated by terrace (yellow), step (red), and kink 
(white) sites. Important structural terms include the kink density (number of kinks 
divided by total number of step plus kink sites), ρhkl, the step separation, λhkl, and the 
monolayer height, dhkl. b-d, The three primary rates influencing the crystal growth rate in 
the orientation normal to a facet. b, The nucleation rate is the rate at which a critical 
nucleus (blue) – an island of adatoms that will continue to grow rather than dissolve – 
forms on a facet (yellow). c, The “diffusion” rate can refer to different processes in 
different theories. Here, we define the rate of diffusion specifically as the flux of growth 
units to the step front – the region of terrace sites that are one jump from step or kink 
sites (highlighted in light yellow). This definition separates bulk and surface diffusion 
from the incorporation reaction process. d, The incorporation “reaction” rate as defined in 
our treatment is the net rate at which adatoms in the step front (highlighted in light 
yellow) diffuse into kink binding sites (red). The delivery of growth units to kink sites is 
therefore divided into two regimes in our theory: diffusion of growth units from the bulk 




 Figure 3.5 shows the relationship between diffusional flux, nucleation rate, and 
the rate-limiting step for growth of {111} and {100} facets as a function of adsorbed 
chloride ions (see Appendix 2 for Matlab scripts). The relationship between nucleation 
and flux rates and the rate-limiting growth process can be easily visualized in contour 
plots. Nucleation-limited growth occurs at high values of flux and reaction rate (i.e. 
incorporation rate); diffusion-limited growth occurs at high nucleation and reaction rates; 
reaction-limited growth proceeds at high values of flux and nucleation rate. When the 
activation energy for growth unit detachment is sufficiently small, the net flux of growth 
units into binding sites is negative, and dissolution occurs. Interestingly, chloride is 
shown to have a pronounced effect on the balance between nucleation-limited, diffusion-
limited, and reaction-limited growth. The origin of this behavior is the catalytic effect of 
chloride to decrease the activation energies of adatom diffusion into and out of binding 




Figure 3.5 | Crystal growth contour plots for {111} and {100} facets of gold 
nanocrystals. Three distinct regimes can be identified wherein the total facet growth rate 
is limited by the nucleation rate (N), growth unit diffusion rate (D), or incorporation 
reaction rate (R). The presence of Cl-, common to gold nanocrystal syntheses, shifts the 
location of the nucleation-limited, diffusion-limited, and reaction-limited regimes by 
decreasing the activation energies of various surface diffusion processes. The contour 
lines represent the logarithm of the growth rate, such that the depicted rates range from 
100 to 108 nm/s. The Matlab program for generating contour plots is available in 
Appendix 2. 
 
 The crystal growth contour plots can be put into context by considering the 
experimental transition between lateral growth and secondary nucleation. Lateral growth 
is characterized by the lateral advance (i.e. step flow) of partial monolayers across a 
surface as growth units are incorporated at the edges (22, 23). Secondary nucleation 
 90 
occurs when the reduction rate becomes so great that growth units begin to nucleate into 
new seeds, either free in solution or at the surface of existing nanoparticles (24).  In our 
synthesis, crystal growth switches from lateral growth to secondary nucleation as the 
growth rate approaches 100 nm/s. Thus, the shape-controlled region of all morphologies 
other than stars and spheres occurs below this rate (Fig. 3.6). The 100 nm/s contour 
appears below the transition to reaction-limited growth, and becomes further removed 
from the reaction-limited transition as the concentration of chloride in solution increases. 
We therefore conclude within the accuracy of the published activation energies that gold 
nanoparticle growth is not reaction-limited on {111} and {100} facets. This conclusion 
validates the classical hypothesis that rate of growth unit exchange at surface steps is 
sufficiently fast to be negligible for the {111} and {100} facets of gold nanoparticles 
(12). 
 Experimental rate contours reveal whether or not growth is reaction-limited. The 
presence of 200 nm long nanorods after 10 s of growth suggests a {111}-facet growth 
rate of approximately 10 nm/s (i.e. 10 nm/s growth from {111} facets in opposite 
directions). Because the reaction-limited regime begins at rates orders of magnitude 




Figure 3.6 | Changes in crystal growth as a function of growth rate. The twelve TEM 
images correspond to reaction conditions “1 – 12” given in the Supplementary Methods. 
All reactions have the same concentration of seeds and HAuCl4, such that the only 
synthetic variables are the amount of H2O2 and NaOH in solution. Panels 1 – 6 have 19.6 
mM H2O2 and NaOH concentrations decreasing from 3.9 mM to 0.49 mM. Panels 7 – 12 
have no NaOH, and H2O2 concentrations decreasing from 9.8 x 10
-1 M to 4.9 x 10-8 M. 
The reduction rate of HAuCl4 and average growth rate of nanoparticles decreases from 
panel 1 to 12. The dominant type of crystal growth, as determined by the products 
observed, changes as labeled from Secondary Nucleation and Growth in panel 1 to 
Lateral Defect-Mediated with strong influences from screw-dislocations in panel 12.  
 
 We determine whether growth is nucleation-limited or diffusion-limited by 
statistical analysis using our theoretical framework. We compared nucleation-limited and 
diffusion-limited growth by modeling nucleation rate and flux, respectively, to be 
normally distributed random variables with mean equal to the value that yields the 
average experimental growth rate, and standard deviation equal to 1% of the mean. We 
simulated the expected distribution of nanorod growth rates using a Monte Carlo method 
to randomly sample each initial distribution 106 times (Figs. 3.7a,b). Three separate 
regions are highlighted: dissolution (white), lateral growth (green), and secondary 
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nucleation (blue). Nanorod formation occurs in the lateral growth regime with an average 
rate highlighted by the blue dashed line. 
Figure 3.7 | Growth mechanism analysis for gold nanorods. a, Simulated growth rate 
distribution in the diffusion-limited regime. The diffusion-limited hypothesis yields a 
distribution of growth rates not observed experimentally, and incorrectly predicts that 
stars and rods form in the same synthesis (i.e. secondary nucleation and lateral growth). 
b, Simulated growth rate distribution in nucleation-limited regime. The nucleation-
limited hypothesis yields accurate predictions of distributions tightly centered about the 
experimentally observed growth rate. c, Length and width versus number of atoms in 
nanorods. The curves are the best theoretical fits for nucleation-limited growth starting 
from a 4 nm seed (dashed line) and a 7.5 nm seed (solid line). The best fit to data occurs 
for a seed that experiences symmetry-breaking at 7.5 nm which induces a nucleation rate 
on {111} facets that is 76 times faster than the nucleation rate on {100} facets. d, High-
resolution transmission electron micrographs (HRTEM) of gold nanorods. The end facets 
exhibit re-entrant grooves, while the side facets are stepped, but relatively smooth by 
comparison. The grooves are known to catalyze monolayer nucleation, which explains 
the faster nucleation rate on the {111} facets. Matlab scripts for the Monte Carlo 
growth rate simulations are provided in Appendix 2. 
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 Our theoretical framework indicates that gold nanorod growth in our surfactant-
free synthesis occurs by a nucleation-limited mechanism. The nucleation-limited 
hypothesis yields normally distributed growth rates entirely within the lateral regime, 
tightly centered about the experimental growth rate. In contrast, the simulated distribution 
of diffusion-limited growth demonstrates a very poor fit to experimental results, with 
only 29% of seeds growing in the lateral regime. Realistic fluctuations in flux during 
growth would therefore preclude nanorod formation if growth was diffusion-limited. 
 The growth of nanorods is initially symmetric but becomes highly anisotropic 
after a symmetry-breaking event at 7.5 nm. Although the initial seed diameter is 
approximately 4 nm, a plot of experimental nanorod dimensions versus the number of 
atoms they comprise is best fit by a 7.5 nm diameter at the time of symmetry-breaking 
and a 76:1 preference for growth of {111} facets over {100} facets (Fig. 3.7c). 
Interestingly, there are no conditions wherein symmetry breaking at the initial seed size 
of 4 nm gives good correlation to data. Indeed, no rod-like particles are experimentally 
observed when the HAuCl4:seed ratio is decreased such that the average nanoparticle 
diameter falls below 7 nm.  
 The anisotropic growth of nanorods is consistent with a nucleation-limited 
mechanism driven by differences in surface structure. We performed selected area 
electron diffraction (SAED) and HRTEM analyses of the nanorods and found that they 
were multiply twinned (Fig. 3.8) with re-entrant grooves on the {111} end facets, but not 
on the {100} side facets (Fig. 3.7d). The re-entrant grooves are known to increase 
monolayer nucleation rates, which explains why the end facets grow faster than the sides 
(13, 25). Eucentric sample tilting was often required to resolve the structures, but they 
 94 
were clearly and consistently observed. The need for high resolution imaging at the 
proper orientation may explain the lack of previous reports for these structures on metal 
nanorods.  
 
Figure 3.8 | Evidence for five-fold structure of gold nanorods produced by the H2O2-
mediated synthesis. a, HRTEM of gold nanorod prepared by our approach. b, Electron 
diffraction pattern of nanorod in (a) demonstrating a superposition of [100] and [112] 
contributions. c, The electron beam is incident upon the nanorod as depicted in the 
schematic. d, Selected Area Electron diffraction pattern of nanorod in (a). The point 
labeled A corresponds to the [100] orientation and the point labeled B corresponds to the 
[112] orientation. e, The view along [100] produces strong contrast confined near the 
central axis of the rod, as expected from cross-section of the V1 tetrahedral subunit of the 
five-fold twinned structure. Dashed outline is included for clarity. f, The view along 
[112] produces strong contrast throughout the nanorod, as expected from the combined 
V3 and V4 tetrahedral subunits. These results provide strong evidence of the five-fold 




Figure 3.9 | Electron diffraction of gold nanoplates. Electron diffraction analysis of the 
nanoplates reveals a forbidden 1/3{224̅} reflection, indicating the presence of twin planes 
parallel to the top and bottom {111} facets. The electron diffraction pattern shown here 
corresponds to the nanoplate on the left. Several plates were analyzed and all 
demonstrated the forbidden reflection.  
 
 Evidence for nucleation-limited growth of morphologies other than nanorods was 
observed. SAED of nanoplates reveals the forbidden 1/3{224̅} reflection (Fig. 3.9) 
characteristic of parallel twin boundaries known to create re-entrant grooves on the 
nanoplate side facets (25, 26). When the HAuCl4 reduction rate falls below 8.2 × 10
-8 
M/s, heavily defected decahedra, icosahedra, plates, and irregularly twinned particles 
constitute virtually all of the products. The re-entrant features are so pronounced on some 
morphologies (e.g. plates, distorted decahedra, etc.) that they are observed on low-
resolution TEM (Fig. 3.6). The lack of nanorods under these conditions appears to result 
from multiply twinned seeds attaining structural defects other than {111}-facet re-entrant 
grooves, such that the symmetry-breaking event for nanorod growth does not occur.  
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Figure 3.10 | Tunability of nanostars. a, As the HAuCl4 reduction kinetics increase, 
protrusions begin to grow outward from the nanoparticle core. The aspect ratio of the 
protrusions increases until an optimum is reached, beyond which the aspect ratio 
decreases and the number of protrusions increases. b, TEM image of characteristic 
nanostars formed under the minimal reaction rate sufficient to produce stable nanostars in 
high yield (1.0 mM/s). c, TEM image of characteristic nanostars formed under the fastest 
reaction kinetics tested shows that the number of protrusions increases and their aspect 
ratio decreases relative to the nanostars formed under slower kinetics. d-f, Nanostars 
grown from different seed diameters. The average number of protrusions per particle 
increases while maintaining the same total diameter as the seed size is increased from (d) 
5 nm, to (e) 15 nm, to (f) 33 nm. Scale bars are 50 nm in b-c, and 100 nm in d-f. 
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 When the kinetics of HAuCl4 reduction exceed 1.4 × 10
-4 M/s secondary 
nucleation occurs, resulting in nanospheres and nanostars. Depending on the relative rates 
of secondary nucleation and Ostwald-type ripening, the nanoparticles either grow by 
dendritic branching (nanostars) or birth and spread of small protrusions (nanospheres). 
Accordingly, the length of the nanostar branches can be tuned to a moderate degree 
simply by controlling the HAuCl4 reduction kinetics and oxidation potential (Fig. 3.10a-
c). The average number of branches per particle could be controlled by the size of the 
initial seed particles, with more branches observed as the seed size increased (Fig. 3.10d-
f). The protrusion ripening process was accelerated by the presence of chlorine in the 
synthesis (27). Consequently, removing the chlorine immediately after synthesis 
stabilized the nanostar morphology (Fig. 3.11). Dialysis of the nanostars afforded 
stability in excess of six months at room temperature. Alternatively, increasing the 







Figure 3.11 | Nanostar transformation and stabilization. a, Absorbance spectra of as-
synthesized gold nanostars that were not subjected to post-processing measured at the 
indicated time points. b, Absorbance spectra of as-synthesized gold nanostars that were 
immediately dialyzed to remove residual reagents measured at the indicated time points. 
c, Localized surface plasmon resonance (LSPR) maximum plotted against time. No shift 
was observed for the dialyzed gold nanostars, while the absorbance maximum of non-
dialyzed gold nanostars rapidly red-shifted over time approaching 540 nm (LSPR of 
spherical gold nanoparticles). d, TEM images demonstrated spherical transformation of 
the non-dialyzed gold nanostars over time, while the star-shape of the dialyzed gold 
nanostars was preserved. Scale bars are 50 nm. 
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Figure 3.12 | Crystal growth regimes for gold nanoparticles. a, The transition between 
lateral growth and secondary nucleation was experimentally observed when growth rates 
approached 100 nm/s. This rate is highlighted in red on the contour plot for chloride-free 
media. As chloride is introduced, the 100 nm/s contour moves toward the nucleation-
limited regime. Lateral growth of {100} and especially {111} gold facets tend to be 
nucleation-limited under surfactant-free conditions. b, The five primary regimes of 
crystal growth are placed into context based on the empirical findings in this study. The 
HAuCl4 reduction rates approximate the transitions between different types of growth. 
The transitions are not sharp, as they represent the conditions when the major product 
(i.e. highest-yield) morphologies of the reaction change. For example, “lateral 
asymmetric” nanorods can be observed as a minority product in the “lateral symmetric” 
regime. Matlab scripts for generating contour plots from the theoretical framework 
are provided in Appendix 2. 
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Figure 3.13 | Kinetics of HAuCl4 reduction. The absorbance of Au(III) was monitored 
by UV-visible spectroscopy at 300 nm. Representative syntheses were performed from 
which aliquots were removed at the measured time points and added to an equal volume 
of a 2 % polyvinylpyrrolidone (PVP; 10 kDa) quenching solution. All measurements, 
including calibration curves, were performed on the same well plate. 
 
 
Extended Data Figure 3.14 | Yield of product morphologies. a, Centrifugal split-flow 
thin (C-SPLITT) separation was performed on a representative sample of nanoparticles 
synthesized in the lateral growth regime. The unpurified sample exclusively contained 
rods, plates, decahedra, and icosahedra, as observed by TEM. The eluent fractions were 
analyzed by TEM and revealed that the particles eluted in the order rods, plates, 
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decahedra, icosahedra. The experimental data was fit by assigning a Gaussian to each 
peak, and the relative area of each Gaussian was used to determine the yield of the 
corresponding shape. The fit shows that our products comprise 44.9% plate-like, 43.3% 
five-fold twinned (i.e. rods plus decahedra), and 11.7% icosahedra. The starting seed 
population has been identified to comprise 45% plate-like, 45% five-fold twinned, and 
10% icosahedral seeds by high-resolution TEM analysis. The correspondence between 
product crystallinity and seed crystallinity indicates that products are predominantly 
formed via growth of single seeds. 
 
 The theoretical and experimental results reported herein can be summarized into 
distinct regimes of gold nanocrystal growth, classified by the type of growth – lateral or 
secondary nucleation – and subclassified by the major products observed (Fig. 3.12). For 
reference, the reduction rates of HAuCl4 that approximate the transitions between 
regimes are labeled in Figure 3.12 (see Fig. 3.13 for spectroscopic data). Because stars 
and spheres form via a secondary nucleation mechanism there is no strong correlation 
between the initial seed structure and the product structure. Lateral growth, however, is 
very sensitive to the initial seed structures. Figure 3.14 demonstrates that the crystallinity 
of products formed in the lateral asymmetric regime directly corresponds to the 
crystallinity of the initial seeds, with the exception that re-entrant grooves become 
introduced into the multiply-twinned seeds that grow into rods. In this regard, the yield of 
a particular shape is fundamentally dependent on the yield of the corresponding seed, 
such that high-yield surfactant-free syntheses can be simply achieved as soon as the 




Figure 3.15 | Performance of surfactant-free nanoparticles in surface-dependent 
applications. Surfactant-free nanoparticles outperform similar morphologies with 
polymer or surfactant coatings. a, Catalytic efficiency for the conversion of resazurin to 
resorufin with hydroxylamine using surfactant-free, PEG-SH, and CTAB-coated gold 
nanostars. Error bars represent the standard deviation of triplicate data. b, Surface-
enhanced Raman scattering spectrum of 1,2-di(4-pyridyl)ethylene on surfactant-free, 
PEG-SH, and CTAB-coated gold nanostars. Nanostars were chosen as the proof-of-
concept morphology tested because uniform samples could be obtained for all surface 




 Although the present findings highlight a gold nanoparticle synthesis free of 
surfactants and polymers, it should be noted that this theoretical framework is broadly 
applicable to more complex synthetic environments, provided the appropriate activation 
energies and vibrational frequencies are computed. Accordingly, we anticipate that this 
work will motivate new investigations into the activation energies of surface diffusion 
processes for various materials under relevant experimental conditions. The concept of 
shape-directing agents, though not discredited by this study, should be cautiously applied 
given the alternative routes to a given morphology. The significantly enhanced 
performance of these additive-free nanoparticles in surface-dependent applications such 
as catalysis and surface-enhanced Raman scattering (Fig. 3.15) is expected to stimulate 
further research into the control of seed crystallinity such that any geometry presented 




Extended Data Figure 3.16 | Summary of design considerations for surfactant-free 
syntheses. Each product morphology forms from a corresponding seed. All types of 
seeds (e.g. icosahedral, five-fold twinned, plate-like, etc.) can grow into spheres and stars 
if the reduction rate of HAuCl4
- is sufficiently fast. The polyhedral shapes can only be 
formed in high yield if the corresponding seed is present in high yield. Nanorod 
formation has the additional requirement that the seed posses re-entrant grooves 
(highlighted in red on five-fold seed) on the {111} facets. The reduction rates and 





 Hydrogen peroxide (TraceSELECT; Sigma Aldrich) and all other chemicals were 
ordered from Sigma-Aldrich with the highest purity available and used as received. In all 
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cases 18.2 MΩ∙cm water was used. Slide-A-Lyzer 2K Dialysis Cassettes G2 were 
ordered from Thermo Scientific and used in all dialysis experiments. 
 
Gold Nanoparticle Characterization 
 HRTEM analyses, bright and dark field images from Fig. 3 and Extended Data 
Figs. 4, and 5, and electron diffraction were performed on 200kV JEOL 2100F High-
Resolution Transmission Electron Microscopes from Brookhaven National Laboratory 
and Hunter College. TEM bright field images from Fig. 1 and Extended Data Figs 3,6, 
and 7 were acquired using a JEOL 1200 EX-II TEM at Memorial Sloan Kettering Cancer 
Center. EDS was obtained with EDAX hardware and software from the JEOL 2100F 
HRTEM at Hunter College. Nanoparticle concentrations were determined by nanoparticle 
tracking analysis (Nanosight; Salisbury, United Kingdom). Nanoparticle separations were 
performed by Postnova Analytics Inc. (Salt Lake City, UT, USA) using centrifugal split-
flow thin fractionation (C-SPLITT). 
 
Gold Nanoparticle Synthesis 
 3.5 nm gold seeds – 3.5 nm seeds were synthesized by a modification of the 
standard NaBH4 method. Briefly, 100 μL of 25.4 mM HAuCl4 was added to 10 mL of 
H2O, then 300 μL of 100 mM ice-cold NaBH4 was added to this solution under vigorous 
stirring. The formation of seeds could be monitored by the immediate appearance of an 
orange-brown color. These seeds were used in all reactions without further treatment. We 
observed that dialysis of the seeds in a 2,000 Da molecular weight cut-off cassette to 
remove unreacted ions did not prevent the formation of any morphologies, nor did the 
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addition of citrate to the seed synthesis. Therefore, the influence of the capping agents 
present on the seeds was treated as negligible in our syntheses. Dr. Stefan Harmsen and 
Gianluca Arianna independently verified all synthetic methods. 
 
Nanoplates – 150 μL of as-prepared 3 nm seeds were added to 9.85 mL of H2O. 150 μL 
of 25.4 mM HAuCl4 was added to the mixture and the reaction was initiated by the 
addition of 200 L of 0.3% (v/v) H2O2 under stirring. 
 
Nanorods – 600 μL of as-prepared 3 nm seeds were added to 9.40 mL of H2O. 30 μL of 
30% H2O2 was added to this mixture and the reaction was initiated by the addition of 300 
μL of 25.4 mM HAuCl4 under vigorous stirring. The best results were obtained by adding 
the HAuCl4 in increments of 30 μL every 2 - 3 seconds. 
 
Nanospheres – 30 μL of as-prepared 3 nm seeds were added to 9.97 mL of ice-cold H2O. 
150 L of 25.4 mM HAuCl4 was added to this mixture and the reaction was initiated by 
adding a solution of 15 μL 1 M NaOH dissolved in 1 mL of 0.3% H2O2. The balance 
between NaOH and seed concentration is very sensitive during sphere formation. When 
the synthesis begins with the appearance of a blue color, less NaOH should be used. 
When rods or other anisotropic polyhedra are observed in the products, more NaOH 
should be used. Addition of chloride or bromide before reduction of HAuCl4 greatly 
improves the symmetry of the spheres. 
 
 107 
Nanostars – 30 μL of as-prepared 3 nm seeds were added to 9.97 mL of ice-cold H2O. 
150 L of 25.4 mM HAuCl4 was added to this mixture and the reaction was initiated by 
adding a solution of 50 μL 1 M NaOH dissolved in 1 mL of 0.3% H2O2. Some syntheses 
generate stars that transform more rapidly than others, but this can be controlled to an 
extent by consideration of the oxidation potential generated during HAuCl4 reduction. In 
general, the amount of NaOH added should be the minimal amount necessary to generate 
stars, and increasing the pH beyond this point results in increasingly rapid transformation. 
 
Procedure for removing residual chemical species 
 
Washing – Immediately after the nanostars are synthesized they are diluted to 150% of 
their original volume by the addition of ice-cold H2O. The solution is then split into two 
separate centrifuge tubes and spun down for the minimal amount of time necessary to 
collect the nanostars at the bottom of the tube at 8000 rpm (e.g. approximately 4 
minutes). The supernatant is removed and a small volume of ice-cold H2O is added in 
order to enable effective redispersion of the nanostars via ultrasonication. Finally, the 
original reaction volume is obtained by dilution with ice-cold H2O. 
 
Note: Repeating this process multiple times can result in aggregation; however it is 
difficult to remove all residual reagent traces in one wash, thus shape-transformation is 
not prevented indefinitely by this method. 
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Dialysis – Immediately after the nanostars are synthesized they are added to a 2,000 Da 
MWCO Slide-A-Lyzer dialysis cassette that is then placed into a large volume of H2O 
and subjected to slow stirring. The dialysis water is replaced periodically until residual 
chemical species are removed. Our investigations did not reveal the presence of any 
impurities on the nanoparticle surface to suggest that cassette-derived particle stabilizing 
effects (e.g. membrane polymer leaching) occurred.  
 
Catalysis 
 The catalytic reduction of resazurin to resorufin mediated by hydroxylamine in 
the presence versus absence of gold nanoparticles serves as an assay for their efficacy as 
catalysts. 1 μL of 5 mM resazurin was added to 100 µL of 33 pM gold nanostars and 150 
mM hydroxylamine in 10 mM pH = 7.3 MES buffer. At the desired time point, the 
sample was centrifuged at 10,000 rpm for three minutes and 80 μL of the supernatant was 
removed, then added to 200 μL of pH = 7.3 MES buffer in a clear-bottom 96 well plate. 
The fluorescence intensity at an excitation wavelength of 571 nm and emission 
wavelength of 584 nm was followed every ten minutes after reaction initiation. The 
fluorescence intensity of the control reaction of resazurin and hydroxylamine in the 
absence of gold nanostars remains virtually constant indicating that resazurin is not being 
converted into resorufin (data not shown). All experiments were performed in triplicate 





Surface-Enhanced Raman Scattering 
 Nanostars were evaluated as substrates for surface-enhanced Raman scattering 
(SERS). 1 μL of 0.5 mM 1,2-Di(4-pyridyl)ethylene was added to 20 μL  of 0.50 nM 
aqueous nanostar samples and allowed to stir for 15 minutes at room temperature. SERS 
spectra were then recorded by a Raman spectrometer (Renishaw, Gloucestershire, UK) 
with 785 nm laser excitation at 3 mW/cm2 for 1 s. No aggregation was present in any of 
the samples, insuring that the SERS intensity was not complicated by the presence of 
aggregation-induced hotspots. 
 
Monte Carlo Calculations: 
 Expected distributions of nanorod growth rates from nucleation-limited and 
diffusion-limited hypotheses were generated in Matlab (see Appendix 2 for Matlab 
Scripts). Nucleation rate and flux (i.e. diffusion rate) were modeled as normally 
distributed random variables. The mean nucleation rate and flux were chosen to be the 
values that that give the experimental growth rate (i.e. 10 nm/s from {111} facets) under 
nucleation-limited and diffusion limited hypotheses, respectively. The standard deviation 
was set to be 1% of the mean. The input distributions were randomly sampled 106 times 
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 Sections 4.8, 4.9, and 4.12 are adapted from our publication in Nano Letters (1). 
Accordingly, the figures and text in those sections are the result of collaborative data 





 Encapsulation – the addition of an outer layer to envelop a substrate – is often 
essential to the performance and longevity of a material for a given application (2-4). The 
advantages of encapsulation are particularly notable on the nanoscale, where 
functionality is strongly correlated with shape and composition (5-8). Encapsulant layers 
can fix the shape and structure of a nanomaterial, shield an active surface or component 
from environmental influences, separate compartments of a multicomponent 
nanostructure, and provide new functionality (3, 9-11).  
 Encapsulation is a necessary step in the synthesis of surface-enhanced Raman 
scattering (SERS) nanoprobes because it inhibits detachment of Raman-active molecules 
and prevents unwanted environmental species from interfering with the substrate-analyte 
(e.g. metal-molecule) interface (3, 12-14).  Furthermore, the encapsulant layer of SERS 
nanoparticles enables incorporation of functional additives (e.g. radiotracers, fluorescent 
molecules, etc.) and surface moieties such as polymers or targeting agents (10, 15-17). In 
this chapter, we focus on the use of silica as a functional encapsulant, particularly as it 
pertains to the creation of multimodal SERS-based contrast agents. 
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4.2 Background 
 Nanoprobes constructed for biomedical applications must provide high signal-to-
noise ratios, demonstrate satisfactory pharmacokinetic properties, and remain sufficiently 
stable and non-toxic in vivo for the benefits of improved imaging or therapy to offset the 
risk of unintended medical consequences (18-21). In the case of SERS nanoprobes, the 
requirements of high signal-to-noise ratio and stability in vivo necessitate encapsulation 
of the substrate-analyte (e.g., metal-molecule) interface (13). Common encapsulant 
materials include Bovine serum albumin (BSA), polymers (e.g., thiolated poly(ethylene 
glycol), polyvinylpyrrolidone, etc.), and silica (12). Although future SERS substrates 
may be made of materials other than gold (e.g. semiconductors) and thus require different 
approaches to encapsulation, the methods and results presented here will focus on the 
current state-of-the art: gold nanoparticle cores encapsulated in silica shells (17, 22, 23). 
 
4.3 The chemistry of silica 
 Silica is typically synthesized by the hydrolysis and condensation of a precursor 
molecule (24-26). The most common approach is the sol-gel synthesis developed by 
Stöber (24). In the Stöber method, tetraethyl orthosilicate (TEOS) is hydrolyzed under 
basic conditions in a solvent of alcohol and water. The hydrolyzed monomers condense 
into nanoparticles or gel-like networks depending upon the ratios of TEOS, base, alcohol, 
and water (27). The reaction scheme is shown in Fig. 4.1.  
 The species and concentration of the silica precursor, the solvent composition, 
and the pH of the solution control the rates of hydrolysis and condensation (24). Both 
reactions proceed via nucleophilic attack in an SN2 mechanism (25, 27). Accordingly, 
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polar protic solvents were initially expected to promote the fastest reaction rates because 
they hydrogen bond with the leaving group, stabilizing the transition state of both 
reactions (25, 28). While polar protic solvents do yield the fastest hydrolysis reactions, 
investigations into the condensation rates revealed that the less polar solvents induced 
faster condensation rates (29). A likely reason for this is that the solubility of hydrolyzed 
moieties decreases as solvent polarity decreases, creating an increased driving force for 
condensation (30).  
 
Fig. 4.1 | Reaction scheme of Stöber process. The formation of silica from silane 
precursors proceeds via hydrolysis and condensation.  
 
 Because silica formation is typically limited by the rate of hydrolysis, the 
nucleation rate increases as the molecular weight of the alcohol decreases, although 
anomalous effects have been reported (30). Reactions with the fastest nucleation rates 
generate the greatest number of nanoparticles. Consequently, the final silica diameter 
decreases as the molecular weight of the solvent alcohol decreases because the 
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concentration of silica precursor is divided into a larger number of particles for the faster 
nucleation rates. 
 
4.4 Synthesis of silica nanoparticles 
 Narrowly dispersed populations of silica nanoparticles can be synthesized by the 
Stöber process. A standard protocol for the formation of 125 nm silica nanoparticles is 
provided in the methods section at the end of the chapter. The average nanoparticle 
diameter can be easily tuned by changing either the water content or solvent alcohol (Fig. 
4.2). Increasing the concentration of water increases the overall rate of hydrolysis and 
condensation such that more particle growth occurs over time. When water is the limiting 
reagent, increasing the amount of water will increase the final nanoparticle diameter 
approximately linearly (Fig. 4.2A). Increasing the molecular weight of the solvent 
alcohol while keeping the concentrations of all other reactants constant also increases the 
average nanoparticle diameter. Decreasing the molecular weight of the solvent alcohol 
increases the solvent polarity, which increases the nucleation rate. Accordingly, the 
higher molecular weight alcohols nucleate fewer silica nanoparticles, but grow them to a 
larger final diameter (Fig. 4.2B) as discussed in section 2.3.  
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Fig. 4.2 | Silica diameter as a function of solvent. (A) Silica nanoparticles synthesized 
according to the Stöber process in ethanol with varying water content. The average 
nanoparticle diameter decreases as the percent by volume of water is decreased from 10 
% to 2.5 %. (B) Silica nanoparticles synthesized in isopropanol (IPA), ethanol (EtOH), 
equal parts ethanol and methanol by volume (EtOH/MeOH), and methanol (MeOH). The 
average nanoparticle diameter decreases as the molecular weight of the alcohol decreases. 
 
4.5 Silica formation from the perspective of nucleation theory  
 Studying the nucleation of silica from the perspective of classical or generalized 
nucleation theory (chapter 2) reveals interesting insights into the process of silica 
formation. Small-angle x-ray scattering (SAXS) coupled with 29Si-nuclear magnetic 
resonance (NMR) experiments show that the nucleation of silica begins with the initial 
build up of singly-hydrolyzed monomers (HO-Si(OCHCH2)3) during an induction period 
wherein no nuclei form (29, 31). In line with the nucleation theories presented in chapter 
2, the concentration of this hydrolyzed species (i.e. growth unit precursor) must reach a 
critical supersaturation before silica nuclei begin to form. Once the size of the nuclei 
exceed the critical radius, they grow spontaneously into larger silica nanoparticles. 
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In contrast to the classical picture of nucleation, however, silica nuclei form by a two-step 
mechanism (29, 31). First, the partially hydrolyzed monomers react with other silica 
precursor species (e.g., monomers and oligomers) via SN2 nucleophilic substitution to 
generate open polymers (25, 27). Next, fractal-like growth increases the density of the 
polymeric structures without notably increasing their overall radii, ultimately resulting 
amorphous solid nanoparticles (29, 31).  
 The two-step nucleation mechanism of silica presents two primary routes to 
controlling the nucleation rate. Because open polymers must form prior to nucleation, 
reaction conditions that yield fast SN2 reactions – polar protic solvents with high 
concentrations of nucleophiles – will exhibit fast nucleation rates. Thus, the first means 
of controlling nucleation rate is to control the rate of hydrolysis reactions (see sections 
4.3, 4.4). The second approach to nucleation rate control is to manipulate the 
condensation process of the open polymer reacting with itself. When a substrate surface 
sufficiently catalyzes this process, encapsulation of the substrate will occur preferentially 
over nucleation free in solution (i.e., heterogeneous nucleation is favored over 
homogeneous nucleation). 
 
4.6 Silica encapsulation of metal nanoparticles 
 Encapsulating a substrate with silica is not as straightforward as simply 
introducing the substrate into an established Stöber process (3, 9). In fact, the rapid 
homogeneous nucleation of silica in the Stöber process presents a significant challenge 
with respect to encapsulation. Because the homogeneous nucleation rate is so fast, it is 
challenging to make the heterogeneous nucleation (i.e., surface nucleation) rate 
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sufficiently favorable to induce encapsulation rather than free silica nanoparticle 
formation (3). The silication of gold nanoparticles is particularly difficult to control 
because gold is not a vitreophilic material (i.e., the binding energy between silica and 
gold is low) (32). 
 Gold nanoparticle silication was originally achieved by a “surface primer” 
method, wherein the gold surface is pretreated to become vitreophilic (32). First, the gold 
surface is modified in aqueous solution with small molecules comprising either an amine 
or thiol functional group bound to a trimethoxysilane moiety. The amine or thiol group 
has high affinity for gold, while the trimethoxysilane moiety is reactive toward silica. 
Next, sodium silicate is introduced to form a thin silica layer at the modified gold surface. 
The nanoparticles are centrifuged and redispersed into a Stöber reaction mixture. When 
the Stöber process is initiated (e.g., by the addition of NH4OH), hydrolysis and 
condensation of silica precursors proceeds rapidly at the nanoparticle surface. Because 
the nanoparticle surface has been primed with a thin layer of silica, surface nucleation is 
not required for growth of the silica shell. Thus, encapsulation proceeds rather than free 
silica formation because growth is not inhibited by a nucleation barrier at the surface. 
 Despite the low affinity of silica for gold, “primer-free” silication can be achieved 
under judicious control of reaction conditions in the Stöber process (2, 12). In order to 
explain the origin of preferential surface nucleation, we recall that the rate of a chemical 
reaction increases exponentially as its activation energy decreases. The activation energy 
is the difference between the average total energy of all reacting pairs of reactants minus 
the average total energy of all pairs of reactants (i.e., reacting and non-reacting pairs) 
(33). Thus, the activation energy can be decreased by increasing the average total free 
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energy of all pairs of reactants. In other words, the surface nucleation rate will be fast if 
the reactants have large enthalpies or small entropies at the substrate-solution interface.  
 The decrease in reactant pair entropy at gold nanoparticle surfaces promotes 
encapsulation rather than free silica nucleation in solution. In particular, adsorbed 
reactant molecules have their translational degrees of freedom decreased, and depending 
upon their diffusion mean free paths may have substantially restricted motion relative to 
their state free in solution. Conceptually, confined motion of reactants at the nanoparticle 
surface increases the probability of collisions that generate products, even if the 
adsorption energy is not particularly high (34). The confined motion at the substrate 
surface will, therefore, catalyze condensation reactions of open polymer silica precursors 
(section 4.5) with other reactants and with themselves (i.e., densification), generating 
amorphous solid silica nuclei selectively at the surface. 
 
 
4.7 Synthesis of SERS nanoprobes 
 
 In addition to the design considerations presented in the last section, the gold-dye 
affinity and colloidal stability must be taken into account (12). In order to maximize the 
number of dye molecules on the gold nanoparticle surface, either positively charged or 
neutral species must be used (assuming a negatively charged gold nanoparticle surface) 
(17). The coulombic repulsion between negatively charged surfaces and negatively 
charged dyes precludes the formation of strong metal-molecule binding. When neutral 
species are used, it is important that either nitrogen or sulfur atoms are available for 
binding to the gold, such that the molecule remains adsorbed to the surface (17). 
Additionally, molecules with large Raman cross-sections are necessary for high SERS 
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intensity. The dyes that meet all of these requirements are typically resonant with the 
incident laser and form J-aggregates or have degenerate vibrational modes that yield one 
or two particularly intense peaks (17, 23, 35, 36). 
 Once the optimal dye has been selected, thorough optimization of the silica 
encapsulation procedure must be done in order to prevent aggregation of the gold 
nanoparticles (i.e., the cores) (12). Introducing a dye molecule, typically with one or 
more counterions, raises the ionic strength of the solution, which decreases the electric 
double layer responsible for colloidal stability. Furthermore, adsorption of positively 
charged dye molecules decreases the magnitude of the zeta-potential at the gold surface. 
 In order to maximize the amount of molecules that can adsorb to the gold surface 
without inducing aggregation, the destabilizing effect of counterions must be mitigated. 
This is achieved by using the most chaotropic counterion species – defined by their 
ability to disrupt the polar protic solvent molecules and stabilize the increasingly non-
polar nanoparticles (i.e., the magnitude of the zeta-potential decreases and the 
hydrophobicity increases as more dye molecules adsorb to the surface) (17). The 
chaotropic anions that we found best-promoted colloidal stability are perchlorate and 
hexafluorophosphate. 
 The optimal reaction conditions for SERS nanoprobe synthesis are those that 
narrowly avoid aggregation. Gold nanoparticles that are far from aggregation (i.e., highly 
stable with respect to precipitation) necessarily have less than their maximum proportion 
of adsorbed Raman dye molecules. Consequently, they do not exhibit their maximum 
SERS. The amount of dye that should be added into a SERS nanoparticle synthesis is 
determined by the relative rates of gold aggregation and silica encapsulation. If the 
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silication procedure has an incubation time of 15 minutes before a shell begins to form, 
then the amount of dye that induces precipitation of gold cores just after 15 minutes 
should be used. Additionally, the initial reaction mixture should be split into two large 
volumes – one containing the gold nanoparticles and the other containing the dye – so 
that the local concentration of dye molecules is never sufficiently high to induce 
precipitation.  
 
Fig. 4.3 | Silica shell diameter as a function of water concentration. When water is the 
limiting reagent of the silication experiment, the final shell thickness is proportional to 




Figure 4.4 | SERRS-signal intensity of resonant cyanine and chalcogenopyrylium 
dyes. (A) Structure of the resonant dye IR792 and chalcogenopyrylium dye CP3 from 
reference 17. (B) SERRS intensity of an equimolar amount of IR792-based SERRS-
nanoprobes and CP3-based SERRS-nanoprobes that were synthesized with equimolar 
amounts of the dyes. (C) Limits of detection of the IR792- and CP3-based SERRS-
nanoprobes were determined to be 1.0 fM and 100 attomolar, respectively. This figure is 
adapted from our publication in Nature Communications (17). Data obtained by Dr. 
Stefan Harmsen. 
 
 The optimized protocol for SERS nanoprobe synthesis is presented in the methods 
section at the end of this chapter. The silica shell thickness is easily tuned by controlling 
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the concentration of water (i.e., increasing water increases silica shell thickness) (Fig. 
4.3). By developing resonant dyes with high affinity for gold nanoparticle surfaces, using 
chaotropic counterions, and optimizing our encapsulation procedure, we have generated 
SERRS nanoprobes with attomolar limits of detection (Fig 4.4) (17). 
 
4.8 Silica as a multifunctional encapsulant 
 
 In addition to stabilizing the structure of a substrate and protecting it from 
environmental factors, the materials properties of an encapsulant layer can afford 
complimentary functionality to a substrate. In the context of SERS nanoparticles, 
encapsulant materials that improve the depth at which the nanoparticles can be detected 
below the tissue surface are particularly desirable. Accordingly, materials capable of 
providing positron emission tomography (PET), single-photon emission computed 
tomography (SPECT), or magnetic resonance imaging (MRI) contrast would prove to be 
particularly attractive encapsulants for SERS nanoparticles (37-40).  
 PET, SPECT, and MRI contrast is typically achieved via surface functionalization 
of small molecular chelating agents that bind radionuclides or gadolinium (41). This 
approach presents several well-known disadvantages, particularly for PET and SPECT. 
Since the coordination chemistry of different nuclides varies greatly, there is no 
molecular chelator that can effectively bind many radionuclides interchangeably. Thus, 
for a given radiotracer, selection of and particle modification with the proper chelator 
may be very difficult or even impossible (42). Even when nuclides are stably chelated 
during radiolabeling, introduction of the nanoparticle in vivo presents a new set of 
challenges. Transchelation by endogenous proteins or detachment of the surface-bound 
molecular chelators can strip the nanoparticles of their radiolabels, yielding images that 
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do not reflect the true biodistribution (43). We note that iron oxide can alternatively be 
used for MRI contrast, but its absorption in the near-infrared window precludes its use as 
an encapsulant for SERS nanoparticles (44). 
 
 In response to the abovementioned concerns, several chelator-free approaches to 
nanoparticle labeling have emerged and are the subject of a recent review (42). These 
methods largely fall into three categories: inclusion of a trace amount of radioactive 
precursor during a typical nanoparticle synthesis (e.g. including a small amount of 64Cu 
during synthesis of CuS nanoparticles) (45), entrapment of radionuclides into sites 
capable of binding specific species (e.g. addition of 18F to NaYF4 nanoparticles, 
64Cu into 
porphysomes, etc.) (46, 47), and cation exchange replacing one (cold) cation present in a 
nanoparticle for a different radioactive cation (e.g. 153Sm replacing Lu3+ or Y3+ in 
upconverting nanoparticles) (48). While these approaches eliminate the need for 
molecular chelators during nanoparticle radiolabeling, they remain restricted to specific 
nuclides, rather than being effective general platforms for many species. 
 A generalized method for producing nanoparticles that are capable of intrinsically 
binding a wide variety of radionuclides without additional selective chelation molecules 
would be highly desirable. It would provide a "one stop" nanoparticle that can be 
radiolabeled for multiple applications without being individually modified with different 
chelators each time. To this end, we first identified some important properties shared 
between many common nuclides. The majority of medically relevant nuclides are 
chelated by electron donors (e.g. oxygen, sulfur, or nitrogen atoms) arranged in a 
symmetry that results in a stable coordination complex (49). In this regard, it is 
reasonable to hypothesize that a chelator-free nanoparticle for intrinsic radiolabeling 
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could be constructed by creating a nanoparticle with oxygen atoms arranged in a variety 
of symmetries. A prototypical example of a material meeting these requirements is 
amorphous silica, which has the benefits of well-established synthetic protocols and 
widespread use in biomedical applications (24, 50). Silica nanoparticles are known to 
bind heavy metal ions for environmental remediation (51, 52).  Because silica 
nanoparticles are inexpensive and certain formulations have been approved for clinical 
trials by the United States Food and Drug Administration, they make for ideal substrates 
in a kit-like protocol for producing intrinsically labeled nanoparticles (53). 
 
4.9 Silica as a general substrate for chelation of oxophilic species 
 We investigated the ability of amorphous silica nanoparticles to bind a variety of 
medically important radionuclides with a range of half-lives and emissions. In particular, 
we explored the labeling efficiency of 68Ga, 64Cu, 89Zr, 90Y, 111In, and 177Lu under various 
temperatures, pH, and incubation times (Fig. 4.5). 89Zr was further investigated using 
silica nanoparticles that had been coated with polyethylene glycol.  The 145 nm silica 
nanoparticles were synthesized according to a modified Stöber process (24), washed three 
times in ethanol and then resuspended in buffered solutions at either pH = 5.7, 7.3, or 8.8 
(see methods). The silica nanoparticles maintained a constant size and did not aggregate 
during this process (Fig. 4.6). The radiochemical yield was assessed both by instant thin-




Fig. 4.5 | Scheme for intrinsic radiolabeling of silica nanoparticles. The nanoparticles 
are incubated with free radionuclide at 70°C for 15 to 60 minutes depending on specific 
radionuclide, then purified by centrifugation and resuspension. 
 
 
Fig. 4.6 | Pre- and post-radiolabeling nanoparticle characterization. (A) Atomic force 
microscopy (AFM) and transmission electron microscopy (TEM) characterization of 
silica nanoparticles before radiolabeling. (B) AFM and TEM characterization of silica 
nanoparticles after radiolabeling with 68Ga. The size and shape of the nanoparticles 
remains unchanged. Scale bars are 100nm. 
 
 When the specific activity is 100 Ci/μmol, all nuclides tested demonstrate 
radiochemical yields of >99% at pH = 7.3, 70°C, and incubation times less than or equal 
to one hour. The radiochemical yield improves as temperature increases from 4°C to 
70°C, but does not vary significantly as a function of pH in the range investigated (pH = 
5.7 – 8.8). Buffer without silica nanoparticles was used as a control for each condition to 
exclude the possibility of false-positive signals due to precipitate formation. Every 
 128 
nuclide except 177Lu shows >95% activity as free in solution, in agreement with previous 
reports (54).  
 
Fig. 4.7 | Radiolabeling and serum stability of silica nanoparticles. (A) Instant thin-
layer chromatographs of radiolabeled silica nanoparticles. The red asterisk denotes the 
origin, where the nanoparticles remain, and the black asterisk denotes the solvent front, 
where the free activity would be located. Controls of buffer-only solutions (no particles) 
were ran with each condition, with >95% signal at the free activity peak. (B) Percent 
radionuclide bound to silica nanoparticles as a function of time and pH. The blue, red, 
and green lines indicate radiolabeling at pH = 5.5, 7.3, and 8.8, respectively. (C) Percent 
radionuclide bound to silica nanoparticles as a function of time and temperature. The 
blue, red, and green lines indicate radiolabeling at 4°C, 37°C, and 70°C, respectively. (D) 
Serum stability of silica nanoparticles radiolabeled at pH = 7.3 and 70°C, then incubated 
in 50 % FBS at 37°C. The approach of using silica nanoparticles for oxophilic 
radiolabeling was proposed by Matthew Wall. The data presented in this figure was 
collected by Travis Shaffer (1). 
 
 Because 177Lu exhibits >10% signal associated with precipitate formation in the 
buffer control, centrifugation and size exclusion filtration is necessary in the analysis of 
177Lu radiolabeling to ensure that false-positive signals from precipitates do not occur.  
Separating the particles from the supernatant shows that virtually all radioactivity is 
associated with the nanoparticles, independent of temperature. Competitive chelation 
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studies with ethylenediaminetetraacetic acid (EDTA) demonstrate that only samples 
incubated at 70°C robustly retain the various nuclides. This suggests that the dominant 
influence of the temperature is in overcoming the activation energy required for stable 
radionuclide binding, rather than enabling delivery of the radionuclides to binding sites 
(i.e. the process is reaction limited, not diffusion limited). This finding is supported by 
the observation that the silica nanoparticles are sufficiently porous to enable diffusion of 
the radionuclides throughout the nanoparticle interior (Fig. 4.8).  
 
Figure 4.8 | Pore size of silica nanoparticles. Atomic force microscopy of silica 
nanoparticle samples reveals porous surfaces with many pore diameters in excess of 5 
nm. Low magnification phase images (left) and high-magnification phase images (right) 
were acquired in tapping mode as described in the methods. The porosity of these silica 
nanoparticles is sufficient for diffusion of radionuclides into the nanoparticle interior, 
making chelation feasible anywhere within the nanoparticle (i.e. not restricted to the 
surface). 
 
 While heating the particles to 70°C precludes pre-labeling attachment of 
temperature-sensitive targeting ligands such as antibodies, other targeting ligands that are 
stable at this temperature such as smaller peptides and aptamers may be used. In Figure 
4.9, we demonstrate that PEGylation of the silica nanoparticles does not preclude 89Zr 
binding. Therefore, attachment of moieties incompatible with the reported labeling 
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procedure can be facilitated by first radiolabeling silica nanoparticles coated with 
functionalized polyethylene glycol, then performing straightforward post-radiolabeling 
reactions.  The nanoparticle size and zeta potential before and after radiolabeling are 
given in Table 4.1.  
 
Figure 4.9 | Intrinsic radiolabeling of 89Zr using PEGylated silica nanoparticles. The 
surface of silica nanoparticles was modified by the addition of 2,000 Da polyethylene 
glycol (PEG) according to the procedure reported in the methods. The red asterisk 
represents the activity remaining at the origin of the ITLC strip and the black asterisk 
represents the activity at the solvent front. Virtually all of the activity appears at the 
origin (i.e. where the silica nanoparticles remain) in the PEGylated silica nanoparticle 
sample, whereas the control sample containing free PEG without silica exhibits the 
majority of activity at the solvent front. These results demonstrate that PEGylating silica 
nanoparticles does not preclude intrinsic radiolabeling. Data collected by Travis Shaffer 
(1). 
 













68Ga 144.1 (± 1.42) 142.5 (± 2.07) -45.2 (± 1.44) -48.7 (± 4.23) 
89Zr 144.1 (± 1.42) 146.0 (± 6.86) -45.2 (± 1.44) -47.7 (± 0.58) 
90Y 144.1 (± 1.42) 145.4 (± 0.30) -45.2 (± 1.44) -47.4 (± 3.25) 
177Lu 144.1 (± 1.42) 141.6 (± 2.98) -45.2 (± 1.44) -45.1 (± 3.16) 
111In 144.1 (± 1.42) 143.4 (± 0.85) -45.2 (± 1.44) -42.1 (± 0.51) 
64Cu 144.1 (± 1.42) 145.0 (± 1.00) -45.2 (± 1.44) -47.7 (± 3.34) 
Table 4.1 | Pre- and post-labeling silica nanoparticle characterization. The size and 
zeta-potential of silica nanoparticles is not significantly affected by intrinsic 
radiolabeling. Silica nanoparticles synthesized by Matthew Wall. Radiolabeling and 
characterization performed by Travis Shaffer (1). 
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 Having established protocols for achieving chelator-free high specific activities, 
we examined the stability of the silica nanoparticles under physiological conditions. The 
serum stability of each nuclide was investigated in 50% fetal bovine serum at 37°C over 
time periods appropriate to each nuclide’s half-life. All nuclides were stably retained 
within the silica nanoparticles except for 64Cu. In the case of copper, 50 % of the bound 
nuclide leached into the serum after 4 h. Since the operating principle of intrinsic labeling 
with silica nanoparticles is the affinity each nuclide has for the oxygen-rich matrix, it is 
unsurprising that copper is most weakly retained because it is the least oxophilic of the 
nuclides tested. In fact, the trend in serum stability of the intrinsically labeled silica 
demonstrated excellent correlation with the oxophilicity (i.e. hardness) of the ions (55). 
The marked decrease in the serum stability of 64Cu can be further attributed to proteins 
present in the serum that actively chelate copper ions, resulting in pronounced 
transchelation effects (56).  
 We investigated the stability and biodistribution of 68Ga- and 89Zr-labeled silica 
nanoparticles in vivo. We were particularly interested in these nuclides because of their 
increasing clinical importance in PET imaging, disparity in half-life, and excellent serum 
stability (57, 58). Because nanoparticles are known to generally accumulate in the 
reticuloendothelial system in amounts well exceeding 90 % of the injected dose (20), 
short-lived nuclides like 68Ga are attractive in minimizing the cross-dose to healthy 
organs while still enabling whole-body cancer imaging. Alternatively, because some 
nanoparticle formulations remain in circulation for extended periods and most 
nanoparticle clearance studies extend for weeks or longer, long-lived nuclides like 89Zr 
are essential for investigating the biological response to nanoparticle administration.  
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Fig. 4.10 | In vivo coronal PET maximum intensity projections (MIPs) of free and 
silica-bound radiotracers in athymic nude mice. (A) MIPs of free (top) and silica-
bound (bottom) 68Ga at 1 h and 3 h post injection. (B) MIPs of free (top) and silica-bound 
(bottom) 89Zr at 4 h, 12 h, and 24 h post injection. The intrinsically labeled silica 
nanoparticles exhibit contrast in reticuloendothelial system, the known biodistribution of 
silica nanoparticles, whereas the free nuclides demonstrate an entirely different 
biodistribution. This stark contrast indicates that the silica nanoparticles remain 
intrinsically labeled in vivo. Data collected by Travis Shaffer (1). 
 
 An additional benefit of studying 68Ga and 89Zr is that their biodistribution free in 
circulation is easily distinguished from their biodistribution when bound to nanoparticles. 
68Ga and 89Zr will preferentially accumulate in the liver and spleen if they are bound to 
nanoparticles (Fig. 4.10A), but not if they are free in circulation. Other radionuclides, like 
64Cu, can naturally accumulate in the liver such that a whole-body image or 
biodistribution would be insufficient to determine whether or not the nuclide was bound 
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to the nanoparticle. Male athymic nude mice (8-10 weeks old, n = 3) were injected with 
250-350 μCi (9.25 – 12.95 MBq) of either free 68Ga or 89Zr while another set was injected 
with 68Ga- or 89Zr-silica nanoparticles (10 nM) in 100 µL of 10 mM pH =7.3 2-(N-
morpholino)ethanesulfonic acid solution via the lateral tail vein. The nanoparticle-bound 
nuclides demonstrated the known biodistribution of silica nanoparticles and remained 
localized in the liver and spleen for the entire period investigated (3 h for 68Ga, 24 h for 
89Zr, n = 3 for each) (Fig. 4.10B) (59). The stark contrast between the free and 
nanoparticle-bound biodistributions demonstrates that the silica stably retain the nuclides 
in vivo (Fig. 4.11).  
Figure 4.11 | Biodistribution of 68Ga- and 89Zr-radiolabeled silica nanoparticles 4 
hours and 24 hours post-injection, respectively. Both biodistributions are consistent 
with the known uptake of silica nanoparticles. The minimally elevated levels of 89Zr 
activity in the bone (< 1 % ID/g) suggest that some radionuclide leaching may be 
occurring in vivo, but the total amount of bone uptake is less than reported for other 
radiolabeled nanoparticles (54). These biodistributions are consistent with the 
observations from the PET images reported in Fig. 4.10. Data collected by Travis Shaffer 
(1). 
 
 Because silica serves as a robust platform for binding radionuclides and retaining 
them in vivo, the nanoprobes generated by this kit-like radiolabeling protocol should be 
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immediately useful in the many known biomedical applications of nanoparticles. As a 
proof of concept, we attempted to use these nanoparticles for lymph node imaging – a 
clinically important application where nanoparticles demonstrate great promise (60). We 
injected either free 89Zr or nanoparticle-bound 89Zr  (n=3 per condition, 3.7-5.5MBq, 20-
30μL) into the footpad of male athymic nude mice (see methods) and performed whole-
body PET-CT scans. In all cases, the nanoparticle-bound radionuclides enabled robust 
detection of local lymph nodes while the free radionuclide controls did not (Figure 4.12). 
 
Fig. 4.12 | In vivo PET-CT (left) and PET-only (right) lymph node tracking after 
injection in the right rear paw of athymic nude mice. (A) Silica nanoparticles 
intrinsically labeled with 89Zr 48 h post injection. (B) Free 89Zr 48 h post injection. 
Images at earlier time points demonstrated the same trend, where the free 89Zr did not 
accumulate in lymph nodes, while the intrinsically labeled silica nanoparticles 
progressively moved through the lymphatic system. Data collected by Travis Shaffer (1). 
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4.10 Chelator-free radiolabeling of SERRS nanoprobes 
 
The in vivo stability demonstrated by silica nanoparticles validates their use in well-
established and future biomedical applications (19, 61), and it is conceivable that other 
particles could be encapsulated with silica for facile and highly efficient radiolabeling 
(18). The radiolabeling procedure outline in section 2.8 may, therefore, be directly 
applicable to SERRS nanoparticles comprising a silica encapsulant. The added 
functionality of whole-body imaging would enable pre-operative staging and 
intraoperative guidance from a single nanoparticle construct. 
 When designing a multimodal probe, it is necessary to realize that combining the 
strengths of each modality does not necessarily mitigate their weaknesses. In particular, 
the high sensitivity of optical nanoparticles, especially SERRS nanoprobes, is among 
their greatest advantages, but when a low-sensitivity whole-body modality like SPECT or 
even MRI is necessary for initial detection, the nanoparticle’s limit of detection becomes 
problematic. In this regard, positron-emitting radionuclides are the ideal compliment to 
optical nanoprobes, because Positron Emission Tomography (PET) tends to be the most 
sensitive whole-body imaging modality. Additionally, PET offers the potential for 
pharmacokinetic and biodistribution studies, which are essential for the development of 
clinically translatable imaging agents and therapeutics. 
 Although the radiolabeling of SERS nanoprobes has been previously reported, the 
labeling method was limited by the requirement of a molecular chelator, and no imaging 
was performed to validate the probe as a contrast agent. Here we show that the general 
method of chelator-free radiolabeling can be applied such that reliance on molecular 
chelators becomes unnecessary. 68Ga and 64Cu are chosen proof-of-principle 
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radionuclides because their half-lives are long enough to provide contrast throughout the 
circulation lifetime of SERS nanoparticles, but short enough to minimize the radioactive 
cross-dose to healthy tissues. 
 We directly applied the 68Ga protocol used for silica nanoparticles (see methods 
section) in an attempt to radiolabel the SERS nanoparticles. In contrast to the findings of 
section 2.8, the silica encapsulant of SERS nanoparticles became very porous and even 
disintegrated entirely for some nanoparticles (Fig. 4.13). The decreased stability of a 
silica shell compared to a silica nanoparticle is likely caused by the different conditions 
under which they are synthesized. In order to generate silica shells around the gold 
nanoparticles, the rate of hydrolysis must be kept low so that heterogeneous nucleation 
occurs more rapidly than free silica formation in solution. As discussed in section 2.3, 
decreasing the rate of hydrolysis also decreases the rate of condensation, leading to more 
broken bonds within the amorphous silica structure and greater susceptibility to 




Fig. 4.13 | Degradation of silica shells upon non-optimized 68Ga radiolabeling. TEM 
reveals that the silica shells become extremely porous and unstable after the 68Ga 
radiolabeling procedure that had been optimized for silica nanoparticles. Scale bar is 100 
nm. 
 
 Given that the rate of silica dissolution is catalyzed by the presence of sodium 
ions, we hypothesized that a radiolabeling procedure free of sodium would be less 
detrimental to the silica shells. Rather than eluting the 68Ga generator with potassium 
hydroxide (KOH) and neutralizing the eluent with acid (e.g., hydrochloric acid, glacial 
acetic acid, etc.) as is done in the standard procedure, we eluted the generator with 
hydrochloric acid (HCl) and neutralized the eluent with ammonium hydroxide (NH4OH). 
We incubated the SERRS nanoparticles with the 68Ga solution for 5 minutes at room 
temperature and observed greater than 95 % of the radioactivity associated with the 
nanoparticles. The silica shells were observed to be intact after radiolabeling, and the 
nanoparticles remained SERRS active (Fig. 4.14).  
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Fig. 4.14 | Characterization of optimized PET-SERRS nanoprobes. (A) TEM of PET-
SERRS nanoparticles after radiolabeling with the optimized 68Ga protocol. (B) SERRS 
spectrum of PET-SERRS nanoparticles. (C) Instant thin layer chromatogram of PET-
SERRS nanoparticles 5 minutes after addition of 68Ga at room temperature. The data in 
(C) was collected by Travis Shaffer. 
 
4.11 In vivo applications of PET-SERRS nanoprobes 
 The whole-body imaging capabilities of PET and high-sensitivity intraoperative 
contrast provided by SERRS (i.e. SERS with a resonant Raman reporter) are a promising 
combination for in vivo imaging. In particular, PET imaging enables pre-operative 
identification of regions of interest, while SERRS imaging facilitates high-resolution 
delineation of diseased tissue in vivo. In this section, we investigate the utility of the 
PET-labeled SERRS nanoparticles (PET-SERRS nanoparticles) in several proof-of-
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concept studies including lymph node (LN) tracking, intraoperative guidance for LN 
resection, and cancer imaging after intravenous (I.V.) injection.  
 We began our in vivo evaluation of PET-SERRS nanoparticles by attempting to 
image lymph nodes near the periphery of an orthotopic 4T1 breast cancer tumor. The 
success of radiolabeled silica for imaging lymph nodes in vivo was established in section 
4.8, but the ability of a silica shell to retain radionuclides in vivo has not yet been 
demonstrated. PET-SERRS nanoparticles were injected subcutaneously at the tumor 
periphery and into the tumor itself. PET imaging 4 h post-injection revealed that much of 
the signal remained concentrated near the tumor, suggesting that most of the PET-SERRS 
nanoparticles had not migrated from the injection sites. Interestingly, the cervical LN 
could be visualized with strong contrast at the 4 h time point (Fig. 4.15A). Although the 
axillary LN is the sentinel node for murine breast tissue, the size and location of the 
implanted tumor completely obstruct the axillary LN from imaging. The cervical LN 
drains multiple regions, including the upper extremities, so the accumulation of PET-
SERRS nanoparticles in the cervical LN occurs because one or more peripheral injection 
sites falls in the region it drains (62, 63). Although direct visualization of the breast’s 
sentinel LN was obstructed, the cervical LN imaging illustrates that LN tracking can be 
achieved in vivo with PET-SERRS nanoparticles.  
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Figure 4.15 | Lymph node tracking with PET-SERRS nanoparticles. (A) PET-CT 
image 4 h after the 68Ga-labeled PET-SERRS nanoparticles were injected around the 
periphery of an orthotopic 4T1 breast tumor. (B) SERRS spectrum of PET-SERRS 
nanoparticles can be tracked in vivo with a handheld Raman detector. The cervical LN 
exhibits the characteristic peaks of the PET-SERRS nanoparticle, which are not present 
in outside of the LN. Accordingly, a quick handheld scan can be performed to guide 
location and resection of the LN. (C) After resection, the handheld detector is used to 
confirm that the SERRS spectrum is only detected in the excised tissue, such that clean 
margins exist in the resection bed. The data in (A) was collected by Travis Shaffer. 
 
 Intraoperative imaging of the cervical LN confirmed the presence of SERRS 
nanoparticles. The characteristic spectrum of the PET-SERRS nanoparticles was 
detectable with a handheld Raman detector, and could be raster scanned by a fixed 
Raman imaging system to generate a map of relative SERRS intensity The SERRS map 
demonstrated excellent co-localization with the pre-operative PET imaging signal, 
confirming that the PET-SERRS nanoparticles remained intact after subcutaneous 
injection and migration through lymphatic channels (Fig. 4.15B,C). We used a handheld 
Raman detector to guide surgical resection of the cervical LN, first by locating it in vivo, 
and then by confirming that all contrast-enhanced tissue had been removed. Post-
operative SERRS imaging was performed to corroborate the handheld results, and indeed 
showed that the lymph node had been completely resected (Fig. 4.16). 
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Figure 4.16 | SERRS map of excised LN and resection bed. (A) Photograph and 
SERRS map of the same excised tissue shown in the top of Fig. 4.15C shows that the LN 
is completely contained within the resected specimen. (B) Photograph and SERRS map 
of the same resection bed shown in the bottom of Fig. 4.15C shows that no detectable 
SERRS signal remains, indicating clean resection margins.  
 
 Because the PET-SERRS nanoparticles naturally accumulate in the 
reticuloendothelial system (RES), we hypothesized that they would be well suited for 
imaging liver cancer. In particular, the rapid uptake of nanoparticles in healthy liver 
tissue and comparatively low uptake of nanoparticles in cancerous tissue was expected to 
yield sufficient contrast to delineate tumors in vivo (64). Because the cancerous regions 
should contain fewer PET-SERRS nanoparticles than the surrounding liver tissue, the 
presence of cancer was expected to yield filling defects (i.e., regions of little to no 
contrast surrounded by regions of high contrast). We tested these hypotheses in mice that 
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had been genetically engineered to develop hepatocellular carcinomas (HCC). 150 μL of 
10 nM PET-SERRS nanoparticles (labeled with 68Ga) were intravenously injected via tail 
vein and PET scans were performed 3 h post-injection (Fig. 4.17A). The PET contrast 
exhibited several distinct filling defects throughout the liver, as hypothesized, suggesting 
the presence of tumors.  
 
Figure 4.17 | Pre-operative staging and intraoperative imaging of liver cancer using 
PET-SERRS nanoparticles. (A) PET contrast provided by PET-SERRS nanoparticles 
reveals clear filling defects. (B) Intraoperative photograph of liver from the mouse 
imaged in (A). Solid tumors are visible by naked eye due to their large size and light 
discolorations. The location of the tumors match the areas of filling defects on the PET 
scan. (C) Maximum intensity projection (MIP) of the PET signal correlates with the 
healthy regions of the liver, revealing the presence of cancer where filling defects occur. 
(D) SERRS image of the tumor-bearing liver reveals high-resolution map of the healthy 
liver, providing intraoperative contrast. The correlation between PET signal and SERRS 
signal indicates that the nanoparticles remain intact and active in vivo. (E) Overlay of 
photograph and SERRS map shows that the filling defects in the SERRS signal 
correspond to cancer. The images in (A) and (C) were provided by Travis Shaffer. 
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 We then surgically exposed the livers of the cancer-bearing mice and performed 
high-resolution SERRS scans in a simulated intraoperative setting. Even without SERRS 
contrast, some large tumors with sizes and locations corresponding to filling defects of 
the PET scan were clearly visible. The SERRS map demonstrated pronounced filling 
defects where tumors were present, and correlated strongly with the pre-operative PET 
signal (Fig. 4.17D-E). The co-registration of PET and SERRS signals in the liver indicate 
that the PET-SERRS nanoparticles remain intact after I.V. injection and circulation. 
Although future work is required to optimize the delivery of PET-SERRS nanoparticles 
to regions of interest outside of the RES, the results presented in this section confirm that 
both modalities remain sufficiently stable in vivo to justify further investigation into their 
use as whole-body, combined pre- and intra-operative multimodal nanoimaging agents. 
Furthermore, this work validates the use of silica encapsulation as a means to render 
nanoparticle substrates capable of binding oxophilic radionuclides without requiring 





Silica Nanoparticle Synthesis   
 Silica Nanoparticles were synthesized according to a modified Stöber method. 
Briefly, 3.75 mL of ultrapure H2O was added to 25 mL of ethanol and 1.25 mL tetraethyl 
orthosilicate. The reaction was initiated by the addition of 0.625 mL of 28% ammonium 
hydroxide and washed three times in ethanol after the nanoparticles had reached the 
desired size.  
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Silica Nanoparticle Characterization  
 The hydrodynamic diameter of the silica nanoparticles pre- and post-labeling was 
determined by dynamic light scattering (DLS) (Nano-ZS, Malvern, Westborough, MA). 
The same instrument was used in nanoparticle surface charge measurement (ζ potential) 
in ultrapure water (>18.2 MΩ cm–1 at 25 °C, Milli-Q, Millipore, Billerica, MA). The 
silica nanoparticle concentration was measured with an NS500 instrument (NanoSight, 
Duxbury, MA).   
68Ga-Silica Nanoparticle Radiolabeling of Silica Nanoparticles 
 68Ga (t1/2=68 minutes) was eluted from a 
68Ge-68Ga generator (ANSTO, Australia) 
as previously described(65), with 8-9mCi activity per elution. After elution in 500 µL of 
0.5 M potassium hydroxide, the 68Ga hydroxide solution was neutralized with 
concentrated hydrochloric acid, immediately added to silica nanoparticle solutions (10 
nM, in 100µL of 10mM buffer) and incubated at the temperature and pH of interest on a 
thermomixer at 500 rpm.  MES buffer was used for pH = 5.5 and 7.3 solutions, while 
HEPES buffer was used for pH = 8.8 solutions. 1µL samples were taken for radioactive 
instant thin layer chromatography (rITLC) at various time points over the course of 1 
hour using silica-gel impregnated ITLC paper (Varian), and analyzed with a Bioscan AR-
2000 radio-TLC plate reader.  For 68Ga, 0.1 M citric acid was used as the elution solvent, 
while 50 mM EDTA (pH = 5) was used for all other nuclides. The solution was 
centrifuged at 10000 rpm for 5 minutes, the supernatant removed and counted, and the 
product re-dispersed in 10 mM MES in order to achieve purification. 
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89Zr-Silica Nanoparticle Radiolabeling  
 89Zr (t1/2=78.4 h) was produced at Memorial Sloan Kettering Cancer Center on a 
TR19/9 cyclotron (Ebco Industries Inc.) via the 89Y(p,n)89Zr reaction and purified to yield 
89Zr-oxalate as previously described(66). 89Zr-oxalate was neutralized with 1.0 M sodium 
carbonate and added to silica nanoparticle solutions as described for the 68Ga-silica 
nanoparticle radiolabeling. 
90Y-Silica Nanoparticle Radiolabeling 
 90Y (t1/2=64 h) was obtained as yttrium (Y-90) chloride in 0.05 N HCl at an 
activity concentration of 25 mCi/mL (Nordion). 90Y was added to silica nanoparticle 
solutions as described for 68Ga-silica nanoparticle radiolabeling. 
111In-Silica Nanoparticle Radiolabeling  
 111In (t1/2=2.8 days) was obtained as Indium (In-111) chloride in 0.05 N HCl at an 
activity concentration of 25 mCi/mL (Nordion). 111In was added to silica nanoparticle 
solutions as described for 68Ga-silica nanoparticle radiolabeling. 
64Cu-Silica Nanoparticle Radiolabeling   
 64Cu (t1/2=12.7 h) was obtained from Washington University, St. Louis, where it 
was produced on a CS-15 cyclotron (Cyclotron Corp.) by the 64Ni(p,n)64Cu reaction and 
purified to yield 64Cu chloride with a specific activity of 7.4–14.8 GBq/μg. 64Cu was 
added to silica nanoparticle solutions as described for 68Ga-silica nanoparticle 
radiolabeling. 
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177Lu-Silica Nanoparticle Radiolabeling  
 177Lu (t1/2=6.71 days) was obtained as Lutetium (Lu-177) chloride in 0.05 N HCl 
at an activity concentration effective specific activity of 29.27 Ci/mg (PerkinElmer). 
177Lu was added to silica nanoparticle solutions as described for 68Ga-silica nanoparticle 
radiolabeling. Because 177Lu in the buffer control showed activity at the origin for ITLC 
analysis (i.e., some radioactivity did not travel with the solvent front), the amount of 
177Lu bound to the silica nanoparticles was determined both by centrifugal nanoparticle 
pelleting and 100kD spin filtration cutoff filters. 
Serum Stability Studies  
 Serum stability experiments at were performed at 37 °C in mixture of 50 % fetal 
bovine serum (FBS, Gemini Bio-products) and 50% MES (total volume 150 μL) on an 
Eppendorf thermomixer at 550 rpm.  Both ITLC and size exclusion filtration analysis 
were completed at the reported time points.  The values given in Figure 2 are those 
measured by ITLC, which showed more free activity for every nuclide and were therefore 
considered more robust than size exclusion filtration. 
In Vivo Experiments  
 All animal experiments were done in accordance with protocols approved by the 
Institutional Animal Care and Use Committee of Memorial Sloan Kettering Cancer 





Positron Emission Tomography 
 Male Nude athymic mice (8-10 weeks old, n = 3) were injected with 250-350 μCi 
(9.25-12.95 MBq) radiolabeled Silica nanoparticles (10 nmol Silica nanoparticle) in 100 
µL MES solution via the lateral tail vein. At predetermined time points (1h, 4h, and 24h) 
animals were anesthetized with isoflurane (Baxter Healthcare, Deerfield, IL) and oxygen 
gas mixture (2% for induction, 1% for maintenance) and scans were then performed 
using an Inveon PET/CT scanner (Siemens Healthcare Global). Whole body PET static 
scans were performed recording a minimum of 50 million coincident events, with 
duration of 10-20 min. The energy and coincidence timing windows were 350−750 keV 
and 6 ns, respectively. The image data were normalized to correct for non-uniformity of 
response of the PET, dead-time count losses, positron branching ratio, and physical decay 
to the time of injection, but no attenuation, scatter, or partial-volume averaging correction 




 Whole body standard low magnification CT scans were performed with the X-ray 
tube setup at a voltage of 80 kV and current of 500 µA. The CT scan was acquired using 
120 rotational steps for a total of 220 degrees yielding and estimated scan time of 120 s 





PET/CT Lymph Node Studies with 89Zr-Silica Nanoparticles   
 For in vivo silica nanoparticle-radiometal lymph node imaging studies, 3 mice 
were injected in the footpad with 89Zr in saline and 3 mice were injected with 100-200 
µCi of 89Zr-silica nanoparticle (10 mM MES, 20µL, 3.7-7.4 MBq) for a total of 6 mice.  
All mice were induced with 2.5% isoflurane and maintained on 2-2.5% isoflurane in 
preparation for the scans. Whole body scans were performed using Inveon Multimodality 
(MM) CT scanner (Siemens) and Inveon dedicated PET scanner for a total of 15-45 min. 
 
SERRS Nanoprobe Synthesis  
 Gold nanoparticles were synthesized through addition of 7.5 ml 1% (w/v) sodium 
citrate to 1000 ml boiling 0.25 mM HAuCl4. The as-synthesized gold nanoparticles were 
concentrated by centrifugation (10 min, 7500 x g, 4 °C) and dialyzed overnight (3.5 kDa 
MWCO; 5L 18.2 MΩ.cm). The dialyzed gold nanoparticles (140 μL; 2.0 nM) were added 
to 1000 μL absolute ethanol in the presence of 50 μL 99.999% tetraethoxyorthosilicate 
(Sigma Aldrich), 20 μL 28% (v/v) ammonium hydroxide (Sigma Aldrich) and 2 μL 
Raman reporter molecule (e.g. IR-780, IR-792, chalcogenopyrylium dye etc.) (1-25 mM) 
in N,N-dimethylformamide. After shaking (375 rpm) for 25 min at ambient conditions in 
a plastic container, the SERRS-Nanoprobes were collected by centrifugation, washed 
with ethanol, and redispersed in water to yield 2.0 nM SERRS-Nanoprobes.  
 
SERRS Nanoprobe Radiolabeling Protocols 
68Ga radiolabeling: 
 68Ga (t1/2=68 m) was eluted from a 
68Ge-68Ga generator (ANSTO, Australia) as 
previously described1, with 555-740 MBq (15-20 mCi) activity per elution. 68Ga was 
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eluted as either a direct elution in 0.4 N HCl, or as purified elution in 0.5 M potassium 
hydroxide. The 68Ga HCl solution was neutralized with 28% ammonium hydroxide while 
the 68Ga hydroxide solution was neutralized with concentrated hydrochloric acid. Upon 
neutralization, 37 MBq (1.0 mCi) of 68Ga was immediately added to silicate gold 
nanoparticle solutions (10 nM, in 100 μL of 10 mM pH = 7.3 MES buffer) and incubated 
at 70 °C on a thermomixer at 500rpm for 30-60 minutes. Purification was completed by 
centrifugation at 10,000 rpm for 120 seconds followed by resuspension.  
 
64Cu radiolabeling: 
 64Cu (t1/2=12.7 h) was obtained from Washington University, St. Louis, as 
64Cu 
chloride in 0.05 N HCl with a specific activity of 7.4–14.8 GBq/μg. 1-2 μL (7.4-14.8 
MBq, 200-400 μCi) was added to 100 μL silicated gold nanoparticles and radiochemistry 
was completed as described for 68Ga. 
 
Determination of Radiochemical Yield in PET-SERRS Experiments 
 Radiochemical yield (% of activity bound to particles) was determined via either 
ITLC or through centrifugal pelleting of nanoparticles. For ITLC, 1 μL samples were 
taken using silica-gel impregnated ITLC paper (Varian), and analyzed with a Bioscan 
AR-2000 radio-TLC plate reader. For 68Ga, 0.1 M citric acid was used as the elution 
solvent, while 50 mM EDTA (pH = 5) was used for 64Cu. Free activity moves with the 
mobile phase, while nanoparticle bound radioactivity stays at the origin.  
The centrifugal pelleting approach to determining radiochemical yield proceeded by 
pelleting of radiolabeled nanoparticles, removal of supernatant, re-dispersion of the pellet 
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APPENDIX 1 
 
Supplementary Discussion of Crystal Growth 
 
A1.1 “Surface blocking” diffusion-limited and reaction-limited mechanisms 
 
 The concept of surface blocking is so intuitive that it has become perhaps the 
most common explanation for the evolution of crystal shapes, yet the actual mechanism 
by which growth is inhibited is rarely articulated. The foundational claim is that auxiliary 
chemicals, termed shape-directing agents, bind with sufficient selectivity to a particular 
family of crystallographic planes to modify their growth rates (1-3). This explanation 
assumes first that the structure or reactivity of crystal facets are significantly different 
such that some will interact strongly with auxiliary species and others will not. While this 
is certainly the case for come crystals, such as those comprised of polar growth units, the 
application of this hypothesis to low index facets of noble metals has, understandably, 
been met with skepticism (4).  
 We have used the most common claims from highly cited articles and reviews to 
articulate the physical processes promoting anisotropic growth in the presence of shape-
directing agents (1-3). The primary difference between the two theories is the mechanism 
by which the shape-directing agents inhibit facet growth. We classify the two theories as 
reaction-limited and diffusion-limited surface blocking. 
 Reaction-limited surface blocking occurs when a chemical other than the crystal 
growth unit inhibits the incorporation of growth units to binding sites. The prototypical 
example of this process is surfactant adsorption to binding sites. In order for growth units 
to become incorporated into the crystal the surfactants must first be displaced. The 
  A1-2 
greater the surfactant coverage and the stronger the surfactant-crystal bond, the slower 
the incorporation rate of growth units (5). 
 Diffusion-limited surface blocking occurs when the adsorbed chemicals inhibit 
delivery of growth units to the step front, but not necessarily the binding of the growth 
unit once the step front is reached. Examples of this process include steric and 
electrostatic repulsion preventing growth units from reaching the surface of a particular 
facet (3, 6). The presence of adsorbed shape-directing agents can also inhibit surface 
diffusion of adsorbed growth units. In short, diffusion-limited surface blocking inhibits 
arrival of growth units at binding sites and reaction-limited surface blocking inhibits the 
incorporation of growth units once they have reached binding sites. 
 Because we observe some highly anisotropic nanoparticles dominated by {111} 
facets and other highly anisotropic nanoparticles dominated by{100} facets in the same 
synthesis, we conclude that shape-directing agents cannot be the sole explanation for the 
crystal habit in our experiments. It is not reasonable to explain the appearance of plate-
like particles with major {111} facets as the result of selective adsorption of shape-
directing agents when rod-like particles comprised primarily of {100} facets form in the 
same solution (4). This is especially unlikely in our synthesis because of the dearth of 
auxiliary chemicals available to act as shape-directing agents. It is also important to note 
that surface reconstructions are likely during growth via reduction of metal salt 
precursors by weak reducing agents (7). When {100} facets undergo hexagonal 
reconstruction they become virtually identical to {111} facets. Although this 
phenomenon receives very little consideration in the nanocrystal community, it must be 
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addressed if differences in surface reactivity are essential to proposed growth 
mechanisms. 
 
A1.2 Structure-related nucleation-, diffusion-, and reaction-limited mechanisms 
 Although growth mechanisms based upon surface structure are uncommon in 
nanocrystal research, with the exception of plate formation, there are several structure 
related mechanisms proposed in classic crystal growth and silver halide literature (8-12). 
The theories can be classified as nucleation-limited, diffusion-limited, or reaction-limited 
based upon the rate-limiting step of growth proposed in the mechanism. Structure-based 
mechanisms are attractive considerations for syntheses such as ours that do not rely 
employ auxiliary species. However, they tend to suffer from a lack of quantitative 
validation. 
 The fundamental hypothesis of surface structure based theories holds that 
structural differences, particularly in the form of defects, alters growth rates of crystal 
facets. Growth occurs preferentially on facets with defects in nucleation-limited theories 
because the rate of monolayer nucleation is faster at defects than at pristine sites (4, 11). 
Diffusion-limited and reaction-limited arguments are most common when it is assumed 
that all facets have perpetual step defects, like screw dislocations, such that monolayer 
nucleation is unnecessary (8). Under these conditions, growth is diffusion-limited when 
growth unit arrival is rate-limiting, and reaction limited when growth unit incorporation 
into binding sites is rate-limiting. It is common, as in the classic Burton-Cabrera-Frank 
theory, to assume that growth is diffusion limited in the presence of perpetual step defects 
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unless the growth unit itself must rearrange at the binding site to become incorporated 
(e.g. urea crystals) (12). 
 Given the defect symmetries confirmed by selected area electron diffraction and 
high-resolution transmission electron microscopy, surface structure hypotheses 
qualitatively fit our experimental observations. We cannot discern from these theories 
whether growth is nucleation-limited, diffusion-limited, or reaction-limited because 
quantitative explanations are not available. This is especially problematic when it comes 
to engineering shape control because the design rules for tuning growth rates depends on 
the rate-limiting mechanism (see sections on shape control during nucleation-limited, 
diffusion-limited and reaction-limited growth). 
 
A1.3 Surface energy minimization mechanism 
 The surface energy minimization theory as an explanation for crystal habit is 
closely associated with the concept of shape-directing agents (2, 13-15). Although the 
hypothesis does not provide a mechanism by which any given shape is achieved, it is 
clearly driven by thermodynamic considerations. When applied to the study of shape 
evolution, it is typically hypothesized that shape-directing agents selectively bind crystal 
facets and modify their surface energy. The crystal habit evolves until the Wulff shape is 
achieved (13, 15, 16). We reject this explanation as representative of our experiments 
because selective binding of shape-directing agents is not a reasonable assumption given 
the product morphologies observed. Moreover, if {111} facets are sufficiently stable to 
generate highly anisotropic platelets a minimum energy configuration, then nanorods 
would not form because the {100} would have to be energetically unfavorable. 
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A1.4 Shape control during nucleation-limited growth 
 In nucleation-limited growth, facet growth rates are determined by the rate at 
which critical nuclei form (17). Controlling the relative growth rates in each 
crystallographic direction, therefore, is a matter of controlling the rate of nucleation on 
the corresponding facets. The rate of nucleation increases in the order of passivated 
surfaces, defect-free unpassivated surfaces, surfaces with stacking-faults, surfaces with 
cross-twinning, surfaces with twin lamellae, and surfaces with screw-dislocations or other 
perpetual step sources. Either inducing defects on the facets where rapid growth is 
desired, or passivating facets where slow growth is desired can therefore enable shape 
control.   
 In practice, seed crystallinities can be identified that have surface defects in the 
required crystallographic orientations for growth of a particular morphology. Shape 
controlled syntheses in nucleation-limited regimes can therefore be achieved by 
identifying the appropriate seed crystallinity, synthesizing seeds with that crystallinity in 
the highest yield possible, and identifying the appropriate reaction kinetics to tune the 
relative facet growth rates according to the prescribed dimensions. The preference for 
growth of a defect-containing facet with respect to a defect-free facet tends to increase as 
reaction kinetics decrease because the nucleation becomes highly improbable on pristine 
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A1.5 Shape control based in diffusion-limited growth 
 In the diffusion-limited regime, the rate of growth in a crystallographic direction 
is dependent on the flux of growth units to binding sites on the corresponding facet. The 
total flux to step sites is a combination of volume and surface diffusion rates. Preferential 
facet growth in this regime can thus be achieved by steering mass transport via surface 
passivation, especially with charged species that induce electric-field directed delivery of 
growth units (6). It should be noted, however, that the shape, step density and defect 
symmetry of nanocrystals creates charge separation at the surface without the 
requirement of charged adsorbates (18, 19). The density of surface charges can be further 
tailored by the redox potential of the solution (20).  
 The relationship between crystal surfaces with accurate electronic structure and 
preferential volume diffusion of growth units has received very little attention, but has 
important consequences in symmetry breaking and anisotropic growth of metal 
nanoparticles. Indeed, shape-controlled syntheses employing weak reducing agents to 
reduce precursor metal complexes generate growth units that diffuse as charged 
complexes. Preferential deposition of these negatively charged metal halide complexes is 
likely to occur at positively charged surfaces, such as facets with small step separations, 
high defect densities or large proportions of edge atoms, because electron smoothing 
creates positively charged regions at convex corners. Preferential accumulation of 
negatively charged growth units should be especially high at facet edges and corners 
because of the combined influences of electron smoothing and the Berg effect (21).  
 After symmetry breaking has occurred, shear forces due to rapid stirring and 
crystal alignment with flow can impart additional preference of volume diffusion. In fact, 
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the very act of preferential facet growth is expected to create a cooperative phenomenon 
of preferential volume diffusion to the faster growing facets because the reservoir of 
growth units is depleted near the fast-growing sites, creating a diffusion field pointing in 
their direction (22, 23).  
 
A1.6 Shape control in reaction-limited growth 
 In the reaction-limited regime, the rate of growth in a crystallographic direction is 
dependent on the net rate of growth unit incorporation into binding sites on the 
corresponding facet. Preferential growth in a given direction can therefore be achieved by 
decreasing the activation energy for diffusing into binding sites or increasing the 
activation energy for detachment from binding sites. Introducing complexing agents, 
varying temperature, and changing the redox potential of the solution can modulate these 
activation energies. Reaction-limited growth is likely to be associated with chemical 
additives adsorbed at binding sites, and thus is not expected to be a significant 
consideration in additive-free syntheses such as the one presented here. 
 
A1.7 The shape-directing role of chemical additives 
 Arguably the most widely accepted explanation for the mechanism of shape 
control during (nano)crystal growth is the assumed presence of selectively bound 
chemical species modulating the growth rates of distinct facet types (2). The prototypical 
example in gold nanoparticle syntheses is the shape-directing surfactant 
cetyltrimethylammonium bromide, which is thought to demonstrate preferential binding 
of {100} and higher index facets over {111} facets (3). Although the selective adsorption 
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is widely agreed upon as the origin of anisotropic growth, the specific mechanism is 
rarely articulated. Instead, the fast-growing {111} facets are characterized as “more 
reactive”, or less “blocked” than the slower growing {100} and {110} facets (2, 3). The 
former terminology implies a reaction-limited hypothesis, whereas the latter suggests a 
diffusion-limited mechanism, however the reader can only speculate without concrete 
propositions.  
 The simplicity and generality of the selective chemical adsorption mechanism has 
an intuitive appeal that facilitates widespread adoption, but is deceptively complicated. 
What is the rate-limiting step? Do the adsorbates control shape by modulating nucleation 
rates, directing flux of growth units, modifying the rate of incorporation into binding 
sites, or something different all together? The answer to these questions likely varies 
from one chemical species to another, and is beyond the scope of the present work. 
However, we can address the analogous, perhaps more fundamental question of the 
intrinsic differences in nucleation rate, diffusion rate, and incorporation rate characteristic 
to different facets without chemical modification (see chapter 2). With this knowledge, 
we can expound upon the origins of preferential growth in different crystallographic 
directions as a function of reaction conditions, and hypothesize the likely effects of 
preferential adsorption.   
 
A1.8 The shape-directing role of halides 
 In addition to surfactants, polymers, and organic molecules, halides have been 
proposed to serve as shape-directing agents in metal nanoparticle syntheses (24-26). 
Because halides are typically present in the precursor metal complexes used in 
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nanoparticle syntheses, this proposition is particularly important to consider. Although 
there exists convincing evidence that the concentration and identity of halides affects 
metal nanoparticle morphology, it should be recognized that the influence of halides 
extends beyond surface passivation, and that the strength of the halide-metal interaction 
varies significantly between species (26).  
 The main arguments for halides as shape-directing agents at the nanoparticle-
solution interface are related to surface blocking. Studies of the seeded growth of Pd 
nanocubes suggest that adlayers of Br- inhibit nucleation of monolayers, and surface 
diffusion to binding sites on Pd {100} facets (24). However, the concentration of halides 
in typical syntheses free of halide additives is on the order of 1000 times lower than 
presented in the referenced work, so caution should be taken when applying these 
conclusions to other metal nanoparticle syntheses, especially when the metal-halide pair 
has a weaker interaction than Pd and Br-.  
 In the absence of a halide adlayer (i.e. monolayer of adsorbed halides), surface 
halides can actually catalyze the diffusion of growth units to binding sites. The only 
available computational study on the effect of Cl on Au surface diffusion shows that the 
formation of AuCl surface complexes lowers the activation energies for surface diffusion 
and kink incorporation – increasing the growth rate of such surfaces (27). The activation 
energy for kink disincorporation is also lowered, however, so the ripening rate of adatom 
islands similarly increases.  
 The role of halides is significant, yet quite complex, and more extensive 
computational studies will be required to sort out the relationships between halide 
concentrations and the formation, and structure, of halide-metal surface complexes for 
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different facet symmetries. The results of these computational studies could be used as 
inputs for the theoretical framework presented herein to determine the influence of halide 
concentration on growth mechanisms and rates. For example, the activation energies for 
surface jumping at relevant sites along the step front (see chapter 2) can be calculated and 
directly input into our equations for facet growth rate. 
 In the present study, we used the activation energies for chloride-modified surface 
diffusion processes as the upper limit for the effect of halide adsorption and investigated 
the expected changes in facet growth rates. Because many shape-controlled syntheses of 
gold nanoparticles, including the one presented here, are mediated by weak reducing 
agents that deposit growth units as gold-halide species onto the nanoparticle surface, we 
anticipate that these considerations will become increasingly important in computational 
investigations. 
 
A1.9 The role of defects on the rate of monolayer nucleation 
 The monolayer nucleation rate – the rate of critical 2D nucleus formation – 
increases in the presence of surface defects (4, 11). The increased coordination number 
for adatoms at defect sites increases their residence time in those locations, which 
increases the probability of collision with other adatoms. Moreover, the higher 
coordination of the defect decreases the size of the critical nucleus with respect to a 
defect-free terrace. This occurs because the number of nearest neighbor bonds per atom is 
greater for an adatom island at a defect than the same island on a pristine terrace, hence 
the decrease in free energy is greater per growth unit added. Additional, less commonly 
discussed phenomena, are also present at defect sites that favorably modulate nucleation 
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rate, such as local changes in electrostatic potential due to electron smoothing at the 
defect (18). 
 
A1.10 Reaction kinetics versus probabilities of defect formation 
 For any crystal in solution, there exist non-zero probabilities for the formation of 
various defects. The rate of defect formation will depend on the vibrational frequencies 
and activation energies that characterize the number of attempts at defect formation per 
unit time and probability of a successful attempt, respectively. The number of attempts at 
defect formation increases linearly over time in accordance with the constant vibration of 
growth units in the crystal. Hence, the number of observed defects in a crystal will 
increase over time until an equilibrium concentration of defects is reached. This implies, 
therefore, that as the net crystal growth rate approaches zero from positive infinity, the 
observed number of crystal defects tends to increase, for a given activation energy of 
defect formation.  
 Because the activation energy for a structural transition, such as defect formation, 
tends to decrease as the number of atoms in a crystal decreases, slow reaction rates that 
increase the time nanoparticles exist at small sizes should generate higher proportions of 
defected seeds. It is important to note that defect formation requires the movement of 
both surface and volume (i.e. interior) atoms. Therefore nanocrystals in reaction 
conditions that catalyze removal, diffusion, and deposition of atoms will have a much 
greater probability of defect formation than the same nanocrystals in pure solvent. 
Defect-catalyzing reaction conditions include the presence of complexing ligands, 
oxidants, and weakly reducing conditions – which result in charge accumulation at the 
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nanoparticle surface and increased atom mobility. It is also important to note that these 
conditions decrease colloidal stability and thereby increase the average number of 
nanoparticle aggregation events which can be a dominant mechanism of creating defected 
seed crystals (5). 
 
A1.11 The role of perpetual steps on the mechanism of crystal growth 
 When defects such as screw dislocations that provide perpetual step sources are 
present, the time for monolayer nucleation equals zero, and the facet growth rate is 
dependent on the rate of growth unit diffusion to binding sites and the subsequent 
incorporation reaction. Because these rates are typically faster than the rate of nucleation 
for gold (nano)crystals, facets with screw dislocations will grow faster than facets that do 
not possess perpetual step sources (8). The rate-limiting step for the growth of facets with 
perpetual step sources will therefore be either diffusion of growth units to step sites or 
incorporation of growth units into binding sites.  
 
A1.12 Problems with the classical rate equations for diffusion 
 Classical diffusion flux equations are determined by applying continuity relations 
to Fick’s laws (8). The relevance of these equations has been the subject of much 
investigation, and it is known that they break down as the rate of adatom island formation 
increases (28). This is a particularly significant point of criticism, because (nano)crystal 
growth appears to only become diffusion-limited in the regime of fast monolayer 
nucleation. More fundamentally, the continuity equations typically employed do not 
represent proper definitions of thermodynamic driving forces, because the logarithmic 
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definition of supersaturation must be replaced by linear definitions in order for analytical 
solutions to exist. For example, a proper application of the Teorell definition of diffusion 
leads to continuity equations of the form c1Ψe
Ψ = ∇2Ψ which have no known analytical 
solution. In general, the obtainable analytical expressions for surface diffusion are so 
restricted by assumptions, particularly on the nanoscale, that these calculations are best 
left to computational investigations, such as multiscale ReaxFF studies. Consequently, 
caution should be exercised when extending the present work to incorporate diffusion 
equations. In fact, this is the reason we left the flux as an input parameter, rather than 
restricting the theoretical framework to a particular set of assumptions regarding growth 
unit diffusion. 
 
A1.13 Design considerations for the nucleation of seeds 
 The proportion of seeds with a particular type of defect can be modulated to some 
degree by control of the capping ligands, solvent, reaction kinetics, and temperature 
during synthesis (25, 29). For example, it was recently shown for Pd that by increasing 
the reduction kinetics during nucleation, the dominant crystal types switch from single 
and parallel twin planes (i.e. plate-like) to icosahedral to single crystalline (i.e. defect-
free) (29). The increased concentration of defect-containing particles formed under slow 
reaction conditions is expected due to the increased probability of seed aggregation and 
the higher surface charge density (20). Conceptually, it stands to reason that more defect-
containing particles would form under slow reaction kinetics because monolayer 
nucleation will only be favored at defect sites, thus the seeds with defects consume the 
available growth units. Defect-free seed populations can also be obtained by using 
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oxidants and complexing agents to selectively dissolve defect-containing seeds (30). It is 
important to note that uncovering the relationship between the structural properties of 
seeds and the reaction conditions employed in their formation is a burgeoning field of 
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APPENDIX 2 
Matlab Scripts  
A2.1 Matlab script for crystal growth contour plots 
 
%% Input: Crystal Growth Contour Plot 
  
%Temperature in Kelvin 
T = 300; 
  
%number of atoms in first step after nucleation 
m_i = 3; 
  
%number of atoms in step fragment 
m = 10; 
  
%Facet index (do not include brackets. Write 111 or 100) 
facet = 111; 
  
%Chloride coverage (between 0 and 1) 
Cl = 0.0; 
  
%% Input: Activation Energies, Vib. Frequencies 
  
%{111} With Chloride EAM 
%Activation Energies in eV 
E_LLc111 = 0.080; 
E_LSc111 = 0.075; 
E_LKc111 = 0.052; 
E_SSc111 = 0.243; 
E_SKc111 = 0.223; 
E_KSc111 = 0.356; 
E_SLc111 = 0.320; 
E_KLc111 = 0.282; 
E_USc111 = 0.203; 
E_UKc111 = 0.142; 
d_hkl_111 = 0.353; 
  
%{111} Without Chloride EAM 
%Activation Energies in eV 
E_LLp111 = 0.102; 
E_LSp111 = 0.096; 
E_LKp111 = 0.067; 
E_SSp111 = 0.311; 
E_SKp111 = 0.286; 
E_KSp111 = 0.456; 
E_SLp111 = 0.410; 
E_KLp111 = 0.420; 
E_USp111 = 0.260; 
E_UKp111 = 0.181; 
  
%{100} With Chloride EAM 
  A2-2 
%Activation Energies in eV 
E_LLc100 = 0.383; 
E_LSc100 = 0.361; 
E_LKc100 = 0.252; 
E_SSc100 = 0.236; 
E_SKc100 = 0.217; 
E_KSc100 = 0.355; 
E_SLc100 = 0.533; 
E_KLc100 = 0.468; 
E_USc100 = 0.413; 
E_UKc100 = 0.288; 
d_hkl_100 = 0.408; 
  
%{100} Without Chloride EAM 
%Activation Energies in eV 
E_LLp100 = 0.490; 
E_LSp100 = 0.462; 
E_LKp100 = 0.322; 
E_SSp100 = 0.302; 
E_SKp100 = 0.278; 
E_KSp100 = 0.455; 
E_SLp100 = 0.682; 
E_KLp100 = 0.698; 
E_USp100 = 0.528; 
E_UKp100 = 0.368; 
  
%Vibrational Frequencies in 1/s 
v_LL = 1.76E+12; 
v_LS = 1.42E+12; 
v_LK = 1.43E+12; 
v_SS = 1.41E+12; 
v_SK = 1.45E+12; 
v_KS = 1.45E+12; 
v_SL = 1.91E+12; 
v_KL = 1.75E+12; 
v_US = 1.42E+12; 
v_UK = 1.43E+12; 
  
%% Activation Energies 
  
%Facet-dependent activation energies 
if facet == 111 
    E_LLc = E_LLc111; 
    E_LSc = E_LSc111; 
    E_LKc = E_LKc111; 
    E_SSc = E_SSc111; 
    E_SKc = E_SKc111; 
    E_KSc = E_KSc111; 
    E_SLc = E_SLc111; 
    E_KLc = E_KLc111; 
    E_USc = E_USc111; 
    E_UKc = E_UKc111; 
    E_LLp = E_LLp111; 
    E_LSp = E_LSp111; 
    E_LKp = E_LKp111; 
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    E_SSp = E_SSp111; 
    E_SKp = E_SKp111; 
    E_KSp = E_KSp111; 
    E_SLp = E_SLp111; 
    E_KLp = E_KLp111; 
    E_USp = E_USp111; 
    E_UKp = E_UKp111; 
else 
    E_LLc = E_LLc100; 
    E_LSc = E_LSc100; 
    E_LKc = E_LKc100; 
    E_SSc = E_SSc100; 
    E_SKc = E_SKc100; 
    E_KSc = E_KSc100; 
    E_SLc = E_SLc100; 
    E_KLc = E_KLc100; 
    E_USc = E_USc100; 
    E_UKc = E_UKc100; 
    E_LLp = E_LLp100; 
    E_LSp = E_LSp100; 
    E_LKp = E_LKp100; 
    E_SSp = E_SSp100; 
    E_SKp = E_SKp100; 
    E_KSp = E_KSp100; 
    E_SLp = E_SLp100; 
    E_KLp = E_KLp100; 
    E_USp = E_USp100; 
    E_UKp = E_UKp100; 
end 
  
E_LL = Cl*E_LLc+(1-Cl)*E_LLp; 
E_LS = Cl*E_LSc+(1-Cl)*E_LSp; 
E_LK = Cl*E_LKc+(1-Cl)*E_LKp; 
E_SS = Cl*E_SSc+(1-Cl)*E_SSp; 
E_SK = Cl*E_SKc+(1-Cl)*E_SKp; 
E_KS = Cl*E_KSc+(1-Cl)*E_KSp; 
E_SL = Cl*E_SLc+(1-Cl)*E_SLp; 
E_KL = Cl*E_KLc+(1-Cl)*E_KLp; 
E_US = Cl*E_USc+(1-Cl)*E_USp; 
E_UK = Cl*E_UKc+(1-Cl)*E_UKp; 
  
%% Input: Contour Plot Display 
  
interval = 350; 
  
%a = min flux, b = max flux 
a = 10^0; 
b = 10^15; 
  
%f = min Nuc. Rate, g = Nuc. Rate 
f = 10^0; 
g = 10^15; 
  
%nc = number of contours. 
nc = 25; 
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%% Data: Diffusion Rates and Physical Constants 
format longG 
  
%Boltzmann's Constant in eV/K 
k_B = 8.6173324E-5; 
  
%Thermal Energy 
kT = k_B*T; 
  
%Monolayer Height 
if facet == 111 
    d_hkl = d_hkl_111; 
else 





%% Date: Diffusion Rates 
  
preR_LL = v_LL*exp(-E_LL/kT); 
preR_LS = v_LS*exp(-E_LS/kT); 
preR_LK = v_LK*exp(-E_LK/kT); 
preR_SS = v_SS*exp(-E_SS/kT); 
preR_SK = v_SK*exp(-E_SK/kT); 
preR_KS = v_KS*exp(-E_KS/kT); 
preR_SL = v_SL*exp(-E_SL/kT); 
preR_KL = v_KL*exp(-E_KL/kT); 
preR_US = v_US*exp(-E_US/kT); 
preR_UK = v_UK*exp(-E_UK/kT); 
  
%Facet-dependent diffusion rates 
if facet == 111 
    pij_LL = (1/3)*preR_LL; 
    pij_LS = preR_LS/(preR_LS+2*preR_LL); 
    pij_LK = preR_LK/(preR_LK+2*preR_LL); 
    pij_SS = (1/2); 
    pij_SK = preR_SK/(preR_SK+preR_SS); 
    pij_KS = 0; 
    pij_SL = preR_SL/(preR_SL+2*preR_SS); 
    pij_KL = 1; 
    pij_US = preR_US/(preR_US+2*preR_LL); 
    pij_UK = preR_UK/(preR_UK+2*preR_LL); 
else 
    pij_LL = (1/4)*preR_LL; 
    pij_LS = preR_LS/(preR_LS+3*preR_LL); 
    pij_LK = preR_LK/(preR_LK+preR_LS+2*preR_LL); 
    pij_SS = (1/2); 
    pij_SK = preR_SK/(preR_SK+preR_SS); 
    pij_KS = 0; 
    pij_SL = preR_SL/(preR_SL+2*preR_SS); 
    pij_KL = 1; 
    pij_US = preR_US/(preR_US+3*preR_LL); 
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    pij_UK = preR_UK/(preR_UK+3*preR_LL); 
end 
  
R_LL = preR_LL*pij_LL; 
R_LS = preR_LS*pij_LS; 
R_LK = preR_LK*pij_LK; 
R_SS = preR_SS*pij_SS; 
R_SK = preR_SK*pij_SK; 
R_KS = preR_KS*pij_KS; 
R_SL = preR_SL*pij_SL; 
R_KL = preR_KL*pij_KL; 
R_US = preR_US*pij_US; 
R_UK = preR_UK*pij_UK; 
  
  




D_Au = 0.288; 
flux_step = D_Au*Flux; 
  
%E_T0 is the expectation time for growth units to arrive at the step front 
E_T0 = flux_step^(-1); 
  
%% Data: Arrival Time 
  
loga = log10(a); 
logb = log10(b); 
logf = log10(f); 
logg = log10(g); 
  
FL = ones(1,interval+1); 
  
for j = (1:interval+1) 
    k = 10^(loga+(j-1)*(logb-loga)/interval); 
    FL(j) = subs(flux_step,Flux,k); 
        
end 
  
MATFL = ones(m,interval+1); 
  
for l = (1:m) 
    MATFL(l,:) = l*FL; 





ET0_L = 1./MATFL; 
ET0_LU = ET0_L/2; 
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%% Data: Incorporation Generator 
  
Markov_incorporation = ones(m,1); 
MarkovLU_incorporation = ones(m,1); 
  
for n = (3:m) 
  
    ProbjL = 1/n; 
    ProbjLU = 1/(2*n); 
     
    timejL = 1/R_LS; 
    timejU = 1/R_US; 
     
    %Q is the infinitesimal generator 
     
    pkA = ones(n-1); 
    pkB = eye(n-1); 
    pkC = tril(pkA,-2); 
    pkD = triu(pkA,2); 
    pkE = pkA-pkB-pkC-pkD; 
    pkF = -R_SS*pkE; 
    pkG = pkB*(2*R_SS); 
     
    Q = pkF+pkG; 
    Q(1,1) = R_SK+R_SS; 
    Q(n-1,n-1) = R_SS; 
     
    Qone = ones(n-1,1); 
     
    E_partMarkov = Q\Qone; 
     
    T1T2mark = ones(n-1,1); 
       
    for q = (1:n-1) 
        T1T2mark(q) = ProbjL*(timejL+E_partMarkov(q)); 
    end 
     
    T1T2mark0 = ProbjL*(1/R_LK); 
     
    T1T2_Markov = [T1T2mark0;T1T2mark]; 
     
    T1T2one = ones(1,n); 
     
    T1T2L = T1T2one*T1T2_Markov; 
     
    Markov_incorporation(n) = T1T2L; 
     
    E_partMarkovLU = Q\Qone; 
         
    T1T2markLU = ones(n-1,1); 
     
    for h = (1:n-1) 
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        T1T2markLU(h) = ProbjLU*(timejL+timejU+2*E_partMarkovLU(h)); 
    end 
     
    T1T2LUmark0 = ProbjLU*(1/R_LK+1/R_UK); 
     
    T1T2LU_Markov = [T1T2LUmark0;T1T2markLU]; 
     
    T1T2LUone = ones(1,n); 
     
    T1T2LU = T1T2LUone*T1T2LU_Markov; 
     
    MarkovLU_incorporation(n) = T1T2LU; 
end 
  
Markov_incorporation(1) = 1/R_LK; 
  
Markov_incorporation(2) = (1/2)*(1/R_LK)+(1/2)*((1/R_LS)+(1/R_SK)); 
  









%% Data: Expected Time to Complete Step by CTMC 
  
Time_MarkovL = ones(m,interval+1); 
Time_MarkovLU = ones(m,interval+1); 
  
for v = (1:m) 
    Time_MarkovL(v,:) = ET0_L(v,:)+Markov_incorporation(v); 










for v = (1:m) 
    CORXNL(v,:) = (1/R_KL)./((1/R_KL)-Time_MarkovL(v,:)); 




T_markL = ones(m,interval+1); 
T_markLU = ones(m,interval+1); 
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for v = (1:m) 
    T_markL(v,:) = CORXNL(v,:).*Time_MarkovL(v,:); 
    T_markLU(v,:) = CORXNLU(v,:).*Time_MarkovLU(v,:);  
end 
  
numL = numel(T_markL); 
  
for d = (1:numL) 
    if T_markL(d)<0 
        T_markL(d)=NaN; 
    end 
    if T_markLU(d)<0 
        T_markLU(d)=NaN; 






Time_Markov_L = cumsum(T_markL); 
Time_Markov_LU = cumsum(T_markLU); 
  
%% Data: Expected Time for 1D Nucleation 
  
T1DL = ET0_L + 1/R_LS; 
T1DLU = ET0_LU + 0.5/R_LS + 0.5/R_US; 
  
CTMCL = ones(1+m-m_i,interval+1); 
CTMCLU = ones(1+m-m_i,interval+1); 
  
for p = (m_i:m) 
    E_T_M1 = ones(p,interval+1); 
    E_T_M2 = ones(p,interval+1); 
  
    for i = (1:p) 
        E_T_M1(i,:) = (1/p)*Time_Markov_L(max(i-1,p-i),:); 
        E_T_M2(i,:) = (1/p)*Time_Markov_LU(max(i-1,p-i),:); 
    end 
     
    jumpinL = T1DL(p,:); 
    jumpinLU = T1DLU(p,:); 
     
    E_T_ML = sum(E_T_M1); 
    E_T_MLU = sum(E_T_M2); 
     
    EML = E_T_ML + jumpinL; 
    EMLU = E_T_MLU + jumpinLU; 
     
    CTMCL(1+p-m_i,:) = EML; 
    CTMCLU(1+p-m_i,:) = EMLU; 
  
end 
































%% Data: Kink Propagation 
  
kinkL = ones(1+m-m_i,interval+1); 
kinkLU = ones(1+m-m_i,interval+1); 
kinkarrival = ones(m,interval+1); 
kinkarrivalLU = ones(m,interval+1); 
  
for x = (1:m) 
    kinkarrival(x,:) = 1./FL; 
    kinkarrivalLU(x,:) = 1./(2*FL); 
end 
  
kinkcum = cumsum(kinkarrival); 
kinkcumLU = cumsum(kinkarrivalLU); 
  
for y = (1:m) 
    kinkL(y,:) = y/R_LK+kinkcum(y,:); 
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KPL = ones(1+m-m_i,interval+1); 
KPLU = ones(1+m-m_i,interval+1); 
  
for p = (m_i:m) 
    E_T_KPL = ones(p,interval+1); 
    E_T_KPLU = ones(p,interval+1); 
  
    for i = (1:p) 
        E_T_KPL(i,:) = (1/p)*kinkL(max(i-1,p-i),:); 
        E_T_KPLU(i,:) = (1/p)*kinkLU(max(i-1,p-i),:); 
    end 
     
    KPL1 = sum(E_T_KPL); 
    KPLU1 = sum(E_T_KPLU); 
     
    tkL = T1DL(p,:); 
    tkLU = T1DLU(p,:); 
     
    KPL(1+p-m_i,:) = KPL1+tkL; 







%% Data: Filters 
  
Markov_Filter = ones(m,interval+1); 
Markov_Filter_LU = ones(m,interval+1); 
Kink_Filter = ones(m,interval+1); 
Kink_Filter_LU = ones(m,interval+1); 
  
for i = (1:interval+1) 
    Markov_Filter(:,i) = T1DL(:,i)-Markov_incorporation; 
    Markov_Filter_LU(:,i) = T1DLU(:,i)-MarkovLU_incorporation; 
end 
  
for j = (1:m*(interval+1)) 
    if Markov_Filter(j)<=0 
        Markov_Filter(j) = 0; 
    else Markov_Filter(j) = 1; 
    end 
    if Markov_Filter_LU(j)<=0 
        Markov_Filter_LU(j) = 0; 
    else Markov_Filter_LU(j) = 1; 
    end 
end 
  
for i = (1:interval+1) 
    Kink_Filter(:,i) = T1DL(:,i)-Markov_incorporation; 
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    Kink_Filter_LU(:,i) = T1DLU(:,i)-MarkovLU_incorporation; 
end 
  
for j = (1:m*(interval+1)) 
    if Kink_Filter(j)<=0 
        Kink_Filter(j) = 0; 
    else Kink_Filter(j) = 1; 
    end 
    if Kink_Filter_LU(j)<=0 
        Kink_Filter_LU(j) = 0; 
    else Kink_Filter_LU(j) = 1; 




Non_Markov_Filter = 1-Markov_Filter; 
Markov_Filter_LU; 
Non_Markov_Filter_LU = 1-Markov_Filter_LU; 
  
%% Data: Time for Direct Step Adsorption 
  
Direct_Step_L = ones(1+m-m_i,interval+1); 
Direct_Step_LU = ones(1+m-m_i,interval+1); 
premat_step_L = cumsum(ET0_L); 
premat_step_LU = cumsum(ET0_LU); 
  
for s = (m_i:m) 
    Direct_Step_L(1+s-m_i,:) = premat_step_L(s,:)+s/R_LS; 




Direct_Step_LU;        
  
%% Data: Minimum Time Direct Incorporation 
  
MinDirectL = min(Direct_Step_L,KPL); 
MinDirectLU = min(Direct_Step_LU,KPLU); 
     
%% Collection of Important Matrices and Vectors 
  
% Flux vector. 1 x int+1 
FL; 
  








% Expected Time for atom to diffuse via CTMC to kink. n x 1 



























%% Data: Filtered Results 
  
MF = ones(1+m-m_i,interval+1); 
MFLU = ones(1+m-m_i,interval+1); 
  
for f = (m_i:m) 
    MF(1+f-m_i,:) = Markov_Filter(f,:); 
end 
MF; 
nMF = 1-MF; 
  
for g = (m_i:m) 
    MFLU(1+g-m_i,:) = Markov_Filter_LU(g,:); 
end 
MFLU; 
nMFLU = 1-MFLU; 
  
Filtered_CTMCL = MF.*CTMCL; 
Filtered_MINDIR = nMF.*MinDirectL; 
  
Filtered_CTMCLU = MFLU.*CTMCLU; 
Filtered_MINDIRU = nMFLU.*MinDirectLU; 
  
  
% Expected times for step completion 
TIME_L = Filtered_CTMCL+Filtered_MINDIR; 
TIME_LU = Filtered_CTMCLU+Filtered_MINDIRU; 
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%Time for monolayer spread 
  
T_Spread_L = sum(TIME_L)'; 
T_Spread_LU = sum(TIME_LU)'; 
  






























%% Data: Crystal Growth Contour Plot 
  
NL = ones(1,interval+1); 
NR = ones(1,interval+1); 
  
for j = (1:interval+1) 
    k = 10^(logf+(j-1)*(logg-logf)/interval); 
    NR(j) = k; 
    NL(j) = 1/k; 
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Markov_ContourL1 = ones(interval+1,interval+1); 
Markov_ContourLU1 = ones(interval+1,interval+1); 
  
for l = (1:interval+1) 
    Markov_ContourL1(l,:) = NL+T_Spread_L(l); 






Markov_ContourL = Markov_ContourL1/d_hkl; 
Markov_ContourLU = Markov_ContourLU1/d_hkl; 
  
%% Plot: Crystal Growth Contour Plot 
  
logy = log10(FL./D_Au); 
  
  
% for unfilled contour plot use the following: 
%contour(log10(NR),logy,log10(1./Markov_ContourL),nc,'linewidth',2) 
  



























maxv = max(max(log10(1./Markov_ContourL))); 
minv = min(min(log10(1./Markov_ContourL))); 
range = (maxv-minv)/(nc+1); 
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ratematrix = log10(1./Markov_ContourL); 
size(ratematrix); 
  
ndtrans1 = ones(interval+1,interval+1); 
for a = (1:interval) 
    ndtrans1(:,a) = ratematrix(:,a+1)-ratematrix(:,a); 
end 
  
ndtrans1(:,interval+1) = zeros(interval+1,1); 
  
ndtrans2 = ones(interval+1,interval+1); 
for a = (1:interval) 
    ndtrans2(a,:) = ratematrix(a+1,:)-ratematrix(a,:); 
end 
  
ndtrans2(interval+1,:) = zeros(1,interval+1); 
  
ndtransA = ndtrans1 - ndtrans2; 
ndtransB = ndtrans2 - ndtrans1; 
ndtransC = ndtransA.*ndtransB; 
  




testmat = zeros(interval+1); 
  
for b = (1:interval+1) 
    testmat(I(b),b) = 1; 
end 
     
testmat; 
  
testq = maxv-range; 
  
maxmat = testmat.*ratematrix; 
  
[row,col] = find(maxmat>=testq); 
  
lrc = length(row); 
  
maxmat2 = maxmat; 
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for t = (1:lrc) 
    maxmat2(row(t),col(t)) = 0; 
end 
  
maxmat3 = maxmat2; 
  
for s = (1:(interval+1)^2) 
    if maxmat2(s) == 0; 
        maxmat3(s) = NaN; 





testline = max(maxmat3); 
  
N = isnan(testline); 
  
NN = 1-N; 
  
LN = nnz(NN); 
  
rrr = ones(LN,1); 
ccc = ones(LN,1); 
  
for r = (1:LN) 






xxx = log10(NR); 
  
yyy = logy; 
  
xvec = ones(1,LN); 
  
for x = (1:LN) 





yvec = ones(1,LN); 
  
for y = (1:LN) 












J = isnan(ratematrix(:,1)); 
  
JJ = 1-J; 
  
LJ = nnz(JJ); 
  
Jinit = interval+2 - LJ; 
  
minline = ones(interval+1,1); 
  
for j = (1:interval+1) 












%% Plot: Experimental Rate Contour  
  
% z = [log10(experimental growth rate),log10(experimental growth rate)] 










A2.2 Matlab script for diffusion-limited growth rate distribution 
 
%% Input: Diffusion-Limited Simulation 
  
%Temperature in Kelvin 
T = 300; 
  
%number of atoms in first step after nucleation 
m_i = 3; 
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%number of atoms in final step of net monolayer 
m = 10; 
  
%Facet index (do not include brackets. Write 111 or 100) 
facet = 111; 
  
%Chloride coverage (between 0 and 1) 
Cl = 0; 
  
%% Monte Carlo 
% Variables 
mu=534950; % mean  
sd=5349.50; % sigma 
  
%% Input: Activation Energies, Vib. Frequencies 
  
%{111} With Chloride EAM 
%Activation Energies in eV 
E_LLc111 = 0.080; 
E_LSc111 = 0.075; 
E_LKc111 = 0.052; 
E_SSc111 = 0.243; 
E_SKc111 = 0.223; 
E_KSc111 = 0.356; 
E_SLc111 = 0.320; 
E_KLc111 = 0.282; 
E_USc111 = 0.203; 
E_UKc111 = 0.142; 
d_hkl_111 = 0.353; 
  
%{111} Without Chloride EAM 
%Activation Energies in eV 
E_LLp111 = 0.102; 
E_LSp111 = 0.096; 
E_LKp111 = 0.067; 
E_SSp111 = 0.311; 
E_SKp111 = 0.286; 
E_KSp111 = 0.456; 
E_SLp111 = 0.410; 
E_KLp111 = 0.420; 
E_USp111 = 0.260; 
E_UKp111 = 0.181; 
  
%{100} With Chloride EAM 
%Activation Energies in eV 
E_LLc100 = 0.383; 
E_LSc100 = 0.361; 
E_LKc100 = 0.252; 
E_SSc100 = 0.236; 
E_SKc100 = 0.217; 
E_KSc100 = 0.355; 
E_SLc100 = 0.533; 
E_KLc100 = 0.468; 
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E_USc100 = 0.413; 
E_UKc100 = 0.288; 
d_hkl_100 = 0.408; 
  
%{100} Without Chloride EAM 
%Activation Energies in eV 
E_LLp100 = 0.490; 
E_LSp100 = 0.462; 
E_LKp100 = 0.322; 
E_SSp100 = 0.302; 
E_SKp100 = 0.278; 
E_KSp100 = 0.455; 
E_SLp100 = 0.682; 
E_KLp100 = 0.698; 
E_USp100 = 0.528; 
E_UKp100 = 0.368; 
  
%Vibrational Frequencies in 1/s 
v_LL = 1.76E+12; 
v_LS = 1.42E+12; 
v_LK = 1.43E+12; 
v_SS = 1.41E+12; 
v_SK = 1.45E+12; 
v_KS = 1.45E+12; 
v_SL = 1.91E+12; 
v_KL = 1.75E+12; 
v_US = 1.42E+12; 
v_UK = 1.43E+12; 
  
%% Activation energies 
  
%Facet identity 
if facet == 111 
    E_LLc = E_LLc111; 
    E_LSc = E_LSc111; 
    E_LKc = E_LKc111; 
    E_SSc = E_SSc111; 
    E_SKc = E_SKc111; 
    E_KSc = E_KSc111; 
    E_SLc = E_SLc111; 
    E_KLc = E_KLc111; 
    E_USc = E_USc111; 
    E_UKc = E_UKc111; 
    E_LLp = E_LLp111; 
    E_LSp = E_LSp111; 
    E_LKp = E_LKp111; 
    E_SSp = E_SSp111; 
    E_SKp = E_SKp111; 
    E_KSp = E_KSp111; 
    E_SLp = E_SLp111; 
    E_KLp = E_KLp111; 
    E_USp = E_USp111; 
    E_UKp = E_UKp111; 
else 
    E_LLc = E_LLc100; 
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    E_LSc = E_LSc100; 
    E_LKc = E_LKc100; 
    E_SSc = E_SSc100; 
    E_SKc = E_SKc100; 
    E_KSc = E_KSc100; 
    E_SLc = E_SLc100; 
    E_KLc = E_KLc100; 
    E_USc = E_USc100; 
    E_UKc = E_UKc100; 
    E_LLp = E_LLp100; 
    E_LSp = E_LSp100; 
    E_LKp = E_LKp100; 
    E_SSp = E_SSp100; 
    E_SKp = E_SKp100; 
    E_KSp = E_KSp100; 
    E_SLp = E_SLp100; 
    E_KLp = E_KLp100; 
    E_USp = E_USp100; 
    E_UKp = E_UKp100; 
end 
  
E_LL = Cl*E_LLc+(1-Cl)*E_LLp; 
E_LS = Cl*E_LSc+(1-Cl)*E_LSp; 
E_LK = Cl*E_LKc+(1-Cl)*E_LKp; 
E_SS = Cl*E_SSc+(1-Cl)*E_SSp; 
E_SK = Cl*E_SKc+(1-Cl)*E_SKp; 
E_KS = Cl*E_KSc+(1-Cl)*E_KSp; 
E_SL = Cl*E_SLc+(1-Cl)*E_SLp; 
E_KL = Cl*E_KLc+(1-Cl)*E_KLp; 
E_US = Cl*E_USc+(1-Cl)*E_USp; 
E_UK = Cl*E_UKc+(1-Cl)*E_UKp; 
  
%% Input: Growth Phase Diagram Display 
  
interval = 400; 
  
%a = min flux, b = max flux 
a = mu-5*sd; 
b = mu+5*sd; 
  
%f = min Nuc. Rate, g = Nuc. Rate 
f = 10^0; 
g = 10^15; 
  
%nc = number of contours. 
nc = 25; 
  
%% Data: Diffusion Rates and Physical Constants 
format longG 
  
%Boltzmann's Constant in eV/K 
k_B = 8.6173324E-5; 
  
%Thermal Energy 
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kT = k_B*T; 
  
%Monolayer Height 
if facet == 111 
    d_hkl = d_hkl_111; 
else 




     
%Diffusion Rates in Jumps/s 
R_LL = v_LL*exp(-E_LL/kT); 
R_LS = v_LS*exp(-E_LS/kT); 
R_LK = v_LK*exp(-E_LK/kT); 
R_SS = v_SS*exp(-E_SS/kT); 
R_SK = v_SK*exp(-E_SK/kT); 
R_KS = v_KS*exp(-E_KS/kT); 
R_SL = v_SL*exp(-E_SL/kT); 
R_KL = v_KL*exp(-E_KL/kT); 
R_US = v_US*exp(-E_US/kT); 
R_UK = v_UK*exp(-E_UK/kT); 
  
%Flux is the flux of growth units to the step front in atoms nm^-1 s^-1 
  
D_Au = 0.288; 
  
%% Data: Arrival Time 
  
%Construct grid. 
loga = log10(a); 
logb = log10(b); 
logf = log10(f); 




MATFL = ones(m,interval+1); 
  
for l = (1:m) 
    MATFL(l,:) = l*FL; 





ET0_L = 1./MATFL; 
ET0_LU = ET0_L/2; 
  
%% Data: Incorporation Generator 
  
Markov_incorporation = ones(m,1); 
MarkovLU_incorporation = ones(m,1); 
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for n = (3:m) 
  
    ProbjL = 1/n; 
    ProbjLU = 1/(2*n); 
     
    timejL = 1/R_LS; 
    timejU = 1/R_US; 
     
    %Q is the infinitesimal generator 
     
    pkA = ones(n-1); 
    pkB = eye(n-1); 
    pkC = tril(pkA,-2); 
    pkD = triu(pkA,2); 
    pkE = pkA-pkB-pkC-pkD; 
    pkF = -R_SS*pkE; 
    pkG = pkB*(2*R_SS); 
     
    Q = pkF+pkG; 
    Q(1,1) = R_SK+R_SS; 
    Q(n-1,n-1) = R_SS; 
     
    Qone = ones(n-1,1); 
     
    E_partMarkov = Q\Qone; 
     
    T1T2mark = ones(n-1,1); 
       
    for q = (1:n-1) 
        T1T2mark(q) = ProbjL*(timejL+E_partMarkov(q)); 
    end 
     
    T1T2mark0 = ProbjL*(1/R_LK); 
     
    T1T2_Markov = [T1T2mark0;T1T2mark]; 
     
    T1T2one = ones(1,n); 
     
    T1T2L = T1T2one*T1T2_Markov; 
     
    Markov_incorporation(n) = T1T2L; 
     
    E_partMarkovLU = Q\Qone; 
         
    T1T2markLU = ones(n-1,1); 
     
    for h = (1:n-1) 
        T1T2markLU(h) = ProbjLU*(timejL+timejU+2*E_partMarkovLU(h)); 
    end 
     
    T1T2LUmark0 = ProbjLU*(1/R_LK+1/R_UK); 
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    T1T2LU_Markov = [T1T2LUmark0;T1T2markLU]; 
     
    T1T2LUone = ones(1,n); 
     
    T1T2LU = T1T2LUone*T1T2LU_Markov; 
     
    MarkovLU_incorporation(n) = T1T2LU; 
end 
  
Markov_incorporation(1) = 1/R_LK; 
  
Markov_incorporation(2) = (1/2)*(1/R_LK)+(1/2)*((1/R_LS)+(1/R_SK)); 
  








%% Data: Time to Complete Step by CTMC 
  
Time_MarkovL = ones(m,interval+1); 
Time_MarkovLU = ones(m,interval+1); 
  
for v = (1:m) 
    Time_MarkovL(v,:) = ET0_L(v,:)+Markov_incorporation(v); 










for v = (1:m) 
    CORXNL(v,:) = (1/R_KL)./((1/R_KL)-Time_MarkovL(v,:)); 




T_markL = ones(m,interval+1); 
T_markLU = ones(m,interval+1); 
  
for v = (1:m) 
    T_markL(v,:) = CORXNL(v,:).*Time_MarkovL(v,:); 
    T_markLU(v,:) = CORXNLU(v,:).*Time_MarkovLU(v,:);  
end 
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numL = numel(T_markL); 
  
for d = (1:numL) 
    if T_markL(d)<0 
        T_markL(d)=NaN; 
    end 
    if T_markLU(d)<0 
        T_markLU(d)=NaN; 






Time_Markov_L = cumsum(T_markL); 
Time_Markov_LU = cumsum(T_markLU); 
  
%% Data: Expected Time for 1D Nucleation 
  
T1DL = ET0_L + 1/R_LS; 
T1DLU = ET0_LU + 0.5/R_LS + 0.5/R_US; 
  
CTMCL = ones(1+m-m_i,interval+1); 
CTMCLU = ones(1+m-m_i,interval+1); 
  
for p = (m_i:m) 
    E_T_M1 = ones(p,interval+1); 
    E_T_M2 = ones(p,interval+1); 
  
    for i = (1:p) 
        E_T_M1(i,:) = (1/p)*Time_Markov_L(max(i-1,p-i),:); 
        E_T_M2(i,:) = (1/p)*Time_Markov_LU(max(i-1,p-i),:); 
    end 
     
    jumpinL = T1DL(p,:); 
    jumpinLU = T1DLU(p,:); 
     
    E_T_ML = sum(E_T_M1); 
    E_T_MLU = sum(E_T_M2); 
     
    EML = E_T_ML + jumpinL; 
    EMLU = E_T_MLU + jumpinLU; 
     
    CTMCL(1+p-m_i,:) = EML; 







%% Data: Kink Propagation 
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kinkL = ones(1+m-m_i,interval+1); 
kinkLU = ones(1+m-m_i,interval+1); 
kinkarrival = ones(m,interval+1); 
kinkarrivalLU = ones(m,interval+1); 
  
for x = (1:m) 
    kinkarrival(x,:) = 1./FL; 
    kinkarrivalLU(x,:) = 1./(2*FL); 
end 
  
kinkcum = cumsum(kinkarrival); 
kinkcumLU = cumsum(kinkarrivalLU); 
  
for y = (1:m) 
    kinkL(y,:) = y/R_LK+kinkcum(y,:); 






KPL = ones(1+m-m_i,interval+1); 
KPLU = ones(1+m-m_i,interval+1); 
  
for p = (m_i:m) 
    E_T_KPL = ones(p,interval+1); 
    E_T_KPLU = ones(p,interval+1); 
  
    for i = (1:p) 
        E_T_KPL(i,:) = (1/p)*kinkL(max(i-1,p-i),:); 
        E_T_KPLU(i,:) = (1/p)*kinkLU(max(i-1,p-i),:); 
    end 
     
    KPL1 = sum(E_T_KPL); 
    KPLU1 = sum(E_T_KPLU); 
     
    tkL = T1DL(p,:); 
    tkLU = T1DLU(p,:); 
     
    KPL(1+p-m_i,:) = KPL1+tkL; 







%% Data: Filters 
  
Markov_Filter = ones(m,interval+1); 
Markov_Filter_LU = ones(m,interval+1); 
Kink_Filter = ones(m,interval+1); 
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Kink_Filter_LU = ones(m,interval+1); 
  
for i = (1:interval+1) 
    Markov_Filter(:,i) = T1DL(:,i)-Markov_incorporation; 
    Markov_Filter_LU(:,i) = T1DLU(:,i)-MarkovLU_incorporation; 
end 
  
for j = (1:m*(interval+1)) 
    if Markov_Filter(j)<=0 
        Markov_Filter(j) = 0; 
    else Markov_Filter(j) = 1; 
    end 
    if Markov_Filter_LU(j)<=0 
        Markov_Filter_LU(j) = 0; 
    else Markov_Filter_LU(j) = 1; 
    end 
end 
  
for i = (1:interval+1) 
    Kink_Filter(:,i) = T1DL(:,i)-Markov_incorporation; 
    Kink_Filter_LU(:,i) = T1DLU(:,i)-MarkovLU_incorporation; 
end 
  
for j = (1:m*(interval+1)) 
    if Kink_Filter(j)<=0 
        Kink_Filter(j) = 0; 
    else Kink_Filter(j) = 1; 
    end 
    if Kink_Filter_LU(j)<=0 
        Kink_Filter_LU(j) = 0; 
    else Kink_Filter_LU(j) = 1; 




Non_Markov_Filter = 1-Markov_Filter; 
Markov_Filter_LU; 
Non_Markov_Filter_LU = 1-Markov_Filter_LU; 
  
%% Data: Time for direct step adsorption 
  
Direct_Step_L = ones(1+m-m_i,interval+1); 
Direct_Step_LU = ones(1+m-m_i,interval+1); 
premat_step_L = cumsum(ET0_L); 
premat_step_LU = cumsum(ET0_LU); 
  
for s = (m_i:m) 
    Direct_Step_L(1+s-m_i,:) = premat_step_L(s,:)+s/R_LS; 




Direct_Step_LU;        
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%% Data: Minimum Time Direct Incorporation 
  
MinDirectL = min(Direct_Step_L,KPL); 
MinDirectLU = min(Direct_Step_LU,KPLU); 
     
%% Collection of Important Matrices and Vectors 
  
% Flux vector. 1 x int+1 
FL; 
  



































%% Data: Filtered Results 
  
MF = ones(1+m-m_i,interval+1); 
MFLU = ones(1+m-m_i,interval+1); 
  
for f = (m_i:m) 
    MF(1+f-m_i,:) = Markov_Filter(f,:); 
end 
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MF; 
nMF = 1-MF; 
  
for g = (m_i:m) 
    MFLU(1+g-m_i,:) = Markov_Filter_LU(g,:); 
end 
MFLU; 
nMFLU = 1-MFLU; 
  
Filtered_CTMCL = MF.*CTMCL; 
Filtered_MINDIR = nMF.*MinDirectL; 
  
Filtered_CTMCLU = MFLU.*CTMCLU; 
Filtered_MINDIRU = nMFLU.*MinDirectLU; 
  
  
% Expected times for step completion 
TIME_L = Filtered_CTMCL+Filtered_MINDIR; 
TIME_LU = Filtered_CTMCLU+Filtered_MINDIRU; 
  
%Time for monolayer spread 
  
T_Spread_L = sum(TIME_L)'; 
T_Spread_LU = sum(TIME_LU)'; 
  
%% Data: Growth Phase Diagram 
  
NL = ones(1,interval+1); 
NR = ones(1,interval+1); 
  
for j = (1:interval+1) 
    k = 10^(logf+(j-1)*(logg-logf)/interval); 
    NR(j) = k; 
    NL(j) = 1/k; 






Markov_ContourL1 = ones(interval+1,interval+1); 
Markov_ContourLU1 = ones(interval+1,interval+1); 
  
for l = (1:interval+1) 
    Markov_ContourL1(l,:) = NL+T_Spread_L(l); 






Markov_ContourL = Markov_ContourL1/d_hkl; 
Markov_ContourLU = Markov_ContourLU1/d_hkl; 
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RATE_L = 1./Markov_ContourL; 




N=10^6; % # times 
  






    r1=rand; 
    r2=rand; 
    r3=rand; 
    r4=rand; 
    x(i)=sqrt(-2*(0.288*sd)^2*log(r1))*sin(2*pi*r2); 
    x(i)=x(i)+0.288*mu; 
    %x2(i)=sqrt(-2*s2^2*log(r3))*sin(2*pi*r4); 
    %x2(i)=x2(i)+mu2; 
end 
  
bin = histc(x,FL)'; 
%% 
rcol = RATE_L(:,interval+1); 
  





red = sum(isnan(RATE_L(:,interval+1))); 
  
lg = (min(blue)-1)-(max(red)+1)+1; 
lb = max(blue)-min(blue)+1; 
  
green = ones(lg,1); 
  
for g = (max(red)+1:min(blue)-1) 
    green(g-red)=rcol(g); 
end 
  
greenx = ones(lg,1); 
for g = (max(red)+1:min(blue)-1) 
    greenx(g-red)=bin(g); 
end 
  
sumg = sum(greenx); 
  
percentgreen = sumg/1000000; %percent lateral growth 
  




blu = ones(lb,1); 
  
for b = (min(blue):max(blue)) 





bing = ones(lg,1); 
  
for g = (max(red)+1:min(blue)-1) 





binb = ones(lb,1); 
  
for b = (min(blue):max(blue)) 





mu3 = 10; 
sd3 = 100; 
  
intblu = blu(2)-blu(1); 
  
maxred = min(green)-intblu; 
  
minred = mu3-max(blu); 
  
redel = 1+ceil((maxred-minred)/intblu); 
  
reds = ones(redel,1); 
  
for r = (1:redel) 
    reds(r) = maxred-(r-1)*intblu; 
end 
  
redvals = flipud(reds); 
  
xpdf = [redvals;green;blu]; 
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datax = [green;red]; 
  
datay = [bing;binb]; 
  
negdatay = zeros(length(datay)-27,1); 
  
for d = (1:length(datay)-31) 
    negdatay(d) = datay(d+3); 
end 
  
negdatax = flipud(negdatay); 
  
datastitch = [negdatax;bing;binb]; 
  
gaussEqn = 'a*exp(-((x-b)/c)^2)+d'; 
  
startPoints = [1 10 10 0.6]; 
  
gauss = fit(xpdf,datastitch,gaussEqn,'Start',startPoints); 
  
figure(1) 


















A2.3 Matlab script for nucleation-limited growth rate distribution 
 
%% Input: Crystal Growth Contour Plot  
  
%Temperature in Kelvin 
T = 300; 
  
%number of atoms in first step after nucleation 
m_i = 3; 
  
%number of atoms in step fragment 
m = 10; 
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%Facet index (do not include brackets. Write 111 or 100) 
facet = 111; 
  
%Chloride coverage (between 0 and 1) 
Cl = 0; 
  
%% Monte Carlo 
% Variables 
  
mu2=28.5; % mean 2  
sd2=0.285; % sigma 2 
  
%% Input: Activation Energies, Vib. Frequencies 
  
%{111} With Chloride EAM 
%Activation Energies in eV 
E_LLc111 = 0.080; 
E_LSc111 = 0.075; 
E_LKc111 = 0.052; 
E_SSc111 = 0.243; 
E_SKc111 = 0.223; 
E_KSc111 = 0.356; 
E_SLc111 = 0.320; 
E_KLc111 = 0.282; 
E_USc111 = 0.203; 
E_UKc111 = 0.142; 
d_hkl_111 = 0.353; 
  
%{111} Without Chloride EAM 
%Activation Energies in eV 
E_LLp111 = 0.102; 
E_LSp111 = 0.096; 
E_LKp111 = 0.067; 
E_SSp111 = 0.311; 
E_SKp111 = 0.286; 
E_KSp111 = 0.456; 
E_SLp111 = 0.410; 
E_KLp111 = 0.420; 
E_USp111 = 0.260; 
E_UKp111 = 0.181; 
  
%{100} With Chloride EAM 
%Activation Energies in eV 
E_LLc100 = 0.383; 
E_LSc100 = 0.361; 
E_LKc100 = 0.252; 
E_SSc100 = 0.236; 
E_SKc100 = 0.217; 
E_KSc100 = 0.355; 
E_SLc100 = 0.533; 
E_KLc100 = 0.468; 
E_USc100 = 0.413; 
E_UKc100 = 0.288; 
d_hkl_100 = 0.408; 
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%{100} Without Chloride EAM 
%Activation Energies in eV 
E_LLp100 = 0.490; 
E_LSp100 = 0.462; 
E_LKp100 = 0.322; 
E_SSp100 = 0.302; 
E_SKp100 = 0.278; 
E_KSp100 = 0.455; 
E_SLp100 = 0.682; 
E_KLp100 = 0.698; 
E_USp100 = 0.528; 
E_UKp100 = 0.368; 
  
%Vibrational Frequencies in 1/s 
v_LL = 1.76E+12; 
v_LS = 1.42E+12; 
v_LK = 1.43E+12; 
v_SS = 1.41E+12; 
v_SK = 1.45E+12; 
v_KS = 1.45E+12; 
v_SL = 1.91E+12; 
v_KL = 1.75E+12; 
v_US = 1.42E+12; 
v_UK = 1.43E+12; 
  
%% Activation energies 
  
%Facet identity 
if facet == 111 
    E_LLc = E_LLc111; 
    E_LSc = E_LSc111; 
    E_LKc = E_LKc111; 
    E_SSc = E_SSc111; 
    E_SKc = E_SKc111; 
    E_KSc = E_KSc111; 
    E_SLc = E_SLc111; 
    E_KLc = E_KLc111; 
    E_USc = E_USc111; 
    E_UKc = E_UKc111; 
    E_LLp = E_LLp111; 
    E_LSp = E_LSp111; 
    E_LKp = E_LKp111; 
    E_SSp = E_SSp111; 
    E_SKp = E_SKp111; 
    E_KSp = E_KSp111; 
    E_SLp = E_SLp111; 
    E_KLp = E_KLp111; 
    E_USp = E_USp111; 
    E_UKp = E_UKp111; 
else 
    E_LLc = E_LLc100; 
    E_LSc = E_LSc100; 
    E_LKc = E_LKc100; 
    E_SSc = E_SSc100; 
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    E_SKc = E_SKc100; 
    E_KSc = E_KSc100; 
    E_SLc = E_SLc100; 
    E_KLc = E_KLc100; 
    E_USc = E_USc100; 
    E_UKc = E_UKc100; 
    E_LLp = E_LLp100; 
    E_LSp = E_LSp100; 
    E_LKp = E_LKp100; 
    E_SSp = E_SSp100; 
    E_SKp = E_SKp100; 
    E_KSp = E_KSp100; 
    E_SLp = E_SLp100; 
    E_KLp = E_KLp100; 
    E_USp = E_USp100; 
    E_UKp = E_UKp100; 
end 
  
E_LL = Cl*E_LLc+(1-Cl)*E_LLp; 
E_LS = Cl*E_LSc+(1-Cl)*E_LSp; 
E_LK = Cl*E_LKc+(1-Cl)*E_LKp; 
E_SS = Cl*E_SSc+(1-Cl)*E_SSp; 
E_SK = Cl*E_SKc+(1-Cl)*E_SKp; 
E_KS = Cl*E_KSc+(1-Cl)*E_KSp; 
E_SL = Cl*E_SLc+(1-Cl)*E_SLp; 
E_KL = Cl*E_KLc+(1-Cl)*E_KLp; 
E_US = Cl*E_USc+(1-Cl)*E_USp; 
E_UK = Cl*E_UKc+(1-Cl)*E_UKp; 
  
%% Input: Growth Phase Diagram Display 
  
interval = 350; 
  
%a = min flux, b = max flux 
a = 10^0; 
b = 10^15; 
  
%f = min Nuc. Rate, g = Nuc. Rate 
f = mu-5*sd; 
g = mu+5*sd; 
  
%nc = number of contours. 
nc = 25; 
  
  
%% Data: Diffusion Rates and Physical Constants 
format longG 
  
%Boltzmann's Constant in eV/K 
k_B = 8.6173324E-5; 
  
%Thermal Energy 
kT = k_B*T; 
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%Monolayer Height 
if facet == 111 
    d_hkl = d_hkl_111; 
else 




     
%Diffusion Rates in Jumps/s 
R_LL = v_LL*exp(-E_LL/kT); 
R_LS = v_LS*exp(-E_LS/kT); 
R_LK = v_LK*exp(-E_LK/kT); 
R_SS = v_SS*exp(-E_SS/kT); 
R_SK = v_SK*exp(-E_SK/kT); 
R_KS = v_KS*exp(-E_KS/kT); 
R_SL = v_SL*exp(-E_SL/kT); 
R_KL = v_KL*exp(-E_KL/kT); 
R_US = v_US*exp(-E_US/kT); 
R_UK = v_UK*exp(-E_UK/kT); 
  




D_Au = 0.288; 
flux_step = D_Au*Flux; 
  
%E_T0 is the expectation time for growth units to arrive at the step front 
E_T0 = flux_step^(-1); 
  
%% Data: Arrival Time 
  
%Construct grid. 
loga = log10(a); 
logb = log10(b); 
logf = log10(f); 
logg = log10(g); 
  
FL = ones(1,interval+1); 
  
for j = (1:interval+1) 
    k = 10^(loga+(j-1)*(logb-loga)/interval); 
    FL(j) = subs(flux_step,Flux,k); 
        
end 
  
MATFL = ones(m,interval+1); 
  
for l = (1:m) 
    MATFL(l,:) = l*FL; 
        
end 




ET0_L = 1./MATFL; 
ET0_LU = ET0_L/2; 
  
%% Data: Incorporation Generator 
  
Markov_incorporation = ones(m,1); 
MarkovLU_incorporation = ones(m,1); 
  
for n = (3:m) 
  
    ProbjL = 1/n; 
    ProbjLU = 1/(2*n); 
     
    timejL = 1/R_LS; 
    timejU = 1/R_US; 
     
    %Q is the infinitesimal generator 
     
    pkA = ones(n-1); 
    pkB = eye(n-1); 
    pkC = tril(pkA,-2); 
    pkD = triu(pkA,2); 
    pkE = pkA-pkB-pkC-pkD; 
    pkF = -R_SS*pkE; 
    pkG = pkB*(2*R_SS); 
     
    Q = pkF+pkG; 
    Q(1,1) = R_SK+R_SS; 
    Q(n-1,n-1) = R_SS; 
     
    Qone = ones(n-1,1); 
     
    E_partMarkov = Q\Qone; 
     
    T1T2mark = ones(n-1,1); 
       
    for q = (1:n-1) 
        T1T2mark(q) = ProbjL*(timejL+E_partMarkov(q)); 
    end 
     
    T1T2mark0 = ProbjL*(1/R_LK); 
     
    T1T2_Markov = [T1T2mark0;T1T2mark]; 
     
    T1T2one = ones(1,n); 
     
    T1T2L = T1T2one*T1T2_Markov; 
     
    Markov_incorporation(n) = T1T2L; 
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    E_partMarkovLU = Q\Qone; 
         
    T1T2markLU = ones(n-1,1); 
     
    for h = (1:n-1) 
        T1T2markLU(h) = ProbjLU*(timejL+timejU+2*E_partMarkovLU(h)); 
    end 
     
    T1T2LUmark0 = ProbjLU*(1/R_LK+1/R_UK); 
     
    T1T2LU_Markov = [T1T2LUmark0;T1T2markLU]; 
     
    T1T2LUone = ones(1,n); 
     
    T1T2LU = T1T2LUone*T1T2LU_Markov; 
     
    MarkovLU_incorporation(n) = T1T2LU; 
end 
  
Markov_incorporation(1) = 1/R_LK; 
  
Markov_incorporation(2) = (1/2)*(1/R_LK)+(1/2)*((1/R_LS)+(1/R_SK)); 
  









%% Data: Time to Complete Step by CTMC 
  
Time_MarkovL = ones(m,interval+1); 
Time_MarkovLU = ones(m,interval+1); 
  
for v = (1:m) 
    Time_MarkovL(v,:) = ET0_L(v,:)+Markov_incorporation(v); 










for v = (1:m) 
    CORXNL(v,:) = (1/R_KL)./((1/R_KL)-Time_MarkovL(v,:)); 
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T_markL = ones(m,interval+1); 
T_markLU = ones(m,interval+1); 
  
for v = (1:m) 
    T_markL(v,:) = CORXNL(v,:).*Time_MarkovL(v,:); 
    T_markLU(v,:) = CORXNLU(v,:).*Time_MarkovLU(v,:);  
end 
  
numL = numel(T_markL); 
  
for d = (1:numL) 
    if T_markL(d)<0 
        T_markL(d)=NaN; 
    end 
    if T_markLU(d)<0 
        T_markLU(d)=NaN; 






Time_Markov_L = cumsum(T_markL); 
Time_Markov_LU = cumsum(T_markLU); 
  
%% Data: Expected Time for 1D Nucleation 
  
T1DL = ET0_L + 1/R_LS; 
T1DLU = ET0_LU + 0.5/R_LS + 0.5/R_US; 
  
CTMCL = ones(1+m-m_i,interval+1); 
CTMCLU = ones(1+m-m_i,interval+1); 
  
for p = (m_i:m) 
    E_T_M1 = ones(p,interval+1); 
    E_T_M2 = ones(p,interval+1); 
  
    for i = (1:p) 
        E_T_M1(i,:) = (1/p)*Time_Markov_L(max(i-1,p-i),:); 
        E_T_M2(i,:) = (1/p)*Time_Markov_LU(max(i-1,p-i),:); 
    end 
     
    jumpinL = T1DL(p,:); 
    jumpinLU = T1DLU(p,:); 
     
    E_T_ML = sum(E_T_M1); 
    E_T_MLU = sum(E_T_M2); 
     
    EML = E_T_ML + jumpinL; 
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    EMLU = E_T_MLU + jumpinLU; 
     
    CTMCL(1+p-m_i,:) = EML; 







%% Data: Kink Propagation 
  
kinkL = ones(1+m-m_i,interval+1); 
kinkLU = ones(1+m-m_i,interval+1); 
kinkarrival = ones(m,interval+1); 
kinkarrivalLU = ones(m,interval+1); 
  
for x = (1:m) 
    kinkarrival(x,:) = 1./FL; 
    kinkarrivalLU(x,:) = 1./(2*FL); 
end 
  
kinkcum = cumsum(kinkarrival); 
kinkcumLU = cumsum(kinkarrivalLU); 
  
for y = (1:m) 
    kinkL(y,:) = y/R_LK+kinkcum(y,:); 






KPL = ones(1+m-m_i,interval+1); 
KPLU = ones(1+m-m_i,interval+1); 
  
for p = (m_i:m) 
    E_T_KPL = ones(p,interval+1); 
    E_T_KPLU = ones(p,interval+1); 
  
    for i = (1:p) 
        E_T_KPL(i,:) = (1/p)*kinkL(max(i-1,p-i),:); 
        E_T_KPLU(i,:) = (1/p)*kinkLU(max(i-1,p-i),:); 
    end 
     
    KPL1 = sum(E_T_KPL); 
    KPLU1 = sum(E_T_KPLU); 
     
    tkL = T1DL(p,:); 
    tkLU = T1DLU(p,:); 
     
    KPL(1+p-m_i,:) = KPL1+tkL; 
    KPLU(1+p-m_i,:) = KPLU1+tkLU; 







%% Data: Filters 
  
Markov_Filter = ones(m,interval+1); 
Markov_Filter_LU = ones(m,interval+1); 
Kink_Filter = ones(m,interval+1); 
Kink_Filter_LU = ones(m,interval+1); 
  
for i = (1:interval+1) 
    Markov_Filter(:,i) = T1DL(:,i)-Markov_incorporation; 
    Markov_Filter_LU(:,i) = T1DLU(:,i)-MarkovLU_incorporation; 
end 
  
for j = (1:m*(interval+1)) 
    if Markov_Filter(j)<=0 
        Markov_Filter(j) = 0; 
    else Markov_Filter(j) = 1; 
    end 
    if Markov_Filter_LU(j)<=0 
        Markov_Filter_LU(j) = 0; 
    else Markov_Filter_LU(j) = 1; 
    end 
end 
  
for i = (1:interval+1) 
    Kink_Filter(:,i) = T1DL(:,i)-Markov_incorporation; 
    Kink_Filter_LU(:,i) = T1DLU(:,i)-MarkovLU_incorporation; 
end 
  
for j = (1:m*(interval+1)) 
    if Kink_Filter(j)<=0 
        Kink_Filter(j) = 0; 
    else Kink_Filter(j) = 1; 
    end 
    if Kink_Filter_LU(j)<=0 
        Kink_Filter_LU(j) = 0; 
    else Kink_Filter_LU(j) = 1; 




Non_Markov_Filter = 1-Markov_Filter; 
Markov_Filter_LU; 
Non_Markov_Filter_LU = 1-Markov_Filter_LU; 
  
%% Data: Time for direct step adsorption 
  
Direct_Step_L = ones(1+m-m_i,interval+1); 
Direct_Step_LU = ones(1+m-m_i,interval+1); 
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premat_step_L = cumsum(ET0_L); 
premat_step_LU = cumsum(ET0_LU); 
  
for s = (m_i:m) 
    Direct_Step_L(1+s-m_i,:) = premat_step_L(s,:)+s/R_LS; 




Direct_Step_LU;        
  
%% Data: Minimum Time Direct Incorporation 
  
MinDirectL = min(Direct_Step_L,KPL); 
MinDirectLU = min(Direct_Step_LU,KPLU); 
     
%% Collection of Important Matrices and Vectors 
  
% Flux vector. 1 x int+1 
FL; 
  































% (minimum) Expected Time for direct incorporation. n x int+1 




%% Data: Filtered Results 
  
MF = ones(1+m-m_i,interval+1); 
MFLU = ones(1+m-m_i,interval+1); 
  
for f = (m_i:m) 
    MF(1+f-m_i,:) = Markov_Filter(f,:); 
end 
MF; 
nMF = 1-MF; 
  
for g = (m_i:m) 
    MFLU(1+g-m_i,:) = Markov_Filter_LU(g,:); 
end 
MFLU; 
nMFLU = 1-MFLU; 
  
Filtered_CTMCL = MF.*CTMCL; 
Filtered_MINDIR = nMF.*MinDirectL; 
  
Filtered_CTMCLU = MFLU.*CTMCLU; 
Filtered_MINDIRU = nMFLU.*MinDirectLU; 
  
  
% Expected times for step completion 
TIME_L = Filtered_CTMCL+Filtered_MINDIR; 
TIME_LU = Filtered_CTMCLU+Filtered_MINDIRU; 
  
%Time for monolayer spread 
  
T_Spread_L = sum(TIME_L)'; 
T_Spread_LU = sum(TIME_LU)'; 
  





Markov_ContourL1 = ones(interval+1,interval+1); 
Markov_ContourLU1 = ones(interval+1,interval+1); 
  
for l = (1:interval+1) 
    Markov_ContourL1(l,:) = NL+T_Spread_L(l); 






Markov_ContourL = Markov_ContourL1/d_hkl; 
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N=10^6; % # times 
  






    r1=rand; 
    r2=rand; 
    r3=rand; 
    r4=rand; 
    x(i)=sqrt(-2*sd^2*log(r1))*sin(2*pi*r2); 












RATE_L = 1./Markov_ContourL; 
  





%% Plot: Nucleation-Limited Growth Rate Distribution 
  
bing = zeros(1,length(rcol)); 
  
for b = (1:length(rcol)) 
    bing(b) = bin(b); 
end 
  
green = bing'; 
xpdf = rcol'; 
  
gaussEqn = 'a*exp(-((x-b)/c)^2)+d'; 
  
startPoints = [15000 10 0.1 0.1]; 
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gauss = fit(xpdf,green,gaussEqn,'Start',startPoints); 
  
bar(xpdf,green,1,'FaceColor',[0 0.85 0.15],'EdgeColor',[0 0.85 0.15]) 
  
  
xlim([5 15]) 
ylim([0 12000]) 
hold on 
plot(gauss,'--r') 
xlabel('Rhkl','FontSize',28) 
ylabel('Frequency','FontSize',28) 
set(gca,'FontSize',0.1) 
set(gca,'XTick',(0:1:15),'FontSize',28) 
set(gca,'YTick',(0:2000:12000),'FontSize',28) 
set(gcf,'Color','w') 
hold off 
  
 
